Professor Graeme Milligan

  • Gardiner Chair of Biochemistry (Molecular Biosciences)

telephone: 01413305557
email: graeme.milligan@glasgow.ac.uk

Advanced Research Centre (ARC), Centre for Translational Pharmacology, Level 4, Rm 4121, Glasgow G12 8QQ

Import to contacts

ORCID iDhttps://orcid.org/0000-0002-6946-3519

Biography

Graeme Milligan Ph.D., FRSE, FMEd Sci, FBPharmacolS

Professor Graeme Milligan is Gardiner Professor of Biochemistry, former Dean of Research and current Deputy Head of the College of Medical, Veterinary and Life Sciences at the University of Glasgow. His main research group centres on the function, structure, and regulation of G protein-coupled receptors (GPCRs) and their interacting proteins. His experience also includes translating knowledge generated into selection of targets, screening, and identification of small molecule regulators of these proteins and progressing such ligands in drug development programmes.

Prof. Milligan has published more than 550 peer-reviewed articles and his research has been cited more than 35,000 times. He was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and to the Fellowship of the Academy of Medical Sciences in 2016.

Prof. Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for metabolic diseases including Type 2 Diabetes and other indications including non-alcoholic steatohepatitis (NASH) and inflammatory diseases and of Keltic Pharma Therapeutics (2020) which is developing new treatments for malaria.

Education/Training

  • 1976-1979: University of Birmingham: Graduated with B.Sc. (Hons. 1st class) Biochemistry.
  • 1979-1982: University of Nottingham: Graduated with Ph.D.
  • 1982-1985: Fogarty International Visiting Fellow, National Institute of Mental Health Bethesda, MD. U.S.A.

Current Positions

  • 1994-present: Professor of Molecular Pharmacology, University of Glasgow, Glasgow, Scotland, U.K.
  • 2010-present: Deputy Head of College, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, U.K.
  • 2012-present: Gardiner Professor of Biochemistry, University of Glasgow, Glasgow, Scotland, U.K.
  • I was elected to the Fellowship of the Royal Society of Edinburgh in 1998 and to the Fellowship of the Academy of Medical Sciences in 2016.

Awards

  • The ‘Poulsson’ Medal for Pharmacology: Norwegian Society of Pharmacology and Toxicology. 1998.
  • The Ariens Medal: Dutch Pharmacological Society. 2006
  • The JR Vane Medal for Pharmacology: British Pharmacological Society. 2016

Research interests

Publications

List by: Type | Date

Jump to: 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 1998 | 1993 | 1991 | 1987
Number of items: 331.

2025

Gonzalez-Valdivieso, Juan, Ciccone, Giuseppe, Dhawan, Udesh ORCID logoORCID: https://orcid.org/0000-0002-0393-9414, Quon, Tezz, Barcelona-Estaje, Eva, Rodrigo-Navarro, Aleixandre ORCID logoORCID: https://orcid.org/0000-0002-3786-0464, Castillo, Rafael R., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Rico, Patricia and Salmeron-Sanchez, Manuel ORCID logoORCID: https://orcid.org/0000-0002-8112-2100 (2025) NaBC1 boron transporter enables myoblast response to substrate rigidity via fibronectin-binding integrins. Advanced Science, 12(20), 2407548. (doi: 10.1002/advs.202407548) (PMID:40270477) (PMCID:PMC12120709)

Brettell, Skye B., Cann, Gillian, Begen, Abbey, Sharma, Saumya, Mahindra, Amit, Carruthers, Lauren V. ORCID logoORCID: https://orcid.org/0000-0003-4346-2283, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Clarke, David J., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Jamieson, Andrew G. ORCID logoORCID: https://orcid.org/0000-0003-1726-7353 (2025) Lysine targeting covalent inhibitors of malarial kinase PfCLK3. RSC Medicinal Chemistry, (Accepted for Publication)

Quon, Tezz, Lin, Li-Chiung, Ganguly, Amlan ORCID logoORCID: https://orcid.org/0000-0002-2507-022X, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2025) Biased constitutive signaling of the G protein-coupled receptor GPR35 suppresses gut barrier permeability. Journal of Biological Chemistry, 301(1), 108035. (doi: 10.1016/j.jbc.2024.108035) (PMID:39615676) (PMCID:PMC11732441)

2024

Brettell, S. B. et al. (2024) Targeting PfCLK3 with covalent inhibitors: a novel strategy for malaria treatment. Journal of Medicinal Chemistry, (doi: 10.1021/acs.jmedchem.4c01300) (PMID:39441986) (Early Online Publication)

Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2024) Regulation of the pro-inflammatory G protein-coupled receptor GPR84. British Journal of Pharmacology, 181(10), pp. 1500-1508. (doi: 10.1111/bph.16098) (PMID:37085331)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2024) Editorial for GPR84 Pharmacology. British Journal of Pharmacology, 181(10), pp. 1497-1499. (doi: 10.1111/bph.16340)

Tikhonova, Irina, Zhang, Xuan, Guseinov, Abdul-Akim, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Li, Kunpeng, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Zhang, Cheng (2024) Structural basis for the ligand recognition and signaling of free fatty acid receptors. Science Advances, 10(2), eadj2384. (doi: 10.1126/sciadv.adj2384) (PMID:38198545)

2023

Barki, N. et al. (2023) Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner. eLife, 12, RP91861. (doi: 10.7554/eLife.91861) (PMID:38085667) (PMCID:PMC10715726)

Kalita, M. et al. (2023) PET imaging of innate immune activation using 11C radiotracers targeting GPR84. JACS Au, 3(12), pp. 3297-3310. (doi: 10.1021/jacsau.3c00435) (PMID:38155640) (PMCID:PMC10751761)

Ganguly, A. et al. (2023) G protein-receptor kinases 5/6 are the key regulators of G protein-coupled receptor 35-arrestin interactions. Journal of Biological Chemistry, 299(10), 105218. (doi: 10.1016/j.jbc.2023.105218) (PMID:37660910) (PMCID:PMC10520886)

Zhang, X. et al. (2023) Pro-phagocytic function and structural basis of GPR84 signaling. Nature Communications, 14, 5706. (doi: 10.1038/s41467-023-41201-0) (PMID:37709767) (PMCID:PMC10502086)

Valentini, Alice, Schultz-Knudsen, Katrine, Højgaard Hansen, Anders, Tsakoumagkou, Argyro, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Christensen, Henriette B., Manandhar, Asmita, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Ulven, Trond and Rexen Ulven, Elisabeth (2023) Discovery of potent tetrazole free fatty acid receptor 2 antagonists. Journal of Medicinal Chemistry, 66(9), pp. 6105-6121. (doi: 10.1021/acs.jmedchem.2c01935) (PMID:37129317)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2023) GPR35: from enigma to therapeutic target. Trends in Pharmacological Sciences, 44(5), pp. 263-273. (doi: 10.1016/j.tips.2023.03.001) (PMID:37002007)

Meda Venkata, Sai Pranathi, Li, Hainan, Xu, Liping, Koh, Jia Yi, Nguyen, Huong, Minjares, Morgan, Li, Chunying, Kowluru, Anjaneyulu, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Wang, Jie-Mei (2023) Inhibition of GPR39 restores defects in endothelial cell–mediated neovascularization under the duress of chronic hyperglycemia: evidence for regulatory roles of the sonic hedgehog signaling axis. Proceedings of the National Academy of Sciences of the United States of America, 120(1), e2208541120. (doi: 10.1073/pnas.2208541120) (PMID:36574661) (PMCID:PMC9910611)

2022

Alharbi, Abdulrahman G., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2022) How arrestins and GRKs regulate the function of long chain fatty acid receptors. International Journal of Molecular Sciences, 23(20), 12237. (doi: 10.3390/ijms232012237) (PMID:36293091) (PMCID:PMC9602559)

Mahindra, A. et al. (2022) Investigating the structure–activity relationship of 1,2,4-triazine G-protein-coupled receptor 84 (GPR84) antagonists. Journal of Medicinal Chemistry, 65(16), pp. 11270-11290. (doi: 10.1021/acs.jmedchem.2c00804) (PMID:35948061) (PMCID:PMC9421653)

Marsango, Sara, Barki, Natasja, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2022) Therapeutic validation of an orphan G protein-coupled receptor: the case of GPR84. British Journal of Pharmacology, 179(14), pp. 3529-3541. (doi: 10.1111/bph.15248) (PMID:32869860) (PMCID:PMC9361006)

Marsango, S. et al. (2022) The M1 muscarinic receptor is present in situ as a ligand-regulated mixture of monomers and oligomeric complexes. Proceedings of the National Academy of Sciences of the United States of America, 119(24), e220110311. (doi: 10.1073/pnas.2201103119) (PMID:35671422) (PMCID:PMC9214538)

Caspar, Birgit, Cocchiara, Pietro, Melet, Armelle, Van Emelen, Kristof, Van der Aa, Annegret, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Herbeuval, Jean-Philippe (2022) CXCR4 as a novel target in immunology: moving away from typical antagonists. Future Drug Discovery, 4(2), FDD77. (doi: 10.4155/fdd-2022-0007) (PMID:35875591) (PMCID:PMC9298491)

Marsango, S. et al. (2022) Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands. Journal of Biological Chemistry, 298(5), 101932. (doi: 10.1016/j.jbc.2022.101932) (PMID:35427647) (PMCID:PMC9118924)

Barki, N. et al. (2022) Chemogenetics defines the roles of short chain fatty acid receptors within the gut-brain axis. eLife, 11, e73777. (doi: 10.7554/eLife.73777) (PMID:35229717) (PMCID:PMC8887895)

Divorty, Nina, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Ganguly, Amlan ORCID logoORCID: https://orcid.org/0000-0002-2507-022X, Butcher, Adrian J., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Schulz, Stefan, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2022) Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor. Journal of Biological Chemistry, 298(3), 101655. (doi: 10.1016/j.jbc.2022.101655) (PMID:35101446) (PMCID:PMC8892012)

2021

Scarpa, M. et al. (2021) Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease. Proceedings of the National Academy of Sciences of the United States of America, 118(50), e2107389118. (doi: 10.1073/pnas.2107389118) (PMID:34893539) (PMCID:PMC8685681)

Lin, Li-Chiung, Quon, Tezz, Engberg, Susanna, Mackenzie, Amanda E., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2021) G protein-coupled receptor GPR35 suppresses lipid accumulation in hepatocytes. ACS Pharmacology and Translational Science, 4(6), pp. 1835-1848. (doi: 10.1021/acsptsci.1c00224) (PMID:34927014)

Milligan, G. et al. (2021) Discovery and characterization of novel antagonists of the proinflammatory orphan receptor GPR84. ACS Pharmacology and Translational Science, 4(5), pp. 1598-1613. (doi: 10.1021/acsptsci.1c00151) (PMID:34661077) (PMCID:PMC8506611)

Boleij, A. et al. (2021) G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis. Communications Biology, 4, 585. (doi: 10.1038/s42003-021-02014-3) (PMID:33990686) (PMCID:PMC8121840)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Barki, Natasja and Tobin, Andrew ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 (2021) Chemogenetic approaches to explore the functions of Free Fatty Acid Receptor 2. Trends in Pharmacological Sciences, 42(3), pp. 191-202. (doi: 10.1016/j.tips.2020.12.003) (PMID:33495026)

Bolognini, Daniele, Dedeo, Domonkos ORCID logoORCID: https://orcid.org/0000-0003-3796-1713 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2021) Metabolic and inflammatory functions of short-chain fatty acid receptors. Current Opinion in Endocrine and Metabolic Research, 16, pp. 1-9. (doi: 10.1016/j.coemr.2020.06.005) (PMID:32835130) (PMCID:PMC7332907)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Marsango, Sara, Jolly, Richard, Stoneman, Michael R., Biener, Gabriel, Handel, Tracy M., Raicu, Valerica and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2021) Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t. Journal of Biological Chemistry, 296, 100139. (doi: 10.1074/jbc.RA120.016612) (PMID:33268380)

2020

Marti-Solano, M. et al. (2020) Combinatorial expression of GPCR isoforms affects signalling and drug responses. Nature, 587, pp. 650-656. (doi: 10.1038/s41586-020-2888-2) (PMID:33149304)

Labéguère, F. et al. (2020) Discovery of 9-Cyclopropylethynyl-2-((S)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one (GLPG1205), a unique GPR84 negative allosteric modulator undergoing evaluation in a phase II clinical trial. Journal of Medicinal Chemistry, 63(22), pp. 13526-13545. (doi: 10.1021/acs.jmedchem.0c00272) (PMID:32902984)

Prihandoko, R. et al. (2020) Pathophysiological regulation of lung function by the free fatty acid receptor FFA4. Science Translational Medicine, 12(557), eaaw9009. (doi: 10.1126/scitranslmed.aaw9009) (PMID:32817367)

Quon, Tezz, Lin, Li-Chiung, Ganguly, Amlan ORCID logoORCID: https://orcid.org/0000-0002-2507-022X, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2020) Therapeutic opportunities and challenges in targeting the orphan G protein-coupled receptor GPR35. ACS Pharmacology and Translational Science, 3(5), pp. 801-812. (doi: 10.1021/acsptsci.0c00079) (PMID:33073184)

Rexen Ulven, E. et al. (2020) Structure-activity relationship studies of tetrahydroquinolone free fatty acid receptor 3 modulators. Journal of Medicinal Chemistry, 63(7), pp. 3577-3595. (doi: 10.1021/acs.jmedchem.9b02036) (PMID:32141297) (PMCID:PMC7307922)

Sencio, V. et al. (2020) Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. Cell Reports, 30(9), 2934-2947.e6. (doi: 10.1016/j.celrep.2020.02.013) (PMID:32130898)

2019

Heuninck, J. et al. (2019) Context-dependent signaling of CXC chemokine receptor 4 and atypical chemokine receptor 3. Molecular Pharmacology, 96(6), pp. 778-793. (doi: 10.1124/mol.118.115477) (PMID:31092552)

Stoneman, Michael R., Biener, Gabriel, Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Badu, Dammar, Eis, Annie, Popa, Ionel, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Raicu, Valerică (2019) A general method to quantify ligand-driven oligomerization from fluorescence-based images. Nature Methods, 16(6), pp. 493-496. (doi: 10.1038/s41592-019-0408-9) (PMID:31110281)

Bolognini, D. et al. (2019) Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Nature Chemical Biology, 15(5), pp. 489-498. (doi: 10.1038/s41589-019-0270-1) (PMID:30992568)

Mackenzie, Amanda E., Quon, Tezz, Lin, Li-Chiung, Hauser, Alexander S., Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Inoue, Asuka, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Gloriam, David E., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2019) Receptor selectivity between the G proteins Gα12 and Gα13 is defined by a single leucine-to-isoleucine variation. FASEB Journal, 33(4), pp. 5005-5017. (doi: 10.1096/fj.201801956R) (PMID:30601679) (PMCID:PMC6436656)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Ward, Richard J. and Marsango, Sara (2019) GPCR homo-oligomerization. Current Opinion in Cell Biology, 57, pp. 40-47. (doi: 10.1016/j.ceb.2018.10.007) (PMID:30453145) (PMCID:PMC7083226)

Mancini, Sarah, Mahmud, Zobaer Al, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Bolognini, Daniele, Newman, Robert, Barnes, Matt, Edye, Michelle E., McMahon, Stephen B., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2019) On-target and off-target effects of novel orthosteric and allosteric activators of GPR84. Scientific Reports, 9, 1861. (doi: 10.1038/s41598-019-38539-1) (PMID:30755705) (PMCID:PMC6372602)

Müskens, Frederike M., Ward, Richard J., Herkt, Dominik, van de Langemheen, Helmus, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Liskamp, Rob M.J. ORCID logoORCID: https://orcid.org/0000-0001-8897-8975 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2019) Design, synthesis and evaluation of a diazirine photoaffinity probe for ligand-based receptor capture targeting G protein-coupled receptors. Molecular Pharmacology, 95(2), pp. 196-209. (doi: 10.1124/mol.118.114249) (PMID:30514721) (PMCID:PMC6324650)

2018

Kennedy, Amanda J., Ballante, Flavio, Johansson, Johan R., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Sunström, Linda, Nordqvist, Anneli and Carlsson, Jens (2018) Structural characterization of agonist binding to protease-activated receptor 2 through mutagenesis and computational modeling. ACS Pharmacology and Translational Science, 1(2), pp. 119-133. (doi: 10.1021/acsptsci.8b00019)

Hansen, Anders Højgaard, Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693, Bolognini, Daniele, Sprenger, Richard R., Ekberg, Jeppe Hvidtfeldt, Ejsing, Christer S., McKenzie, Christine J., Rexen Ulven, Elisabeth, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2018) Discovery of a potent thiazolidine free fatty acid receptor 2 agonist with favorable pharmacokinetic properties. Journal of Medicinal Chemistry, 61(21), pp. 9534-9550. (doi: 10.1021/acs.jmedchem.8b00855) (PMID:30247908)

Drew, J. E. et al. (2018) Dietary fibers inhibit obesity in mice, but host responses in the cecum and liver appear unrelated to fiber-specific changes in cecal taxonomic composition. Scientific Reports, 8, 15566. (doi: 10.1038/s41598-018-34081-8) (PMID:30349136) (PMCID:PMC6197265)

Divorty, Nina, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Graham, Delyth ORCID logoORCID: https://orcid.org/0000-0002-7328-4708 and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2018) The orphan receptor GPR35 contributes to angiotensin II–induced hypertension and cardiac dysfunction in mice. American Journal of Hypertension, 31(9), pp. 1049-1058. (doi: 10.1093/ajh/hpy073) (PMID:29860395) (PMCID:PMC6077831)

Marsango, Sara, Ward, Richard J., Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2018) Muscarinic receptor oligomerization. Neuropharmacology, 136(Part C), pp. 401-410. (doi: 10.1016/j.neuropharm.2017.11.023) (PMID:29146505) (PMCID:PMC6078712)

Binti Mohd Amir, Nurul A.S., Mackenzie, Amanda E., Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Boustani, Karim, Hillier, Marston C., Tsuchiya, Tomoko, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Pease, James E. (2018) Evidence for the existence of a CXCL17 receptor distinct from GPR35. Journal of Immunology, 201(2), pp. 714-724. (doi: 10.4049/jimmunol.1700884) (PMID:29875152) (PMCID:PMC6036231)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2018) G protein-coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35. British Journal of Pharmacology, 175(13), pp. 2543-2553. (doi: 10.1111/bph.14042) (PMID:28940377) (PMCID:PMC6003633)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Inoue, Asuka (2018) Genome editing provides new insights into receptor-controlled signalling pathways. Trends in Pharmacological Sciences, 39(5), pp. 481-493. (doi: 10.1016/j.tips.2018.02.005) (PMID:29548548)

Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Ward, Richard J., Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2018) Spatial intensity distribution analysis: studies of G Protein-coupled receptor oligomerization. Trends in Pharmacological Sciences, 39(2), pp. 175-186. (doi: 10.1016/j.tips.2017.09.001) (PMID:29032835) (PMCID:PMC5783713)

Reichardt, N. et al. (2018) Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production. ISME Journal, 12, pp. 610-622. (doi: 10.1038/ismej.2017.196) (PMID:29192904)

2017

Mahmud, Zobaer Al, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Ulven, Trond, Labéguère, Frédéric, Gosmini, Romain, De Vos, Steve, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Tikhonova, Irina G. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84. Scientific Reports, 7, 17953. (doi: 10.1038/s41598-017-18159-3) (PMID:29263400) (PMCID:PMC5738391)

Viskaitis, P. et al. (2017) Modulation of SF1 neuron activity coordinately regulates both feeding behaviour and associated emotional states. Cell Reports, 21(12), pp. 3559-3572. (doi: 10.1016/j.celrep.2017.11.089) (PMID:29262334) (PMCID:PMC5746599)

Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693, Hansen, Anders Højgaard, Bolognini, Daniele, Kawakami, Kouki, Kishi, Takayuki, Aoki, Junken, Ulven, Trond, Inoue, Asuka, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias. Scientific Reports, 7, 13741. (doi: 10.1038/s41598-017-14096-3) (PMID:29061999) (PMCID:PMC5653858)

Herrick-Davis, Katharine, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Di Giovanni, Giuseppe (Eds.) (2017) G-Protein-Coupled Receptor Dimers. Series: Receptors. Humana Press: Cham. ISBN 9783319601724

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Prihandoko, Rudi and Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 (2017) FFA4/GPR120: pharmacology and therapeutic opportunities. Trends in Pharmacological Sciences, 38(9), pp. 809-821. (doi: 10.1016/j.tips.2017.06.006) (PMID:28734639) (PMCID:PMC5582618)

Ward, Richard J., Marsango, Sara, Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) The use of spatial intensity distribution analysis to examine G protein-coupled receptor oligomerization. In: Herrick-Davis, Katharine, Milligan, Graeme and Di Giovanni, Giuseppe (eds.) G-Protein-Coupled Receptor Dimers. Series: Receptors (33). Humana Press: Cham, pp. 15-38. ISBN 9783319601724 (doi: 10.1007/978-3-319-60174-8_2)

Prokop, Susanne, Perry, Nicole A., Vishnivetskiy, Sergey A., Toth, Andras D., Inoue, Asuka, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Iverson, Tina M., Hunyady, Laszlo and Gurevich, Vsevolod V. (2017) Differential manipulation of arrestin-3 binding to basal and agonist-activated G protein-coupled receptors. Cellular Signalling, 36, pp. 98-107. (doi: 10.1016/j.cellsig.2017.04.021) (PMID:28461104)

Lopez-Gimenez, Juan, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) M3 muscarinic acetylcholine receptor facilitates the endocytosis of mu opioid receptor mediated by morphine independently of the formation of heteromeric complexes. Cellular Signalling, 35, pp. 208-222. (doi: 10.1016/j.cellsig.2017.04.006) (PMID:28411124)

Kaspersen, Mads Holmgaard, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Dunlop, Julia ORCID logoORCID: https://orcid.org/0000-0003-3180-6763, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2017) Succinct synthesis of saturated hydroxy fatty acids and in vitro evaluation of all hydroxylauric acids on FFA1, FFA4 and GPR84. MedChemComm, 8(6), pp. 1360-1365. (doi: 10.1039/c7md00130d)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Harikumar, Kaleeckal G., Miller, Laurence J. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) Spatial intensity distribution analysis quantifies the extent and regulation of homodimerization of the secretin receptor. Biochemical Journal, 474(11), pp. 1879-1895. (doi: 10.1042/BCJ20170184) (PMID:28424368) (PMCID:PMC5442643)

Watterson, K. R. et al. (2017) Probe-dependent negative allosteric modulators of the long-chain free fatty acid receptor FFA4. Molecular Pharmacology, 91(6), pp. 630-641. (doi: 10.1124/mol.116.107821) (PMID:28385906) (PMCID:PMC5438128)

Marsango, Sara, Caltabiano, Gianluigi, Jiménez-Rosés, Mireia, Millan, Mark J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Ward, Richard J. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) A molecular basis for selective antagonist destabilization of dopamine D3 receptor quaternary organization. Scientific Reports, 7, 2134. (doi: 10.1038/s41598-017-02249-3) (PMID:28522847) (PMCID:PMC5437050)

Houthuijzen, J. M. et al. (2017) Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance. FASEB Journal, 31(5), pp. 2195-2209. (doi: 10.1096/fj.201601248R) (PMID:28183801) (PMCID:PMC5388545)

Mackenzie, Amanda E. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) The emerging pharmacology and function of GPR35 in the nervous system. Neuropharmacology, 113(part B), pp. 661-671. (doi: 10.1016/j.neuropharm.2015.07.035) (PMID:26232640)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kimura, Ikuo (Eds.) (2017) Free Fatty Acid Receptors. Series: Handbook of experimental pharmacology. Springer International Publishing. ISBN 9783319506920

Hansen, Anders Højgaard, Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693, Pandey, Sunil K., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Christiansen, Elisabeth, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2017) Development and characterization of a fluorescent tracer for the free fatty acid receptor 2 (FFA2/GPR43). Journal of Medicinal Chemistry, 60(13), pp. 5638-5645. (doi: 10.1021/acs.jmedchem.7b00338) (PMID:28570808)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Bolognini, Daniele and Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693 (2017) Ligands at the free fatty acid receptors 2/3 (GPR43/GPR41). In: Milligan, Graeme and Kimura, Ikuo (eds.) Free Fatty Acid Receptors. Series: Handbook of experimental pharmacology (236). Springer International Publishing, pp. 17-32. ISBN 9783319506920 (doi: 10.1007/164_2016_49)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Shimpukade, Bharat, Ulven, Trond and Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 (2017) Complex pharmacology of free fatty acid receptors. Chemical Reviews, 117(1), pp. 67-110. (doi: 10.1021/acs.chemrev.6b00056) (PMID:27299848)

2016

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Inoue, Asuka, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Raihan, Sheikh Zahir, Prihandoko, Rudi, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Targeted elimination of G proteins and arrestins defines their specific contributions to both intensity and duration of G protein-coupled receptor signalling. Journal of Biological Chemistry, 291(53), pp. 27147-27159. (doi: 10.1074/jbc.M116.754887) (PMID:27852822) (PMCID:PMC5207144)

Azevedo, C. M. G. et al. (2016) Non-acidic free fatty acid receptor 4 agonists with antidiabetic activity. Journal of Medicinal Chemistry, 59(19), pp. 8868-8878. (doi: 10.1021/acs.jmedchem.6b00685)

Bolognini, D. et al. (2016) A novel allosteric activator of free fatty acid 2 receptor displays unique Gi-functional bias. Journal of Biological Chemistry, 291, pp. 18915-18931. (doi: 10.1074/jbc.M116.736157) (PMID:27385588) (PMCID:PMC5009265)

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Metabolism meets immunity: the role of free fatty acid receptors in the immune system. Biochemical Pharmacology, 114, pp. 3-13. (doi: 10.1016/j.bcp.2016.03.017) (PMID:27002183)

Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Ward, Richard J., Godin, Antoine G., Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Dynamic regulation of quaternary organization of the M1 muscarinic receptor by subtype-selective antagonist drugs. Journal of Biological Chemistry, 291, pp. 13132-13146. (doi: 10.1074/jbc.M115.712562) (PMID:27080256) (PMCID:PMC4933229)

Nuber, Susanne, Zabel, Ulrike, Lorenz, Kristina, Nuber, Andreas, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Lohse, Martin J. and Hoffmann, Carsten (2016) β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle. Nature, 531, pp. 661-664. (doi: 10.1038/nature17198) (PMID:27007855)

Hansen, S. V.F. et al. (2016) Discovery of a potent free fatty acid 1 receptor agonist with low lipophilicity, low polar surface area and robust in vivo efficacy. Journal of Medicinal Chemistry, 59, pp. 2841-2846. (doi: 10.1021/acs.jmedchem.5b01962)

Grundmann, Manuel, Tikhonova, Irina G., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Smith, Nicola J., Mohr, Klaus, Ulven, Trond, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Kenakin, Terry and Kostenis, Evi (2016) A molecular mechanism for sequential activation of a G Protein-coupled receptor. Cell Chemical Biology, 23(3), pp. 392-403. (doi: 10.1016/j.chembiol.2016.02.014) (PMID:26991104)

Bolognini, Daniele, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Moss, Catherine E. (2016) The pharmacology and function of receptors for short-chain fatty acids. Molecular Pharmacology, 89(3), pp. 388-398. (doi: 10.1124/mol.115.102301) (PMID:26719580)

Moreno, J. L. et al. (2016) Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia. Science Signaling, 9(410), ra5. (doi: 10.1126/scisignal.aab0467) (PMID:26758213) (PMCID:PMC4819166)

Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693, Hansen, Anders Højgaard, Pandey, Sunil K., MacKenzie, Amanda E., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Ulven, Trond and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Non-equivalence of key positively charged residues of the free fatty acid 2 receptor in the recognition and function of agonist versus antagonist ligands. Journal of Biological Chemistry, 291, pp. 303-317. (doi: 10.1074/jbc.M115.687939) (PMID:26518871) (PMCID:PMC4697166)

Christiansen, Elisabeth, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Hansen, Anders Højgaard, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2016) Development and characterization of a potent free fatty acid receptor 1 (FFA1) fluorescent tracer. Journal of Medicinal Chemistry, 59(10), pp. 4849-4858. (doi: 10.1021/acs.jmedchem.6b00202) (PMID:27074625)

McCallum, Jennifer E., Mackenzie, Amanda E., Divorty, Nina, Clarke, Carolyn, Delles, Christian ORCID logoORCID: https://orcid.org/0000-0003-2238-2612, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2016) G protein-coupled receptor 35 mediates human saphenous vein vascular smooth muscle cell migration and endothelial cell proliferation. Journal of Vascular Research, 52(6), pp. 383-395. (doi: 10.1159/000444754) (PMID:27064272) (PMCID:PMC4959467)

Prihandoko, Rudi, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Butcher, Adrian J., Ulven, Trond, Miller, Ashley M., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Distinct phosphorylation clusters determines the signalling outcome of the free fatty acid receptor FFA4/GPR120. Molecular Pharmacology, 89(5), pp. 505-520. (doi: 10.1124/mol.115.101949) (PMID:26873857)

2015

Schrage, R. et al. (2015) The experimental power of FR900359 to study Gq-regulated biological processes. Nature Communications, 6, p. 10156. (doi: 10.1038/ncomms10156) (PMID:26658454) (PMCID:PMC4682109)

Brown, J.H., Catterall, W.A., Conn, P.J., Cull-Candy, S.G., Dingledine, R., Harden, T.K., Insel, P.A., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Traynelis, S.F. (2015) The first 50 years of molecular pharmacology. Molecular Pharmacology, 88(1), pp. 139-140. (doi: 10.1124/mol.115.099564) (PMID:25943115)

Mckinney, C.A., Kennedy, S. ORCID logoORCID: https://orcid.org/0000-0003-0887-5840, Baillie, G.S. ORCID logoORCID: https://orcid.org/0000-0003-2469-6316, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, S.A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2015) Angiotensin-(1-7) and angiotensin-(1-9) inhibit vascular smooth muscle cell growth and migration in vitro and vascular remodelling in vivo. Atherosclerosis, 241(1), e44. (doi: 10.1016/j.atherosclerosis.2015.04.158)

Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Alvarez-Curto, E. ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Watterson, K.R. ORCID logoORCID: https://orcid.org/0000-0003-3819-4026, Ulven, T. and Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 (2015) Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4. British Journal of Pharmacology, 172(13), pp. 3254-3265. (doi: 10.1111/bph.12879) (PMID:25131623)

Marsango, Sara, Caltabiano, Gianluigi, Pou, Chantevy, Varela Liste, Maria Jose and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Analysis of human dopamine D3 receptor quaternary structure. Journal of Biological Chemistry, 290, pp. 15146-15162. (doi: 10.1074/jbc.M114.630681) (PMID:25931118) (PMCID:PMC4463457)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Liste, María José Varela, Caltabiano, Gianluigi Caltabiano, Alvarez-Curto, Elisa and Marsango, Sara (2015) Defining the organizational structure of dopamine and muscarninic acetylcholine receptors. SpringerPlus, 4(Sup 1), L7. (doi: 10.1186/2193-1801-4-s1-l7) (PMID:27386224) (PMCID:PMC4796694)

Aslanoglou, Despoina, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Distinct agonist regulation of muscarinic acetylcholine M2-M3 heteromers and their corresponding homomers. Journal of Biological Chemistry, 290(23), pp. 14785-14796. (doi: 10.1074/jbc.M115.649079) (PMID:25918156) (PMCID:PMC4505543)

Christiansen, E. et al. (2015) Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases. British Journal of Nutrition, 113(11), pp. 1677-1688. (doi: 10.1017/S000711451500118X) (PMID:25916176)

Liste, Maria J., Caltabiano, Gianluigi, Ward, Richard J., Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) The molecular basis of oligomeric organization of the human m3 muscarinic acetylcholine receptor. Molecular Pharmacology, 87(6), pp. 936-953. (doi: 10.1124/mol.114.096925) (PMID:25769304)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Godin, Antoine G. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Regulation of oligomeric organization of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor observed by spatial intensity distribution analysis. Journal of Biological Chemistry, 290(20), pp. 12844-12857. (doi: 10.1074/jbc.M115.644724) (PMID:25825490) (PMCID:PMC4432300)

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Defining the functional equivalence of wild-type and chemically engineered G protein-coupled receptors. In: Thiel, Gerald (ed.) Designer Receptors Exclusively Activated by Designer Drugs. Series: Neuromethods (108). Springer New York, pp. 1-28. ISBN 9781493929436 (doi: 10.1007/978-1-4939-2944-3_1)

Divorty, Nina, Mackenzie, Amanda, Nicklin, Stuart ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease. Frontiers in Pharmacology, 6, 41. (doi: 10.3389/fphar.2015.00041) (PMID:25805994) (PMCID:PMC4354270)

Marsango, Sara, Varela, María José and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Approaches to characterize and quantify oligomerization of GPCRs. In: Filizola, Marta (ed.) G Protein-Coupled Receptors in Drug Discovery. Series: Methods in Molecular Biology, 1335 (1335). Springer New York, pp. 95-105. ISBN 9781493929139 (doi: 10.1007/978-1-4939-2914-6_7)

2014

Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Christiansen, Elisabeth, Murdoch, Hannah, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Hansen, Anders Højgaard, Madsen, Ole, Ulven, Trond and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2014) Complex pharmacology of novel allosteric free fatty acid 3 receptor ligands. Molecular Pharmacology, 86(2), pp. 200-210. (doi: 10.1124/mol.114.093294)

Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Shimpukade, Bharat, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2014) The molecular basis of ligand interaction at free fatty acid receptor 4 (FFA4/GPR120). Journal of Biological Chemistry, 289, pp. 20345-20358. (doi: 10.1074/jbc.M114.561449) (PMID:24860101) (PMCID:PMC4106347)

Zakrys, Linas, Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Godin, Antoine G., Graham, Gerard J. ORCID logoORCID: https://orcid.org/0000-0002-7801-204X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2014) Roundabout 1 exists predominantly as a basal dimeric complex and this is unaffected by binding of the ligand Slit2. Biochemical Journal, 461(1), pp. 61-73. (doi: 10.1042/BJ20140190)

Butcher, Adrian J., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Shimpukade, Bharat, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Prihandoko, Rudi, Ulven, Trond, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 (2014) Concomitant action of structural elements and receptor phosphorylation determine arrestin-3 interaction with the free fatty acid receptor FFA4. Journal of Biological Chemistry, 289, pp. 18451-18465. (doi: 10.1074/jbc.M114.568816) (PMID:24817122) (PMCID:PMC4140278)

Fjaere, E. et al. (2014) Indomethacin treatment prevents high fat diet-induced obesity and insulin resistance but not glucose intolerance in C57BL/6J mice. Journal of Biological Chemistry, 289(23), pp. 16032-16045. (doi: 10.1074/jbc.M113.525220)

McKinney, Clare A., Fattah, Caroline, Loughrey, Christopher M. ORCID logoORCID: https://orcid.org/0000-0003-1297-9159, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2014) Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodeling. Clinical Science, 126, pp. 815-827. (doi: 10.1042/CS20130436)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Ulven, Trond, Murdoch, Hannah and Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 (2014) G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets. British Journal of Nutrition, 111(S1), S3-S7. (doi: 10.1017/S0007114513002249)

Ferre, Sergi, Casado, Vicent, Devi, Lakshmi A., Filizola, Marta, Jockers, Ralf, Lohse, Martin J., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Pin, Jean-Philippe and Guitart, Xavier (2014) G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacological Reviews, 66(2), pp. 413-434. (doi: 10.1124/pr.113.008052)

Ward, R.J. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2014) Structural and biophysical characterisation of G protein-coupled receptor ligand binding using resonance energy transfer and fluorescent labelling techniques. Biochimica et Biophysica Acta: Biomembranes, 1838(1A), pp. 3-14. (doi: 10.1016/j.bbamem.2013.04.007)

Mackenzie, A.E. et al. (2014) The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat gpr35. Molecular Pharmacology, 85(1), pp. 91-104. (doi: 10.1124/mol.113.089482)

Watterson, Kenneth R. ORCID logoORCID: https://orcid.org/0000-0003-3819-4026, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Ulven, Trond and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2014) Treatment of type 2 diabetes by free fatty acid receptor agonists. Frontiers in Endocrinology, 5, 137. (doi: 10.3389/fendo.2014.00137) (PMID:25221541) (PMCID:PMC4147718)

2013

Horobin, R.W. ORCID logoORCID: https://orcid.org/0000-0002-6612-6664, Rashid-Doubell, F., Pediani, J.D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) Predicting small molecule fluorescent probe localization in living cells using QSAR modeling. 1. Overview and models for probes of structure, properties and function in single cells. Biotechnic and Histochemistry, 88(8), pp. 440-460. (doi: 10.3109/10520295.2013.780634)

Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Shimpukade, B., Mackenzie, A.E., Butcher, A.J., Pediani, J.D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Christiansen, E., Heathcote, H., Tobin, A.B., Ulven, T. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Molecular Pharmacology, 84(5), pp. 710-725. (doi: 10.1124/mol.113.087783)

Perez-Aso, M., Segura, V., Montó, F., Barettino, D., Noguera, M.A., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and D'Ocon, P. (2013) The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation. Biochimica et Biophysica Acta: Molecular Cell Research, 1833(10), pp. 2322-2333. (doi: 10.1016/j.bbamcr.2013.06.013)

Scott, Elizabeth, Loya, Komal, Mountford, Joanne, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Baker, Andrew H. (2013) MicroRNA regulation of endothelial homeostasis and commitment—implications for vascular regeneration strategies using stem cell therapies. Free Radical Biology and Medicine, 64, pp. 52-60. (doi: 10.1016/j.freeradbiomed.2013.04.037)

Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Murdoch, H. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) The effects of species ortholog and SNP variation on receptors for free fatty acids. Molecular Endocrinology, 27(8), pp. 1177-1187. (doi: 10.1210/me.2013-1085)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization. Molecular Pharmacology, 84(1), pp. 158-169. (doi: 10.1124/mol.113.084780)

Hudson, B.D. et al. (2013) Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor. Journal of Biological Chemistry, 288(24), pp. 17296-17312. (doi: 10.1074/jbc.M113.455337)

Christiansen, E. et al. (2013) Discovery of TUG-770: a highly potent free fatty acid receptor 1 (FFA1/GPR40) agonist for treatment of type 2 diabetes. ACS Medicinal Chemistry Letters, 4(5), pp. 441-445. (doi: 10.1021/ml4000673)

Neetoo-Isseljee, Z., MacKenzie, A.E., Southern, C., Jerman, J., McIver, E. G., Harries, N., Taylor, D. L. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) High-throughput identification and characterization of novel, species-selective GPR35 agonists. Journal of Pharmacology and Experimental Therapeutics, 344(3), pp. 568-578. (doi: 10.1124/jpet.112.201798)

Christiansen, E. et al. (2013) Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability. Journal of Medicinal Chemistry, 56(3), pp. 982-992. (doi: 10.1021/jm301470a)

Clarke, Carolyn, Flores-Muñoz, Monica, McKinney, Clare A., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2013) Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin–angiotensin system. Future Cardiology, 9(1), pp. 23-38. (doi: 10.2217/fca.12.75)

Howard, Lynsey, MacKenzie, Ruth M., Pchelintsev, Nikolay A., McBryan, Tony, McClure, John D. ORCID logoORCID: https://orcid.org/0000-0003-4839-5462, McBride, Martin W. ORCID logoORCID: https://orcid.org/0000-0002-6323-124X, Kane, Nicole M., Adams, Peter D., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Baker, Andrew H. (2013) Profiling of transcriptional and epigenetic changes during directed endothelial differentiation of human embryonic stem cells identifies FOXA2 as a marker of early mesoderm commitment. Stem Cell Research and Therapy, 4(2), Art. 36. (doi: 10.1186/scrt192)

Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Ulven, Trond and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs. Current Topics in Medicinal Chemistry, 13(1), pp. 14-25. (doi: 10.2174/1568026611313010004)

Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Harries, N., Lappin, J.E., MacKenzie, A.E., Neetoo-Isseljee, Z., Southern, C., McIver, E.G., Nicklin, S.A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210, Taylor, D.L. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) Antagonists of GPR35 display high species ortholog selectivity and varying modes of action. Journal of Pharmacology and Experimental Therapeutics, 343(3), pp. 683-695. (doi: 10.1124/jpet.112.198945) (PMID:22967846) (PMCID:PMC3500541)

Mackenzie, Amanda Elaine, Neetoo-Isseljee, Zaynab, Southern, Craig, Jerman, Jeff, McIver, Edward G., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Taylor, Debra L. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) Novel and potent GPR35 agonists aid identification of residues important in ligand interaction. FASEB Journal, 27, 655.1.

Patowary, S., Alvarez-Curto, E. ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Xu, T.-R., Holz, J.D., Oliver, J.A., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Raicu, V. (2013) The muscarinic M3acetylcholine receptor exists as two differently sized complexes at the plasma membrane. Biochemical Journal, 452(2), pp. 303-312. (doi: 10.1042/BJ20121902) (PMID:23521066)

Segura, V., Pérez-Aso, M., Montó, F., Carceller, E., Noguera, M.A., Pediani, J. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, McGrath, I.C. ORCID logoORCID: https://orcid.org/0000-0002-5276-0381 and D’Ocon, P. (2013) Differences in the signaling pathways of α1A- and α1B-adrenoceptors are related to different endosomal targeting. PLoS ONE, 8(5), e64996. (doi: 10.1371/journal.pone.0064996) (PMID:23717684) (PMCID:PMC3663791)

Ward, R.W., Xu, T.-X. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) GPCR oligomerization and receptor trafficking. Methods in Enzymology, 521, pp. 69-90. (doi: 10.1016/B978-0-12-391862-8.00004-1)

2012

Moreno, J.L. et al. (2012) Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A{middle dot}mGlu2) receptor heteromerization and its psychoactive behavioral function. Journal of Biological Chemistry, 287(53), pp. 44301-44319. (doi: 10.1074/jbc.M112.413161)

Hudson, B. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Christiansen, E., Tikhonova, I.G., Grundmann, M., Kostenis, E., Adams, D.R., Ulven, T. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB Journal, 26(12), pp. 4951-4965. (doi: 10.1096/fj.12-213314)

Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Tikhonova, I.G., Pandey, S.K., Ulven, T. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3. Journal of Biological Chemistry, 287(49), pp. 41195-41209. (doi: 10.1074/jbc.M112.396259)

Christiansen, E. et al. (2012) Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties. Journal of Medicinal Chemistry, 55(14), pp. 6624-6628. (doi: 10.1021/jm3002026)

Cunningham, Margaret R., McIntosh, Kathryn A., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Robben, Joris, Cooke, Alexandra E., Nilsson, Mary, Gould, Gwyn W. ORCID logoORCID: https://orcid.org/0000-0001-6571-2875, Mundell, Stuart, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Plevin, Robin (2012) Novel role for proteinase-activated receptor 2 (PAR2) in membrane trafficking of proteinase-activated receptor 4 (PAR4). Journal of Biological Chemistry, 287(20), pp. 16656-16669. (doi: 10.1074/jbc.M111.315911)

Shimpukade, B., Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Hogaard, C.K., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, T. (2012) Discovery of a potent and selective GPR120 agonist. Journal of Medicinal Chemistry, 55(9), pp. 4511-4515. (doi: 10.1021/jm300215x)

Xu, Tian-Rui, Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation. Journal of Biological Chemistry, 287, pp. 14937-14949. (doi: 10.1074/jbc.M111.334300)

Kane, N. M. et al. (2012) Role of MicroRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells, 30(4), pp. 643-654. (doi: 10.1002/stem.1026)

White, Katie, Kane, Nicole M., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Baker, Andrew H. (2012) The role of miRNA in stem cell pluripotency and commitment to the vascular endothelial lineage. Microcirculation, 19(3), pp. 196-207. (doi: 10.1111/j.1549-8719.2012.00161.x)

Xu, Tian-Rui, Lu, Rui-Fang, Romano, David, Pitt, Andrew, Houslay, Miles D., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kolch, Walter (2012) Eukaryotic translation initiation factor 3, subunit a, regulates the extracellular signal-regulated kinase pathway. Molecular and Cellular Biology, 32(1), pp. 88-95. (doi: 10.1128/​MCB.05770-11)

Flores, M., Graham, D. ORCID logoORCID: https://orcid.org/0000-0002-7328-4708, Dominiczak, A.F. ORCID logoORCID: https://orcid.org/0000-0003-4913-3608, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Baker, A.H. and Nicklin, S.A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2012) Angiotensin-(1-9) antagonises Angiotensin II-induced cardiac remodeling via the angiotensin type 2 receptor. Proceedings of the Physiological Society, 27, C1.

Flores, Monica, Graham, Delyth ORCID logoORCID: https://orcid.org/0000-0002-7328-4708, Dominiczak, Anna F. ORCID logoORCID: https://orcid.org/0000-0003-4913-3608, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Baker, Andrew H. and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2012) Abstract 231: angiotensin-(1-9) antagonises cardiac remodelling in a mouse model of Angiotensin Ii-induced hypertension. Hypertension, 60, A231.

Georgoussi, Z., Georganta, E.M. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) The other side of opioid receptor signalling: regulation by protein-protein interaction. Current Drug Targets, 13(1), pp. 80-102. (doi: 10.2174/138945012798868470)

Laarman, A.J. et al. (2012) Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis. EMBO Journal, 31(17), pp. 3607-3619. (doi: 10.1038/emboj.2012.212)

Pou, C., Mannoury la Cour, C., Stoddart, L.A., Millan, M.J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface. Journal of Biological Chemistry, 287(12), pp. 8864-8878. (doi: 10.1074/jbc.M111.326678)

Terhzaz, S. ORCID logoORCID: https://orcid.org/0000-0002-6192-6558, Cabrero, P. ORCID logoORCID: https://orcid.org/0000-0003-2141-7852, Robben, J.H., Radford, J.C., Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Dow, J.A.T. ORCID logoORCID: https://orcid.org/0000-0002-9595-5146 and Davies, S.A. ORCID logoORCID: https://orcid.org/0000-0002-0472-1302 (2012) Mechanism and function of drosophila capa GPCR: a desiccation stress-responsive receptor with functional homology to human neuromedinU receptor. PLoS ONE, 7(1), e29897. (doi: 10.1371/journal.pone.0029897) (PMID:22253819) (PMCID:PMC3256212)

2011

Mackenzie, A.E., Lappin, J.E., Taylor, D.L., Nicklin, S.A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) GPR35 as a novel therapeutic target. Frontiers in Endocrinology, 2, 68. (doi: 10.3389/fendo.2011.00068) (PMID:22654822) (PMCID:PMC3356001)

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Prihandoko, Rudi, Tautermann, Christofer S., Zwier, Jurriaan M., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Lohse, Martin J., Hoffmann, Carsten, Tobin, Andrew B. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a Receptor Activated Solely by Synthetic Ligand (RASSL). Molecular Pharmacology, 80(6), pp. 1033-1046. (doi: 10.1124/mol.111.074674) (PMID:21880827) (PMCID:PMC3228535)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Heteromultimerization of cannabinoid CB1 receptor and orexin OX1 receptor generates a unique complex in which both protomers are regulated by orexin A. Journal of Biological Chemistry, 286(43), pp. 37414-37428. (doi: 10.1074/jbc.M111.287649)

Howard, Lynsey, Kane, Nicole, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Baker, Andrew H. (2011) MicroRNAs regulating cell pluripotency and vascular differentiation. Vascular Pharmacology, 55(4), pp. 69-78. (doi: 10.1016/j.vph.2011.08.002)

Xu, Tian‑Rui, Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) The orexin OX1 receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands. Biochemical Journal, 439(1), pp. 171-183. (doi: 10.1042/BJ20110230)

Van Lith, Marcel, Tiwari, Shweta, Pediani, John ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Bulleid, Neil J. ORCID logoORCID: https://orcid.org/0000-0002-9839-5279 (2011) Real-time monitoring of redox changes in the mammalian endoplasmic reticulum. Journal of Cell Science, 124(14), pp. 2349-2356. (doi: 10.1242/jcs.085530)

Smith, N.J. et al. (2011) Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator. Molecular Pharmacology, 80(1), pp. 163-173. (doi: 10.1124/mol.110.070789)

Nejsum, L.N., Christensen, T.M., Robben, J.H., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Deen, P.M.T., Bichet, D.G. and Levin, K. (2011) Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptor. NDT Plus, 4(3), pp. 158-163. (doi: 10.1093/ndtplus/sfr010) (PMID:21629670) (PMCID:PMC3103721)

Schmidt, J. et al. (2011) Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. Journal of Biological Chemistry, 286(12), pp. 10628-10640. (doi: 10.1074/jbc.M110.210872)

Anthony, D.F., Sin, Y.Y. ORCID logoORCID: https://orcid.org/0000-0001-6537-5266, Vadrevu, S., Advant, N., Day, J.P., Byrne, A.M., Lynch, M.J., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Houslay, M.D. and Baillie, G.S. ORCID logoORCID: https://orcid.org/0000-0003-2469-6316 (2011) β-Arrestin 1 inhibits the GAP function of ARHGAP21 so as to promote the activation of RhoA following angiotensin II type 1A receptor stimulation. Molecular and Cellular Biology, 31(5), pp. 1066-1075. (doi: 10.1128/MCB.00883-10) (PMID:21173159) (PMCID:PMC3067824)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Ligand-induced internalisation of the orexin OX1 and cannabinoid CB1 receptors assessed via N-terminal SNAP and CLIP-tagging. British Journal of Pharmacology, 162(6), pp. 1439-1452. (doi: 10.1111/j.1476-5381.2010.01156.x)

Flores-Munoz, M., Smith, N. J., Haggerty, C., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, S. A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2011) Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor. Journal of Physiology, 589(4), pp. 939-951. (doi: 10.1113/jphysiol.2010.203075)

Smith, N.J., Bennett, K. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) When simple agonism is not enough: Emerging modalities of GPCR ligands. Molecular and Cellular Endocrinology, 331(2), pp. 241-247. (doi: 10.1016/j.mce.2010.07.009)

Dimond, P. et al. (2011) G protein-coupled receptor modulation with pepducins: moving closer to the clinic. Annals of the New York Academy of Sciences, 1226(1), pp. 34-49. (doi: 10.1111/j.1749-6632.2011.06039.x)

Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Smith, N.J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors. In: Neubig, R.R. (ed.) Pharmacology of G Protein Coupled Receptors. Series: Advances in Pharmacology (62). Elsevier Academic Press: Amsterdam, The Netherlands, pp. 175-218. ISBN 9780123859525 (doi: 10.1016/B978-0-12-385952-5.00006-3)

Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Orthologue selectivity and ligand bias: translating the pharmacology of GPR35. Trends in Pharmacological Sciences, 32(5), pp. 317-325. (doi: 10.1016/j.tips.2011.02.002)

MX PA/A/2005/012546 (2011) Materials and Methods Relating to G-Protein Coupled Oligomers. .

US 10/555,709 (2011) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

US 12/119,401 (2011) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

CN 200480017258.7 (2011) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

TW 093114280 (2011) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

US 09/913, 762 (2011) Receptor Assay. .

Saenz del Burgo, L. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Ligand regulation of GPCR quaternary structure. In: Giraldo, J. and Pin, J.-P. (eds.) G Protein-Coupled Receptors: From Structure to Function G Protein-Coupled Receptors: From Structure to Function. Series: RSC drug discovery (8). RSC Publishing: Cambridge, UK, pp. 111-152. ISBN 9781849733441 (doi: 10.1039/9781849733441-00111)

Schröder, R. et al. (2011) Applying label-free dynamic mass redistribution technology to frame signaling of G protein–coupled receptors noninvasively in living cells. Nature Protocols, 6(11), pp. 1748-1760. (doi: 10.1038/nprot.2011.386)

Tarrasón, G. et al. (2011) The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice. International Immunopharmacology, 11(11), pp. 1773-1779. (doi: 10.1016/j.intimp.2011.07.004)

Ward, R.J., Alvarez-Curto, E. ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Using the Flp-In™ T-Rex™ System to Regulate GPCR Expression. Methods in Molecular Biology, 746, pp. 21-37. (doi: 10.1007/978-1-61779-126-0_2)

2010

Burton, P. et al. (2010) Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells. Biochemical Journal, 432(3), pp. 575-584. (doi: 10.1042/BJ20100726)

Kane, N. M. et al. (2010) Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors. Molecular Therapy, 18(12), pp. 2139-2145. (doi: 10.1038/mt.2010.231)

Smith, Nicola J. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Allostery at G protein-coupled receptor Homo- and Heteromers: uncharted pharmacological landscapes. Pharmacological Reviews, 62(4), pp. 701-725. (doi: 10.1124/pr.110.002667) (PMID:21079041) (PMCID:PMC2993260)

Lopez-Gimenez, J.F. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Opioid regulation of Mu receptor internalisation: relevance to the development of tolerance and dependence. CNS and Neurological Disorders: Drug Targets, 9(5), pp. 616-626. (doi: 10.2174/187152710793361522) (PMID:20632966)

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors. Analytical and Bioanalytical Chemistry, 398(1), pp. 167-180. (doi: 10.1007/s00216-010-3823-4) (PMID:20517598)

Schroder, R. et al. (2010) Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements. Nature Biotechnology, 28(9), pp. 943-949. (doi: 10.1038/nbt.1671)

Burton, P. et al. (2010) Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells. Biochemical Society Transactions, 38(4), pp. 1058-1061. (doi: 10.1042/BST0381058)

Alvarez-Curto, Elisa, Ward, Richard J., Pediani, John D. and Milligan, Graeme (2010) Ligand regulation of the quaternary organization of cell surface M3 muscarinic acetylcholine receptors analyzed by fluorescence resonance energy transfer (FRET) imaging and homogenous time-resolved FRET. Journal of Biological Chemistry, 285(30), pp. 23318-23330. (doi: 10.1074/jbc.M110.122184) (PMID:20489201) (PMCID:PMC2906324)

Khelashvili, G. et al. (2010) GPCR-OKB: the G protein coupled receptor oligomer knowledge base. Bioinformatics, 26(14), pp. 1804-1805. (doi: 10.1093/bioinformatics/btq264)

Kane, Nicole M., Meloni, Marco, Spencer, Helen L., Craig, Margaret A., Strehl, Raimund, Milligan, Graeme, Houslay, Miles D., Mountford, Joanne C., Emanueli, Costanza and Baker, Andrew H. (2010) Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(7), pp. 1389-1397. (doi: 10.1161/ATVBAHA.110.204800)

del Burgo, Laura Saenz and Milligan, Graeme (2010) Heterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening. Expert Opinion on Drug Discovery, 5(5), pp. 461-474. (doi: 10.1517/17460441003720467) (PMID:22823130)

PA/A/2005/012546 (2010) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

Milligan, Graeme (2010) The role of dimerisation in the cellular trafficking of G-protein-coupled receptors. Current Opinion in Pharmacology, 10(1), pp. 23-29. (doi: 10.1016/j.coph.2009.09.010) (PMID:19850521)

Andrews, P. et al. (2010) High content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules. Biochemical Journal, 432(Pt 1), pp. 21-33. (doi: 10.1042/BJ20101022)

Burton, P. et al. (2010) Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells. Biochemical Society Transactions, 38(4), pp. 1058-1061. (doi: 10.1042/BST0381058)

Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Alvarez-Curto, E. ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Campbell, Kate, De Munnik, Sabrina, Canals Buj, M., Schlyer, Sabine and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β-arrestin-2. British Journal of Pharmacology, 162(3), pp. 733-748. (doi: 10.1111/j.1476-5381.2010.01082.x)

Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Brea, J., Smith, N.J., Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Reilly, G., Bryant, N.J., Castro, M., Loza, M.I. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13. Biochemical Journal, 432(3), pp. 451-459. (doi: 10.1042/BJ20101287)

Stoddart, L.A. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Constitutive activity of GPR40/FFA1 intrinsic or assay dependent? Methods in Enzymology, 484, pp. 569-590. (doi: 10.1016/B978-0-12-381298-8.00028-9) (PMID:21036251)

Xu, T. et al. (2010) Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species. Science Signaling, 3(113), ra20. (doi: 10.1126/scisignal.2000517)

2009

Robben, J.H., Fenton, R.A., Vargas, S.L., Schweer, H., Peti-Peterdi, J., Deen, P.M.T. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney International, 76(12), pp. 1258-1267. (doi: 10.1038/ki.2009.360)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. British Journal of Pharmacology, 158(1), pp. 5-14. (doi: 10.1111/j.1476-5381.2009.00169.x) (PMID:19309353) (PMCID:PMC2795239)

Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and McGrath, J.C. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) GPCR theme editorial. British Journal of Pharmacology, 158(1), pp. 1-4. (doi: 10.1111/j.1476-5381.2009.00422.x)

Robben, J.H., Kortenoeven, M.L.A., Sze, M., Yae, C., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Oorschot, V.M., Klumperman, J., Knoers, N.V.A.M. and Deen, P.M.T. (2009) Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proceedings of the National Academy of Sciences of the United States of America, 106(29), pp. 12195-12200. (doi: 10.1073/pnas.0900130106)

Smith, N.J., Stoddart, L.A., Devine, N.M., Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547 and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1. Journal of Biological Chemistry, 284(26), pp. 17527-17539. (doi: 10.1074/jbc.M109.012849) (PMID:19398560) (PMCID:PMC2719392)

Idris, A.I., Sophocleous, A., Landao-Bassonga, E., Merkouris, M., Milligan, G., Baker, D., van't Hof, R.J. and Ralston, S.H. (2009) Cannabinoid receptor type 1 protects against age-related bone loss by regulating osteoblast and adipocyte differentiation of bone marrow stromal cells. Bone, 44(Supple), S222. (doi: 10.1016/j.bone.2009.03.067)

Ward, Richard J., Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) Selectivity and functional consequences of interactions of family A G protein-coupled receptors with neurochondrin and periplakin. Journal of Neurochemistry, 109(1), pp. 182-192. (doi: 10.1111/j.1471-4159.2009.05918.x)

Ferre, S. et al. (2009) Building a new conceptual framework for receptor heteromers. Nature Chemical Biology, 5(3), pp. 131-134. (doi: 10.1038/nchembio0309-131)

Canals, Meritxell, Lopez-Gimenez, Juan F. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective α1b-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. Biochemical Journal, 417(1), pp. 161-172. (doi: 10.1042/BJ20081227)

Appelbe, Shirley and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) Hetero‐Oligomerization of Chemokine Receptors. In: Chemokines, Part B. Series: Methods in Enzymology., 461. Academic Press, pp. 207-225. ISBN 9780123749079 (doi: 10.1016/S0076-6879(09)05410-X)

Bennett, K.A., Langmead, C.J., Wise, A. and Milligan, G. (2009) Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-agonists but not allosteric regulators for activation of the G protein G{alpha}o1 by the ghrelin receptor. Molecular Pharmacology, 76(4), pp. 802-811. (doi: 10.1124/mol.109.056101)

Brea, J.H. et al. (2009) Evidence for distinct antagonist-revealed functional states of 5-HT2A receptor homodimers. Molecular Pharmacology, 75(6), pp. 1380-1391. (doi: 10.1124/mol.108.054395)

Idris, A. I., Sophocleous, A., Landa-Bassonga, E., Canals, M., Milligan, G., Baker, D., van't Hof, R. J. and Ralston, S. (2009) Cannabinoid receptor type 1 protects against age-related bone loss by regulating osteoblast and adipocyte differentiation of bone marrow stromal cells. Cell Metabolism, 10(2), pp. 139-147. (doi: 10.1016/j.cmet.2009.07.006)

Milligan, G., Stoddart, L.A. and Smith, N.J. (2009) Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3. British Journal of Pharmacology, 158(1), pp. 146-153. (doi: 10.1111/j.1476-5381.2009.00421.x) (PMID:19719777) (PMCID:PMC2795255)

2008

Lopez-Gimenez, Juan F., Vilaro, M. Teresa and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) Morphine desensitization, internalization and down-regulation of the μ opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor co-activation. Molecular Pharmacology, 74(5), pp. 1278-1291. (doi: 10.1124/mol.108.048272) (PMID:18703670)

10/555709 (2008) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

Xu, Tian-Rui, Baillie, George S. ORCID logoORCID: https://orcid.org/0000-0003-2469-6316, Bhari, Narinder, Houslay, Thomas M., Pitt, Andrew M., Adams, David R., Kolch, Walter, Houslay, Miles D. and Milligan, Graeme (2008) Mutations of β-arrestin 2 that limit self-association also interfere with interactions with the β2-adrenoceptor and the ERK1/2 MAPKs: implications for β2-adrenoceptor signalling via the ERK1/2 MAPKs. Biochemical Journal, 413(1), pp. 51-60. (doi: 10.1042/BJ20080685)

Canals Buj, Meritxell and Milligan, Graeme (2008) Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors. Journal of Biological Chemistry, 283(17), pp. 11424-11434. (doi: 10.1074/jbc.M710300200)

González-Maeso, J. et al. (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature, 452(7183), pp. 93-97. (doi: 10.1038/nature06612)

Milligan, G. (2008) A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. British Journal of Pharmacology, 153(.), S216-S229. (doi: 10.1038/sj.bjp.0707490)

Hill, C., Brownlie, Z., Davey, J., Milligan, G. and Ladds, G. (2008) Isolation and characterization of a novel human RGS mutant displaying gain-of-function activity. Cellular Signalling, 20(2), pp. 323-336. (doi: 10.1016/j.cellsig.2007.10.016) (PMID:18031991)

Lane, J.R., Henderson, D., Powney, B., Wise, A., Rees, S., Daniels, D., Plumpton, C., Kinghorn, I. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) Antibodies that identify only the active conformation of Gi family G protein α subunits. FASEB Journal, 22, pp. 1924-1932. (doi: 10.1096/fj.07-100388)

Lane, J.R., Powney, B., Wise, A., Rees, S. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) G protein-coupling and ligand selectivity of the D2L and D3 dopamine receptors. Journal of Pharmacology and Experimental Therapeutics, 325(1), pp. 319-330. (doi: 10.1124/jpet.107.134296)

McCulloch, CV, Morrow, V, Milasta, S, Comerford, I, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Graham, GJ ORCID logoORCID: https://orcid.org/0000-0002-7801-204X, Isaacs, NW and Nibbs, RJ (2008) Multiple roles for the C-terminal tail of the chemokine scavenger D6. Journal of Biological Chemistry, 283(12), pp. 7972-7982. (doi: 10.1074/jbc.M710128200)

Noubade, R., Saligrama, N., Spach, K., del Rio, R., Blankenhorn, E.P., Kantidakis, T., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Rincon, M. and Teuscher, C. (2008) Autoimmune disease-associated histamine receptor H1 alleles exhibit differential protein trafficking and cell surface expression. Journal of Immunology, 180(11), pp. 7471-7479.

Parenty, G., Applebe, S. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor hetero-dimer. Biochemical Journal, 412(Pt2), pp. 215-256. (doi: 10.1042/BJ20071689)

Stoddart, L. A., Smith, N. J., Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Brown, A. J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids. Journal of Biological Chemistry, 283(47), pp. 32913-32924. (doi: 10.1074/jbc.M805601200) (PMID:18801738)

Stoddart, L. A., Smith, N. J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions. Pharmacological Reviews, 60(4), pp. 405-417. (doi: 10.1124/pr.108.00802)[Book Review]

2007

Snook, L.A., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Kieffer, B.L. and Massotte, D. (2007) Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms. Journal of Neurochemistry, 105(3), pp. 865-873. (doi: 10.1111/j.1471-4159.2008.05215.x)

Noubade, R, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Zachary, J.F., Blankenhorn, E.P., del Rio, R., Rincorn, M. and Teuscher, C. (2007) Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-γ production in mice. Journal of Clinical Investigation, 117(11), pp. 3507-3518.

Baillie, G.S. et al. (2007) Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays. Biochemical Journal, 404(1), pp. 71-80. (doi: 10.1042%2FBJ20070005)

Skrabanek, L. et al. (2007) Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base. BMC Bioinformatics, 8(177), (doi: 10.1186/1471-2105-8-177)

Lopez-Gimenez, Juan F., Canals Buj, Meritxell, Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) The 1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Molecular Pharmacology, 71(4), pp. 1015-1029. (doi: 10.1124/mol.106.033035)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) G protein-coupled receptor dimerisation: molecular basis and relevance to function. Biochimica et Biophysica Acta: Biomembranes, 1768(4), pp. 825-835. (doi: 10.1016/j.bbamem.2006.09.021)

Pin, J.P. et al. (2007) International union of basic and clinical pharmacology. LXVII. Recommendations for the recognition and nomenclature of g protein-coupled receptor heteromultimers. Pharmacological Reviews, 59(1), pp. 5-13. (doi: 10.1124/pr.59.1.5)

Bouvier, Michel, Heveker, Nikolaus, Jockers, Ralf, Marullo, Stefano and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) BRET analysis of GPCR oligomerization: newer does not mean better. Nature Methods, 4(1), pp. 3-4. (doi: 10.1038/nmeth0107-3)

Fredholm, BB, Hokfelt, T and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) G-protein-coupled receptors: an update. Acta Physiologica, 190, pp. 3-7. (doi: 10.1111/j.1748-1716.2007.01689.x)

Jameson, EE, Pei, J, Wade, SM, Neubig, RR, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kennedy, RT (2007) Capillary electrophoresis assay for G protein-coupled receptor-mediated GTPase activity. Analytical Chemistry, 79, pp. 1158-1163. (doi: 10.1021/ac061099g)

Lane, JR, Powney, B, Wise, A, Rees, S and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) Protean agonism at the dopamine D-2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of G(o1) but an antagonist/inverse agonist for G(i1), G(i2), and G(i3). Molecular Pharmacology, 71, pp. 1349-1359. (doi: 10.1124/mol.106.032722)

Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Vanderbauwhede, W. ORCID logoORCID: https://orcid.org/0000-0001-6768-0037 (2007) Implementation of finite state machines on a reconfigurable device. In: Arslan, T. (ed.) Second NASA/ESA Conference on Adaptive Hardware and Systems (AHS 2007), 5-8 Aug. 2007, Edinburgh, UK. IEEE Computer Society: Los Alamitos, USA, pp. 386-396. ISBN 9780769528663 (doi: 10.1109/AHS.2007.64)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends in Pharmacological Sciences, 28(12), pp. 615-620. (doi: 10.1016/j.tips.2007.11.001)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Parenty, G, Stoddart, LA and Lane, JR (2007) Novel pharmacological applications of G-protein-coupled receptor-G protein fusions. Current Opinion in Pharmacology, 7, pp. 521-526. (doi: 10.1016/j.coph.2007.06.007)

Noubade, R, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Zachary, JF, Blankenhorn, EP, del Rio, R, Rincon, M and Teuscherl, C (2007) Histamine receptor H-1 is-required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. Journal of Clinical Investigation, 117, pp. 3507-3518. (doi: 10.1172/JC132792)

Orth, JHC, Lang, SN, Preuss, I, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Aktories, K (2007) Action of Pasteurella multocida toxin on G alpha(q) is persistent and independent of interaction with G-protein-coupled receptors. Cellular Signalling, 19, pp. 2174-2182. (doi: 10.1016/j.cellsig.2007.06.016)

Sartania, Nana ORCID logoORCID: https://orcid.org/0000-0002-3196-2312, Appelbe, Shirley, Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme (2007) Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta(2)-adrenoceptor. Cellular Signalling, 19, pp. 1928-1938. (doi: 10.1016/j.cellsig.2007.05.002)

Stoddart, LA, Brown, AJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) Uncovering the pharmacology of the G protein-coupled receptor GPR40: High apparent constitutive activity in guanosine 5'-O-(3-[S-35] thio) triphosphate binding studies reflects binding of an endogenous agonist. Molecular Pharmacology, 71, pp. 994-1005. (doi: 10.1124/mol.106.031534)

2006

Ellis, J., Pediani, J.D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Canals Buj, M., Milasta, S. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. Journal of Biological Chemistry, 281(25), pp. 38812-38824. (doi: 10.1074/jbc.M602494200)

Comerford, Iain, Milasta, Sandra, Morrow, Valerie, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nibbs, Robert ORCID logoORCID: https://orcid.org/0000-0002-8150-0044 (2006) The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro. European Journal of Immunology, 36(7), pp. 1904-1916. (doi: 10.1002/eji.200535716)

Batenburg, W. et al. (2006) Carvedilol-induced antagonism of angiotensin II: a matter of alpha(1)-adrenoceptor blockade. Journal of Hypertension, 24, pp. 1355-1363.

Canals, M, Jenkins, L, Kellett, E and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of G(q)/G(11) by MAS. Journal of Biological Chemistry, 281, pp. 16757-16767. (doi: 10.1074/jbc.M601121200)

Ciruela, F. et al. (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A(1)-A(2A) receptor heteromers. Journal of Neuroscience, 26, pp. 2080-2087. (doi: 10.1523/JNEUROSCI.3574-05.2006)

Francke, F, Ward, RJ, Jenkins, L, Kellett, E, Richter, D, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Bachner, D (2006) Interaction of neurochondrin with the melanin-concentrating hormone receptor 1 interferes with G protein-coupled signal transduction but not agonist-mediated internalization. Journal of Biological Chemistry, 281, pp. 32496-32507. (doi: 10.1074/jbc.M602889200)

Milasta, S, Pediani, J, Appelbe, S, Trim, S, Wyatt, M, Cox, P, Fidock, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD. Molecular Pharmacology, 69, pp. 479-491. (doi: 10.1124/mol.105.018788)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. Drug Discovery Today, 11, pp. 541-549. (doi: 10.1016/j.drudis.2006.04.007)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kostenis, E (2006) Heterotrimeric G-proteins: a short history. British Journal of Pharmacology, 147, S46-S55.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Pediani, JD, Canals, M and Lopez-Gimenez, JF (2006) Oligomeric structure of the alpha(1b)-adrenoceptor: Comparisons with rhodopsin. Vision Research, 46, pp. 4434-4441. (doi: 10.1016/j.visres.2006.08.007)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Stoddart, LA and Brown, AJ (2006) G protein-coupled receptors for free fatty acids. Cellular Signalling, 18, pp. 1360-1365. (doi: 10.1016/j.cellsig.2006.03.011)

Novotny, J, Durchankova, D, Ward, RJ, Carrillo, JJ, Svoboda, P and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) Functional interactions between the alpha(1b)-adrenoceptor and G alpha(11) are compromised by de-palmitoylation of the G protein but not of the receptor. Cellular Signalling, 18, pp. 1244-1251. (doi: 10.1016/j.cellsig.2005.10.004)

Snook, LA, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Kieffer, BL and Massotte, D (2006) mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions. Journal of Pharmacology and Experimental Therapeutics, 318, pp. 683-690. (doi: 10.1124/jpet.106.101220)

2005

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Bouvier, Michel (2005) Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS Journal, 272(12), pp. 2914-2925. (doi: 10.1111/j.1742-4658.2005.04731.x)

Barclay, E, OReilly, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Activation of an alpha(2A)-adrenoceptor-G alpha(o1), fusion protein dynamically regulates the palmitoylation status of the G protein but not of the receptor. Biochemical Journal, 385, pp. 197-206.

Barnes, WG, Reiter, E, Violin, JD, Ren, XR, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Lefkowitz, RJ (2005) beta-arrestin 1 and G(alpha q/11) coordinately activate RhoA and stress fiber formation following receptor stimulation. Journal of Biological Chemistry, 280, pp. 8041-8050. (doi: 10.1074/jbc.M412924200)

Holdsworth, G, Slocombe, P, Hutchinson, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Analysis of endogenous S1P and LPA receptor expression in CHO-K1 cells. Gene, 350, pp. 59-63. (doi: 10.1016/j.gene.2005.01.016)

Hunton, DL, Barnes, WG, Kim, J, Ren, XR, Violin, JD, Reiter, E, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Patel, DD and Lefkowitz, RJ (2005) beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Molecular Pharmacology, 67, pp. 1229-1236. (doi: 10.1124/mol.104.006270)

Kostenis, E, Martini, L, Ellis, J, Waldhoer, M, Heydorn, A, Rosenkilde, MM, Norregaard, PK, Jorgensen, R, Whistler, JL and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) A highly conserved glycine within linker I and the extreme C terminus of G protein alpha subunits interact cooperatively in switching G protein-coupled receptor-to-effector specificity. Journal of Pharmacology and Experimental Therapeutics, 313, pp. 78-87. (doi: 10.1124/jpet.104.080424)

Kostenis, E. et al. (2005) (G)-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation, 111, pp. 1806-1813. (doi: 10.1161/01.CIR.0000160867.23556.7D)

Kostenis, E, Waelbroeck, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Techniques: Promiscuous G alpha proteins in basic research and drug discovery. Trends in Pharmacological Sciences, 26, pp. 595-602. (doi: 10.1016/j.tips.2005.09.007)

Milasta, S, Evans, NA, Ormiston, L, Wilson, S, Lefkowitz, RJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. Biochemical Journal, 387, pp. 573-584.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Opioid receptors and their interacting proteins. Neuromolecular Medicine, 7, pp. 51-59. (doi: 10.1385/NMM)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Wilson, S and Lopez-Gimenez, JF (2005) The specificity and molecular basis of alpha(1)-adrenoceptor and CXCR chemokine receptor dimerization. Journal of Molecular Neuroscience, 26, pp. 161-167. (doi: 10.1385/JMN/26)

Murdoch, H, Feng, GJ, Bachner, DB, Ormiston, L, White, JH, Richter, D and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Periplakin interferes with g protein activation by the melanin-concentrating hormone receptor-1 by binding to the proximal segment of the receptor C-terminal tail. Journal of Biological Chemistry, 280, pp. 8208-8220. (doi: 10.1074/jbc.M405215200)

Pascal, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Functional complementation and the analysis of opioid receptor homodimerization. Molecular Pharmacology, 68, pp. 905-915. (doi: 10.1124/mol.105.013847)

Pediani, JD, Colston, JF, Caldwell, D, Milligan, G, Daly, CJ and McGrath, JC (2005) beta-arrestin-dependent spontaneous alpha(1a)-adrenoceptor endocytosis causes intracellular transportation of alpha-blockers via recycling compartments. Molecular Pharmacology, 67, pp. 992-1004. (doi: 10.1124/mol.104.008417)

Rudajev, V, Novotny, J, Hejnova, L, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Svoboda, P (2005) Dominant portion of thyrotropin-releasing hormone receptor is excluded from lipid domains. Detergent-resistant and detergent-sensitive pools of TRH receptor and G(q)alpha/G(11)alpha protein. Journal of Biochemistry, 138, pp. 111-125. (doi: 10.1093/jb/mvi114)

Ward, RJ and Milligan, G (2005) A key serine for the GTPase-activating protein function of regulator of G protein signaling proteins is not a general target for 14-3-3 interactions. Molecular Pharmacology, 68, pp. 1821-1830. (doi: 10.1124/moi.105.015073) (PMID:16160139)

Wilson, S, Wilkinson, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. Journal of Biological Chemistry, 280, pp. 28663-28674. (doi: 10.1074/jbc.M413475200)

2004

093114280 (2004) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

Milligan, G., Feng, G.J., Ward, R.J., Sartania, Nana ORCID logoORCID: https://orcid.org/0000-0002-3196-2312, Ramsay, D., McLean, A.J. and Carrillo, J.J. (2004) G protein-coupled receptor fusion proteins in drug discovery. Current Pharmaceutical Design, 10(17), pp. 1989-2001. (doi: 10.2174/1381612043384295) (PMID:15279540)

Bakker, RA, Dees, G, Carrillo, JJ, Booth, RG, Lopez-Gimenez, JF, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Strange, PG and Leurs, R (2004) Domain swapping in the human histamine H-1 receptor. Journal of Pharmacology and Experimental Therapeutics, 311, pp. 131-138. (doi: 10.1124/jpet.104.067041)

Carrillo, JJ, Lopez-Gimenez, JF and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) Multiple interactions between transmembrane helices generate the oligomeric alpha(1b)-adrenoceptor. Molecular Pharmacology, 66, pp. 1123-1137. (doi: 10.1124/mol.104.001586)

Heydorn, A, Ward, RJ, Jorgensen, R, Rosenkilde, MM, Frimurer, TM, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kostenis, E (2004) Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction. Molecular Pharmacology, 66, pp. 250-259.

Holdsworth, G., Osborne, D.A., Thi Pham, T., Fells, J.I., Hutchinson, G., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Parrill, A.L. (2004) A single amino acid determines preference between phospholipids and reveals length restriction for activation ofthe S1P4 receptor. BMC Biochemistry, 5(12), (doi: 10.1186/1471-2091-5-12)

Klaasse, E, de Ligt, RAF, Roerink, SF, Lorenzen, A, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Leurs, R and IJzerman, AP (2004) Allosteric modulation and constitutive activity of fusion proteins between the adenosine A(1) receptor and different (351)Cys-mutated G(i) alpha-subunits. European Journal of Pharmacology, 499, pp. 91-98. (doi: 10.1016/j.ejphar.2004.07.108)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. European Journal of Pharmaceutical Sciences, 21, pp. 397-405. (doi: 10.1016/j.ejps.2003.11.010)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) G protein-coupled receptor dimerization: Function and ligand pharmacology. Molecular Pharmacology, 66, pp. 1-7. (doi: 10.1124/mol.104.000497)

Milligan, G (2004) A single amino acid determines preference between phospholipids and reveals length restriction for activation ofthe S1P4 receptor. BMC Biochemistry, 5(12), pp. 1-12. (doi: 10.1186/1471-2091-5-12)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Lopez-Gimenez, J, Wilson, S and Carrillo, JJ (2004) Selectivity in the oligomerisation of G protein-coupled receptors. Seminars in Cell and Developmental Biology, 15, pp. 263-268. (doi: 10.1016/j.semcdb.2003.12.012)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Murdoch, H, Kellett, E, White, JH and Feng, GJ (2004) Interactions between G-protein-coupled receptors and periplakin: a selective means to regulate G-protein activation. Biochemical Society Transactions, 32, pp. 878-880.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Pascal, G and Carrillo, JJ (2004) Monitoring receptor dimerisation. Medicinal Chemistry Research, 13, pp. 18-24.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Pediani, J, Fidock, M and Lopez-Gimenez, JF (2004) Dimerization of alpha(1)-adrenoceptors. Biochemical Society Transactions, 32, pp. 847-850.

Moravcova, Z., Rudajev, V., Stohr, J., Novotny, J., Cerny, J., Parenti, M., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Svoboda, P. (2004) Long-term agonist stimulation of IP prostanoid receptor depletes the cognate G(s)alpha protein in membrane domains but does not change the receptor level. Biochimica et Biophysica Acta: Molecular Cell Research, 1691, pp. 51-65. (doi: 10.1016/j.bbamcr.2003.12.004)

Ramsay, D, Carr, IC, Pediani, J, Lopez-Gimenez, JF, Thurlow, R, Fidock, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) High-affinity interactions between human alpha(1A)-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha(1L)-adrenoceptor. Molecular Pharmacology, 66, pp. 228-239.

Ward, R.J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) Analysis of function of receptor-G-protein and receptor-RGS fusion proteins. Methods in Molecular Biology, 259, pp. 225-247. (PMID:15250496)

2003

60/472025 (2003) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

Adie, EJ, Francis, MJ, Davies, J, Smith, L, Marenghi, A, Hather, C, Hadingham, K, Michael, NP, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Gamel, S (2003) CypHer 5: A generic approach for measuring the activation and trafficking of G protein-coupled receptors in live cells. Assay and Drug Development Technologies, 1, pp. 251-259.

Bahia, Daljit S., Sartania, Nana ORCID logoORCID: https://orcid.org/0000-0002-3196-2312, Ward, Richard j., Cavalli, Antonella, Jones, Teresa L.Z., Druey, Kirk M. and Milligan, Graeme (2003) Concerted stimulation and deactivation of pertussis toxin-sensitive G proteins by chimeric G protein-coupled receptor-regulator of G protein signaling 4 fusion proteins: analysis of the contribution of palmitoylated cysteine residues to the GAP activity o. Journal of Neurochemistry, 85(5), pp. 1289-1298. (doi: 10.1046/j.1471-4159.2003.01769.x) (PMID:12753087)

Benians, A, Leaney, JL, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Tinker, A (2003) The dynamics of formation and action of the ternary complex revealed in living cells using a G-protein-gated K+ channel as a biosensor. Journal of Biological Chemistry, 278, pp. 10851-10858. (doi: 10.1074/jbc.M212299200)

Bertaso, F, Ward, RJ, Viard, P, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Dolphin, AC (2003) Mechanism of action of G(q) to inhibit G beta gamma modulation of Ca(v)2.2 calcium channels: Probed by the use of receptor-G alpha tandems. Molecular Pharmacology, 63, pp. 832-843.

Bourova, L, Kostrnova, A, Hejnova, L, Moravcova, Z, Moon, HE, Novotny, J, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Svoboda, P (2003) delta-Opioid receptors exhibit high efficiency when activating trimeric G proteins in membrane domains. Journal of Neurochemistry, 85, pp. 34-49. (doi: 10.1046/j.1471-4159.2003.01667.x)

Carrillo, JJ, Pediani, J and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. Journal of Biological Chemistry, 278, pp. 42578-42587. (doi: 10.1074/jbc.M306165200)

Derrien, A, Zheng, B, Osterhout, JL, Ma, YC, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Farquhar, MG and Druey, KM (2003) Src-mediated RGS16 tyrosine phosphorylation promotes RGS16 stability. Journal of Biological Chemistry, 278, pp. 16107-16116. (doi: 10.1074/jbc.M210371200)

Feng, GJ, Kellett, E, Scorer, CA, Wilde, J, White, JH and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Selective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activation. Journal of Biological Chemistry, 278, pp. 33400-33407. (doi: 10.1074/jbc.M305866200)

Hiol, A, Davey, PC, Osterhout, JL, Waheed, AA, Fischer, ER, Chen, CK, Milligan, G, Druey, KM and Jones, TLZ (2003) Palmitoylation regulates regulators of G-protein signaling (RGS) 16 function - I. Mutation of amino-terminal cysteine residues on RGS16 prevents its targeting to lipid rafts and palmitoylation of an internal cysteine residue. Journal of Biological Chemistry, 278, pp. 19301-19308. (doi: 10.1074/jbc.M210123200) (PMID:12642593)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Molecular Pharmacology, 64, pp. 1271-1276.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) High-content assays for ligand regulation of G-protein-coupled receptors. Drug Discovery Today, 8, pp. 579-585.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Mechanism of action of Gq to inhibit Gbg modulation of Cav2.2 calcium channls probed by use of receptor-Ga tandems. Molecular Pharmacology, 63(4), pp. 832-843. (doi: 10.1124/mol.63.4.832)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Principles: Extending the utility of [S-35]GTP gamma S binding assays. Trends in Pharmacological Sciences, 24, pp. 87-90.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Ramsay, D, Pascal, G and Carrillo, JJ (2003) GPCR dimerisation. Life Sciences, 74, pp. 181-188. (doi: 10.1016/j.lfs.2003.09.005)

Osterhout, JL, Waheed, AA, Hiol, A, Ward, RJ, Davey, PC, Nini, L, Wang, J, Milligan, G, Jones, TLZ and Druey, KM (2003) Palmitoylation regulates regulator of G-protein signaling (RGS) 16 function - II. Palmitoylation of a cysteine residue in the RGS box is critical for RGS16 GTPase accelerating activity and regulation of G(i)-coupled signaling. Journal of Biological Chemistry, 278, pp. 19309-19316. (doi: 10.1074/jbc.M210124200) (PMID:12642592)

Zeng, FY, McLean, AJ, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Lerner, M, Chalmers, DT and Behan, DP (2003) Ligand specific up-regulation of a Renilla reniformis luciferase-tagged, structurally unstable muscarinic M-3 chimeric G protein-coupled receptor. Molecular Pharmacology, 64, pp. 1474-1484.

2002

Adamson, P, Wilbourn, B, Etienne-Manneville, S, Calder, V, Beraud, E, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Couraud, PO and Greenwood, J (2002) Lymphocyte trafficking through the blood-brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling. FASEB Journal, 16,

Adie, EJ, Kalinka, S, Smith, L, Francis, MJ, Marenghi, A, Cooper, ME, Briggs, M, Michael, NP, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Game, S (2002) A pH-sensitive fluor, CypHer (TM) 5, used to monitor agonist-induced g protein-coupled receptor internalization in live cells. Biotechniques, 33, pp. 1152-1157.

Carrillo, JJ, Stevens, PA and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Measurement of agonist-dependent and -independent signal initiation of alpha(1b)-adrenoceptor mutants by direct analysis of guanine nucleotide exchange on the G protein G alpha(11). Journal of Pharmacology and Experimental Therapeutics, 302, pp. 1080-1088. (doi: 10.1124/jpet.102.035501)

Feng, GJ, Cavalli, A and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Engineering a V-2 vasopressin receptor agonist- and regulator of G-protein-signaling-sensitive G protein. Analytical Biochemistry, 300, pp. 212-220. (doi: 10.1006/abio.2001.5448)

Liu, S, Carrillo, JJ, Pediani, JD and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Effective information transfer from the alpha(1b)-adrenoceptor to G alpha(11) requires both beta/gamma interactions and an aromatic group four amino acids from the C terminus of the G protein. Journal of Biological Chemistry, 277, pp. 25707-25714. (doi: 10.1074/jbc.M201015200)

Lyall, F, Lye, SJ, Teoh, TG, Cousins, F, Milligan, G and Robson, SC (2002) Expression of Gs alpha, connexin-43, connexin-26, and EP1, 3, and 4 receptors in myometrium of prelabor singleton versus multiple gestations and the effects of mechanical stretch and steroids on Gs alpha. Journal of the Society For Gynecologic Investigation, 9, pp. 299-307.

Massotte, D, Brillet, K, Kieffer, B and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Agonists activate G(i1)alpha or G(i2)alpha fused to the human mu opioid receptor differently. Journal of Neurochemistry, 81, pp. 1372-1382.

McLean, AJ, Zeng, FY, Behan, D, Chalmers, D and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Generation and analysis of constitutively active and physically destabilized mutants of the human beta(1)-adrenoceptor. Molecular Pharmacology, 62, pp. 747-755.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Construction and analysis of function of G protein-coupled receptor-G protein fusion proteins. G Protein Pathways, Pt A, Receptors, 343, pp. 260-273.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Strategies to identify ligands for orphan G-protein-coupled receptors. Biochemical Society Transactions, 30, pp. 789-793.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) The use of receptor G-protein fusion proteins for the study of ligand activity. Receptors and Channels, 8, pp. 309-317. (doi: 10.1080/10606820290005281)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Stevens, PA, Ramsay, D and McLean, AJ (2002) Ligand rescue of constitutively active mutant receptors. Neurosignals, 11, pp. 29-33.

Ramsay, Douglas, Kellett, Elaine, McVey, Mary ORCID logoORCID: https://orcid.org/0000-0003-3740-6023, Rees, Stephen and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less. Biochemical Journal, 365, pp. 429-440. (doi: 10.1042/BJ20020251)

Ward, RJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Reciprocal mutations of highly conserved residues in transmembrane helices 2 and 7 of the alpha(2A)-adrenoceptor restore agonist activation of G(i1 alpha). Cellular Signalling, 14, pp. 139-144.

Welsby, PJ, Carr, IC, Wilkinson, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Regulation of the avidity of ternary complexes containing the human 5-HT1A receptor by mutation of a receptor contact site on the interacting G protein alpha subunit. British Journal of Pharmacology, 137, pp. 345-352. (doi: 10.1038/sj.bjp.0704880)

Welsby, PJ, Kellett, E, Wilkinson, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: Applications to the detection and analysis of inverse agonists and low-efficacy partial agonists. Molecular Pharmacology, 61, pp. 1211-1221.

2001

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and White, Julia H. (2001) Protein-protein interactions at G-protein-coupled receptors. Trends in Pharmacological Sciences, 22(10), pp. 513-518. (doi: 10.1016/S0165-6147(00)01801-0)

Evans, NA, Groarke, DA, Warrack, J, Greenwood, CJ, Dodgson, K, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Wilson, S (2001) Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors. Journal of Neurochemistry, 77, pp. 476-485.

Fernandez-Fernandez, JM, Abogadie, FC, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Delmas, P and Brown, DA (2001) Multiple pertussis toxin-sensitive G-proteins can couple receptors to GIRK channels in rat sympathetic neurons when expressed heterologously, but only native G(i)-proteins do so in situ. European Journal of Neuroscience, 14, pp. 283-292.

Groarke, DA, Drmota, T, Bahia, DS, Evans, NA, Wilson, S and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Analysis of the C-terminal tail of the rat thyrotropin-releasing hormone receptor-1 in interactions and cointernalization with beta-arrestin 1-green fluorescent protein. Molecular Pharmacology, 59, pp. 375-385.

Hoffmann, M, Ward, RJ, Cavalli, A, Carr, IC and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Differential capacities of the RGS1, RGS16 and RGS-GAIP regulators of G protein signaling to enhance alpha(2A)-adrenoreceptor agonist-stimulated GTPase activity of G(o1)alpha. Journal of Neurochemistry, 78, pp. 797-806.

McVey, M, Ramsay, D, Kellett, E, Rees, S, Wilson, S, Pope, AJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer - The human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulate. Journal of Biological Chemistry, 276, pp. 14092-14099.

Millan, M. et al. (2001) Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization. Journal of Pharmacology and Experimental Therapeutics, 297, pp. 876-887.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) The human d opioid receptor activates Gi1a more efficiently than Go1a. Journal of Neurochemistry, 76(6), pp. 1805-1813. (doi: 10.1046/j.1471-4159.2001.00196.x)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Oligomerisation of G-protein-coupled receptors. Journal of Cell Science, 114, pp. 1265-1271.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Kellett, E, Dacquet, C, Dubreuil, V, Jacoby, E, Millan, MJ, Lavielle, G and Spedding, M (2001) S 14506: novel receptor coupling at 5-HT1A receptors. Neuropharmacology, 40, pp. 334-344.

Moon, HE, Bahia, DS, Cavalli, A, Hoffmann, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Control of the efficiency of agonist-induced information transfer and stability of the ternary complex containing the delta opioid receptor and the alpha subunit of G(i1) by mutation of a receptor/G protein contact interface. Neuropharmacology, 41, pp. 321-330.

Moon, HE, Cavalli, A, Bahia, DS, Hoffmann, M, Massotte, D and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) The human delta opioid receptor activates G(i1)alpha more efficiently than G(o1)alpha. Journal of Neurochemistry, 76, pp. 1805-1813.

Ramsay, D, Bevan, N, Rees, S and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor. British Journal of Pharmacology, 133, pp. 315-323.

Stevens, PA, Pediani, J, Carrillo, JJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Coordinated agonist regulation of receptor and G protein palmitoylation and functional rescue of palmitoylation-deficient mutants of the G protein G(11)alpha following fusion to the alpha(1b)-adrenoreceptor - Palmitoylation of G(11 alpha) is not required. Journal of Biological Chemistry, 276, pp. 35883-35890.

1998

Daly, C.J. ORCID logoORCID: https://orcid.org/0000-0002-0410-7548, Milligan, C.M., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Mackenzie, J.F. and McGrath, J.C. ORCID logoORCID: https://orcid.org/0000-0002-5276-0381 (1998) Cellular localization and pharmacological characterization of functioning alpha-1 adrenoceptors by fluorescent ligand binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors. Journal of Pharmacology and Experimental Therapeutics, 286(2), pp. 984-990.

1993

Ross, Brian M., McLaughlin, Mark ORCID logoORCID: https://orcid.org/0000-0001-5317-2090, Roberts, Margaret, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, McCulloch, James and Knowler, John T. (1993) Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease. Brain Research, 622(1-2), pp. 35-42. (doi: 10.1016/0006-8993(93)90798-R) (PMID:8242380)

1991

McLaughlin, Mark ORCID logoORCID: https://orcid.org/0000-0001-5317-2090, Ross, Brian M., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, McCulloch, James and Knowler, John T. (1991) Robustness of G proteins in Alzheimer's disease: an immunoblot study. Journal of Neurochemistry, 57(1), pp. 9-14. (doi: 10.1111/j.1471-4159.1991.tb02092.x) (PMID:1904911)

1987

Pyne, N.J., Anderson, N., Lavan, B.E., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Nimmo, H.G. ORCID logoORCID: https://orcid.org/0000-0003-1389-7147 and Houslay, M.D. (1987) Specific antibodies and the selective inhibitor ICI 118233 demonstrate that the hormonally stimulated 'dense-vesicle' and peripheral-plasma-membrane cyclic AMP phosphodiesterases display distinct tissue distributions in the rat. Biochemical Journal, 248(3), pp. 897-901. (doi: 10.1042/bj2480897) (PMID:2829845) (PMCID:PMC1148634)

This list was generated on Sun Jun 15 03:29:00 2025 BST.
Number of items: 331.

Articles

Gonzalez-Valdivieso, Juan, Ciccone, Giuseppe, Dhawan, Udesh ORCID logoORCID: https://orcid.org/0000-0002-0393-9414, Quon, Tezz, Barcelona-Estaje, Eva, Rodrigo-Navarro, Aleixandre ORCID logoORCID: https://orcid.org/0000-0002-3786-0464, Castillo, Rafael R., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Rico, Patricia and Salmeron-Sanchez, Manuel ORCID logoORCID: https://orcid.org/0000-0002-8112-2100 (2025) NaBC1 boron transporter enables myoblast response to substrate rigidity via fibronectin-binding integrins. Advanced Science, 12(20), 2407548. (doi: 10.1002/advs.202407548) (PMID:40270477) (PMCID:PMC12120709)

Brettell, Skye B., Cann, Gillian, Begen, Abbey, Sharma, Saumya, Mahindra, Amit, Carruthers, Lauren V. ORCID logoORCID: https://orcid.org/0000-0003-4346-2283, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Clarke, David J., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Jamieson, Andrew G. ORCID logoORCID: https://orcid.org/0000-0003-1726-7353 (2025) Lysine targeting covalent inhibitors of malarial kinase PfCLK3. RSC Medicinal Chemistry, (Accepted for Publication)

Quon, Tezz, Lin, Li-Chiung, Ganguly, Amlan ORCID logoORCID: https://orcid.org/0000-0002-2507-022X, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2025) Biased constitutive signaling of the G protein-coupled receptor GPR35 suppresses gut barrier permeability. Journal of Biological Chemistry, 301(1), 108035. (doi: 10.1016/j.jbc.2024.108035) (PMID:39615676) (PMCID:PMC11732441)

Brettell, S. B. et al. (2024) Targeting PfCLK3 with covalent inhibitors: a novel strategy for malaria treatment. Journal of Medicinal Chemistry, (doi: 10.1021/acs.jmedchem.4c01300) (PMID:39441986) (Early Online Publication)

Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2024) Regulation of the pro-inflammatory G protein-coupled receptor GPR84. British Journal of Pharmacology, 181(10), pp. 1500-1508. (doi: 10.1111/bph.16098) (PMID:37085331)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2024) Editorial for GPR84 Pharmacology. British Journal of Pharmacology, 181(10), pp. 1497-1499. (doi: 10.1111/bph.16340)

Tikhonova, Irina, Zhang, Xuan, Guseinov, Abdul-Akim, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Li, Kunpeng, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Zhang, Cheng (2024) Structural basis for the ligand recognition and signaling of free fatty acid receptors. Science Advances, 10(2), eadj2384. (doi: 10.1126/sciadv.adj2384) (PMID:38198545)

Barki, N. et al. (2023) Phosphorylation bar-coding of free fatty acid receptor 2 is generated in a tissue-specific manner. eLife, 12, RP91861. (doi: 10.7554/eLife.91861) (PMID:38085667) (PMCID:PMC10715726)

Kalita, M. et al. (2023) PET imaging of innate immune activation using 11C radiotracers targeting GPR84. JACS Au, 3(12), pp. 3297-3310. (doi: 10.1021/jacsau.3c00435) (PMID:38155640) (PMCID:PMC10751761)

Ganguly, A. et al. (2023) G protein-receptor kinases 5/6 are the key regulators of G protein-coupled receptor 35-arrestin interactions. Journal of Biological Chemistry, 299(10), 105218. (doi: 10.1016/j.jbc.2023.105218) (PMID:37660910) (PMCID:PMC10520886)

Zhang, X. et al. (2023) Pro-phagocytic function and structural basis of GPR84 signaling. Nature Communications, 14, 5706. (doi: 10.1038/s41467-023-41201-0) (PMID:37709767) (PMCID:PMC10502086)

Valentini, Alice, Schultz-Knudsen, Katrine, Højgaard Hansen, Anders, Tsakoumagkou, Argyro, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Christensen, Henriette B., Manandhar, Asmita, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Ulven, Trond and Rexen Ulven, Elisabeth (2023) Discovery of potent tetrazole free fatty acid receptor 2 antagonists. Journal of Medicinal Chemistry, 66(9), pp. 6105-6121. (doi: 10.1021/acs.jmedchem.2c01935) (PMID:37129317)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2023) GPR35: from enigma to therapeutic target. Trends in Pharmacological Sciences, 44(5), pp. 263-273. (doi: 10.1016/j.tips.2023.03.001) (PMID:37002007)

Meda Venkata, Sai Pranathi, Li, Hainan, Xu, Liping, Koh, Jia Yi, Nguyen, Huong, Minjares, Morgan, Li, Chunying, Kowluru, Anjaneyulu, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Wang, Jie-Mei (2023) Inhibition of GPR39 restores defects in endothelial cell–mediated neovascularization under the duress of chronic hyperglycemia: evidence for regulatory roles of the sonic hedgehog signaling axis. Proceedings of the National Academy of Sciences of the United States of America, 120(1), e2208541120. (doi: 10.1073/pnas.2208541120) (PMID:36574661) (PMCID:PMC9910611)

Alharbi, Abdulrahman G., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2022) How arrestins and GRKs regulate the function of long chain fatty acid receptors. International Journal of Molecular Sciences, 23(20), 12237. (doi: 10.3390/ijms232012237) (PMID:36293091) (PMCID:PMC9602559)

Mahindra, A. et al. (2022) Investigating the structure–activity relationship of 1,2,4-triazine G-protein-coupled receptor 84 (GPR84) antagonists. Journal of Medicinal Chemistry, 65(16), pp. 11270-11290. (doi: 10.1021/acs.jmedchem.2c00804) (PMID:35948061) (PMCID:PMC9421653)

Marsango, Sara, Barki, Natasja, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2022) Therapeutic validation of an orphan G protein-coupled receptor: the case of GPR84. British Journal of Pharmacology, 179(14), pp. 3529-3541. (doi: 10.1111/bph.15248) (PMID:32869860) (PMCID:PMC9361006)

Marsango, S. et al. (2022) The M1 muscarinic receptor is present in situ as a ligand-regulated mixture of monomers and oligomeric complexes. Proceedings of the National Academy of Sciences of the United States of America, 119(24), e220110311. (doi: 10.1073/pnas.2201103119) (PMID:35671422) (PMCID:PMC9214538)

Caspar, Birgit, Cocchiara, Pietro, Melet, Armelle, Van Emelen, Kristof, Van der Aa, Annegret, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Herbeuval, Jean-Philippe (2022) CXCR4 as a novel target in immunology: moving away from typical antagonists. Future Drug Discovery, 4(2), FDD77. (doi: 10.4155/fdd-2022-0007) (PMID:35875591) (PMCID:PMC9298491)

Marsango, S. et al. (2022) Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands. Journal of Biological Chemistry, 298(5), 101932. (doi: 10.1016/j.jbc.2022.101932) (PMID:35427647) (PMCID:PMC9118924)

Barki, N. et al. (2022) Chemogenetics defines the roles of short chain fatty acid receptors within the gut-brain axis. eLife, 11, e73777. (doi: 10.7554/eLife.73777) (PMID:35229717) (PMCID:PMC8887895)

Divorty, Nina, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Ganguly, Amlan ORCID logoORCID: https://orcid.org/0000-0002-2507-022X, Butcher, Adrian J., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Schulz, Stefan, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2022) Agonist-induced phosphorylation of orthologues of the orphan receptor GPR35 functions as an activation sensor. Journal of Biological Chemistry, 298(3), 101655. (doi: 10.1016/j.jbc.2022.101655) (PMID:35101446) (PMCID:PMC8892012)

Scarpa, M. et al. (2021) Biased M1 muscarinic receptor mutant mice show accelerated progression of prion neurodegenerative disease. Proceedings of the National Academy of Sciences of the United States of America, 118(50), e2107389118. (doi: 10.1073/pnas.2107389118) (PMID:34893539) (PMCID:PMC8685681)

Lin, Li-Chiung, Quon, Tezz, Engberg, Susanna, Mackenzie, Amanda E., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2021) G protein-coupled receptor GPR35 suppresses lipid accumulation in hepatocytes. ACS Pharmacology and Translational Science, 4(6), pp. 1835-1848. (doi: 10.1021/acsptsci.1c00224) (PMID:34927014)

Milligan, G. et al. (2021) Discovery and characterization of novel antagonists of the proinflammatory orphan receptor GPR84. ACS Pharmacology and Translational Science, 4(5), pp. 1598-1613. (doi: 10.1021/acsptsci.1c00151) (PMID:34661077) (PMCID:PMC8506611)

Boleij, A. et al. (2021) G-protein coupled receptor 35 (GPR35) regulates the colonic epithelial cell response to enterotoxigenic Bacteroides fragilis. Communications Biology, 4, 585. (doi: 10.1038/s42003-021-02014-3) (PMID:33990686) (PMCID:PMC8121840)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Barki, Natasja and Tobin, Andrew ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 (2021) Chemogenetic approaches to explore the functions of Free Fatty Acid Receptor 2. Trends in Pharmacological Sciences, 42(3), pp. 191-202. (doi: 10.1016/j.tips.2020.12.003) (PMID:33495026)

Bolognini, Daniele, Dedeo, Domonkos ORCID logoORCID: https://orcid.org/0000-0003-3796-1713 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2021) Metabolic and inflammatory functions of short-chain fatty acid receptors. Current Opinion in Endocrine and Metabolic Research, 16, pp. 1-9. (doi: 10.1016/j.coemr.2020.06.005) (PMID:32835130) (PMCID:PMC7332907)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Marsango, Sara, Jolly, Richard, Stoneman, Michael R., Biener, Gabriel, Handel, Tracy M., Raicu, Valerica and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2021) Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t. Journal of Biological Chemistry, 296, 100139. (doi: 10.1074/jbc.RA120.016612) (PMID:33268380)

Marti-Solano, M. et al. (2020) Combinatorial expression of GPCR isoforms affects signalling and drug responses. Nature, 587, pp. 650-656. (doi: 10.1038/s41586-020-2888-2) (PMID:33149304)

Labéguère, F. et al. (2020) Discovery of 9-Cyclopropylethynyl-2-((S)-1-[1,4]dioxan-2-ylmethoxy)-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one (GLPG1205), a unique GPR84 negative allosteric modulator undergoing evaluation in a phase II clinical trial. Journal of Medicinal Chemistry, 63(22), pp. 13526-13545. (doi: 10.1021/acs.jmedchem.0c00272) (PMID:32902984)

Prihandoko, R. et al. (2020) Pathophysiological regulation of lung function by the free fatty acid receptor FFA4. Science Translational Medicine, 12(557), eaaw9009. (doi: 10.1126/scitranslmed.aaw9009) (PMID:32817367)

Quon, Tezz, Lin, Li-Chiung, Ganguly, Amlan ORCID logoORCID: https://orcid.org/0000-0002-2507-022X, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2020) Therapeutic opportunities and challenges in targeting the orphan G protein-coupled receptor GPR35. ACS Pharmacology and Translational Science, 3(5), pp. 801-812. (doi: 10.1021/acsptsci.0c00079) (PMID:33073184)

Rexen Ulven, E. et al. (2020) Structure-activity relationship studies of tetrahydroquinolone free fatty acid receptor 3 modulators. Journal of Medicinal Chemistry, 63(7), pp. 3577-3595. (doi: 10.1021/acs.jmedchem.9b02036) (PMID:32141297) (PMCID:PMC7307922)

Sencio, V. et al. (2020) Gut dysbiosis during influenza contributes to pulmonary pneumococcal superinfection through altered short-chain fatty acid production. Cell Reports, 30(9), 2934-2947.e6. (doi: 10.1016/j.celrep.2020.02.013) (PMID:32130898)

Heuninck, J. et al. (2019) Context-dependent signaling of CXC chemokine receptor 4 and atypical chemokine receptor 3. Molecular Pharmacology, 96(6), pp. 778-793. (doi: 10.1124/mol.118.115477) (PMID:31092552)

Stoneman, Michael R., Biener, Gabriel, Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Badu, Dammar, Eis, Annie, Popa, Ionel, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Raicu, Valerică (2019) A general method to quantify ligand-driven oligomerization from fluorescence-based images. Nature Methods, 16(6), pp. 493-496. (doi: 10.1038/s41592-019-0408-9) (PMID:31110281)

Bolognini, D. et al. (2019) Chemogenetics defines receptor-mediated functions of short chain free fatty acids. Nature Chemical Biology, 15(5), pp. 489-498. (doi: 10.1038/s41589-019-0270-1) (PMID:30992568)

Mackenzie, Amanda E., Quon, Tezz, Lin, Li-Chiung, Hauser, Alexander S., Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Inoue, Asuka, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Gloriam, David E., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2019) Receptor selectivity between the G proteins Gα12 and Gα13 is defined by a single leucine-to-isoleucine variation. FASEB Journal, 33(4), pp. 5005-5017. (doi: 10.1096/fj.201801956R) (PMID:30601679) (PMCID:PMC6436656)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Ward, Richard J. and Marsango, Sara (2019) GPCR homo-oligomerization. Current Opinion in Cell Biology, 57, pp. 40-47. (doi: 10.1016/j.ceb.2018.10.007) (PMID:30453145) (PMCID:PMC7083226)

Mancini, Sarah, Mahmud, Zobaer Al, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Bolognini, Daniele, Newman, Robert, Barnes, Matt, Edye, Michelle E., McMahon, Stephen B., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2019) On-target and off-target effects of novel orthosteric and allosteric activators of GPR84. Scientific Reports, 9, 1861. (doi: 10.1038/s41598-019-38539-1) (PMID:30755705) (PMCID:PMC6372602)

Müskens, Frederike M., Ward, Richard J., Herkt, Dominik, van de Langemheen, Helmus, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Liskamp, Rob M.J. ORCID logoORCID: https://orcid.org/0000-0001-8897-8975 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2019) Design, synthesis and evaluation of a diazirine photoaffinity probe for ligand-based receptor capture targeting G protein-coupled receptors. Molecular Pharmacology, 95(2), pp. 196-209. (doi: 10.1124/mol.118.114249) (PMID:30514721) (PMCID:PMC6324650)

Kennedy, Amanda J., Ballante, Flavio, Johansson, Johan R., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Sunström, Linda, Nordqvist, Anneli and Carlsson, Jens (2018) Structural characterization of agonist binding to protease-activated receptor 2 through mutagenesis and computational modeling. ACS Pharmacology and Translational Science, 1(2), pp. 119-133. (doi: 10.1021/acsptsci.8b00019)

Hansen, Anders Højgaard, Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693, Bolognini, Daniele, Sprenger, Richard R., Ekberg, Jeppe Hvidtfeldt, Ejsing, Christer S., McKenzie, Christine J., Rexen Ulven, Elisabeth, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2018) Discovery of a potent thiazolidine free fatty acid receptor 2 agonist with favorable pharmacokinetic properties. Journal of Medicinal Chemistry, 61(21), pp. 9534-9550. (doi: 10.1021/acs.jmedchem.8b00855) (PMID:30247908)

Drew, J. E. et al. (2018) Dietary fibers inhibit obesity in mice, but host responses in the cecum and liver appear unrelated to fiber-specific changes in cecal taxonomic composition. Scientific Reports, 8, 15566. (doi: 10.1038/s41598-018-34081-8) (PMID:30349136) (PMCID:PMC6197265)

Divorty, Nina, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Graham, Delyth ORCID logoORCID: https://orcid.org/0000-0002-7328-4708 and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2018) The orphan receptor GPR35 contributes to angiotensin II–induced hypertension and cardiac dysfunction in mice. American Journal of Hypertension, 31(9), pp. 1049-1058. (doi: 10.1093/ajh/hpy073) (PMID:29860395) (PMCID:PMC6077831)

Marsango, Sara, Ward, Richard J., Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2018) Muscarinic receptor oligomerization. Neuropharmacology, 136(Part C), pp. 401-410. (doi: 10.1016/j.neuropharm.2017.11.023) (PMID:29146505) (PMCID:PMC6078712)

Binti Mohd Amir, Nurul A.S., Mackenzie, Amanda E., Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Boustani, Karim, Hillier, Marston C., Tsuchiya, Tomoko, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Pease, James E. (2018) Evidence for the existence of a CXCL17 receptor distinct from GPR35. Journal of Immunology, 201(2), pp. 714-724. (doi: 10.4049/jimmunol.1700884) (PMID:29875152) (PMCID:PMC6036231)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2018) G protein-coupled receptors not currently in the spotlight: free fatty acid receptor 2 and GPR35. British Journal of Pharmacology, 175(13), pp. 2543-2553. (doi: 10.1111/bph.14042) (PMID:28940377) (PMCID:PMC6003633)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Inoue, Asuka (2018) Genome editing provides new insights into receptor-controlled signalling pathways. Trends in Pharmacological Sciences, 39(5), pp. 481-493. (doi: 10.1016/j.tips.2018.02.005) (PMID:29548548)

Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Ward, Richard J., Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2018) Spatial intensity distribution analysis: studies of G Protein-coupled receptor oligomerization. Trends in Pharmacological Sciences, 39(2), pp. 175-186. (doi: 10.1016/j.tips.2017.09.001) (PMID:29032835) (PMCID:PMC5783713)

Reichardt, N. et al. (2018) Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production. ISME Journal, 12, pp. 610-622. (doi: 10.1038/ismej.2017.196) (PMID:29192904)

Mahmud, Zobaer Al, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Ulven, Trond, Labéguère, Frédéric, Gosmini, Romain, De Vos, Steve, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Tikhonova, Irina G. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) Three classes of ligands each bind to distinct sites on the orphan G protein-coupled receptor GPR84. Scientific Reports, 7, 17953. (doi: 10.1038/s41598-017-18159-3) (PMID:29263400) (PMCID:PMC5738391)

Viskaitis, P. et al. (2017) Modulation of SF1 neuron activity coordinately regulates both feeding behaviour and associated emotional states. Cell Reports, 21(12), pp. 3559-3572. (doi: 10.1016/j.celrep.2017.11.089) (PMID:29262334) (PMCID:PMC5746599)

Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693, Hansen, Anders Højgaard, Bolognini, Daniele, Kawakami, Kouki, Kishi, Takayuki, Aoki, Junken, Ulven, Trond, Inoue, Asuka, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) A single extracellular amino acid in Free Fatty Acid Receptor 2 defines antagonist species selectivity and G protein selection bias. Scientific Reports, 7, 13741. (doi: 10.1038/s41598-017-14096-3) (PMID:29061999) (PMCID:PMC5653858)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Prihandoko, Rudi and Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 (2017) FFA4/GPR120: pharmacology and therapeutic opportunities. Trends in Pharmacological Sciences, 38(9), pp. 809-821. (doi: 10.1016/j.tips.2017.06.006) (PMID:28734639) (PMCID:PMC5582618)

Prokop, Susanne, Perry, Nicole A., Vishnivetskiy, Sergey A., Toth, Andras D., Inoue, Asuka, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Iverson, Tina M., Hunyady, Laszlo and Gurevich, Vsevolod V. (2017) Differential manipulation of arrestin-3 binding to basal and agonist-activated G protein-coupled receptors. Cellular Signalling, 36, pp. 98-107. (doi: 10.1016/j.cellsig.2017.04.021) (PMID:28461104)

Lopez-Gimenez, Juan, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) M3 muscarinic acetylcholine receptor facilitates the endocytosis of mu opioid receptor mediated by morphine independently of the formation of heteromeric complexes. Cellular Signalling, 35, pp. 208-222. (doi: 10.1016/j.cellsig.2017.04.006) (PMID:28411124)

Kaspersen, Mads Holmgaard, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Dunlop, Julia ORCID logoORCID: https://orcid.org/0000-0003-3180-6763, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2017) Succinct synthesis of saturated hydroxy fatty acids and in vitro evaluation of all hydroxylauric acids on FFA1, FFA4 and GPR84. MedChemComm, 8(6), pp. 1360-1365. (doi: 10.1039/c7md00130d)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Harikumar, Kaleeckal G., Miller, Laurence J. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) Spatial intensity distribution analysis quantifies the extent and regulation of homodimerization of the secretin receptor. Biochemical Journal, 474(11), pp. 1879-1895. (doi: 10.1042/BCJ20170184) (PMID:28424368) (PMCID:PMC5442643)

Watterson, K. R. et al. (2017) Probe-dependent negative allosteric modulators of the long-chain free fatty acid receptor FFA4. Molecular Pharmacology, 91(6), pp. 630-641. (doi: 10.1124/mol.116.107821) (PMID:28385906) (PMCID:PMC5438128)

Marsango, Sara, Caltabiano, Gianluigi, Jiménez-Rosés, Mireia, Millan, Mark J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Ward, Richard J. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) A molecular basis for selective antagonist destabilization of dopamine D3 receptor quaternary organization. Scientific Reports, 7, 2134. (doi: 10.1038/s41598-017-02249-3) (PMID:28522847) (PMCID:PMC5437050)

Houthuijzen, J. M. et al. (2017) Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance. FASEB Journal, 31(5), pp. 2195-2209. (doi: 10.1096/fj.201601248R) (PMID:28183801) (PMCID:PMC5388545)

Mackenzie, Amanda E. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) The emerging pharmacology and function of GPR35 in the nervous system. Neuropharmacology, 113(part B), pp. 661-671. (doi: 10.1016/j.neuropharm.2015.07.035) (PMID:26232640)

Hansen, Anders Højgaard, Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693, Pandey, Sunil K., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Christiansen, Elisabeth, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2017) Development and characterization of a fluorescent tracer for the free fatty acid receptor 2 (FFA2/GPR43). Journal of Medicinal Chemistry, 60(13), pp. 5638-5645. (doi: 10.1021/acs.jmedchem.7b00338) (PMID:28570808)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Shimpukade, Bharat, Ulven, Trond and Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 (2017) Complex pharmacology of free fatty acid receptors. Chemical Reviews, 117(1), pp. 67-110. (doi: 10.1021/acs.chemrev.6b00056) (PMID:27299848)

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Inoue, Asuka, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Raihan, Sheikh Zahir, Prihandoko, Rudi, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Targeted elimination of G proteins and arrestins defines their specific contributions to both intensity and duration of G protein-coupled receptor signalling. Journal of Biological Chemistry, 291(53), pp. 27147-27159. (doi: 10.1074/jbc.M116.754887) (PMID:27852822) (PMCID:PMC5207144)

Azevedo, C. M. G. et al. (2016) Non-acidic free fatty acid receptor 4 agonists with antidiabetic activity. Journal of Medicinal Chemistry, 59(19), pp. 8868-8878. (doi: 10.1021/acs.jmedchem.6b00685)

Bolognini, D. et al. (2016) A novel allosteric activator of free fatty acid 2 receptor displays unique Gi-functional bias. Journal of Biological Chemistry, 291, pp. 18915-18931. (doi: 10.1074/jbc.M116.736157) (PMID:27385588) (PMCID:PMC5009265)

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Metabolism meets immunity: the role of free fatty acid receptors in the immune system. Biochemical Pharmacology, 114, pp. 3-13. (doi: 10.1016/j.bcp.2016.03.017) (PMID:27002183)

Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Ward, Richard J., Godin, Antoine G., Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Dynamic regulation of quaternary organization of the M1 muscarinic receptor by subtype-selective antagonist drugs. Journal of Biological Chemistry, 291, pp. 13132-13146. (doi: 10.1074/jbc.M115.712562) (PMID:27080256) (PMCID:PMC4933229)

Nuber, Susanne, Zabel, Ulrike, Lorenz, Kristina, Nuber, Andreas, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Lohse, Martin J. and Hoffmann, Carsten (2016) β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle. Nature, 531, pp. 661-664. (doi: 10.1038/nature17198) (PMID:27007855)

Hansen, S. V.F. et al. (2016) Discovery of a potent free fatty acid 1 receptor agonist with low lipophilicity, low polar surface area and robust in vivo efficacy. Journal of Medicinal Chemistry, 59, pp. 2841-2846. (doi: 10.1021/acs.jmedchem.5b01962)

Grundmann, Manuel, Tikhonova, Irina G., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Smith, Nicola J., Mohr, Klaus, Ulven, Trond, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Kenakin, Terry and Kostenis, Evi (2016) A molecular mechanism for sequential activation of a G Protein-coupled receptor. Cell Chemical Biology, 23(3), pp. 392-403. (doi: 10.1016/j.chembiol.2016.02.014) (PMID:26991104)

Bolognini, Daniele, Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Moss, Catherine E. (2016) The pharmacology and function of receptors for short-chain fatty acids. Molecular Pharmacology, 89(3), pp. 388-398. (doi: 10.1124/mol.115.102301) (PMID:26719580)

Moreno, J. L. et al. (2016) Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia. Science Signaling, 9(410), ra5. (doi: 10.1126/scisignal.aab0467) (PMID:26758213) (PMCID:PMC4819166)

Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693, Hansen, Anders Højgaard, Pandey, Sunil K., MacKenzie, Amanda E., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Ulven, Trond and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Non-equivalence of key positively charged residues of the free fatty acid 2 receptor in the recognition and function of agonist versus antagonist ligands. Journal of Biological Chemistry, 291, pp. 303-317. (doi: 10.1074/jbc.M115.687939) (PMID:26518871) (PMCID:PMC4697166)

Christiansen, Elisabeth, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Hansen, Anders Højgaard, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2016) Development and characterization of a potent free fatty acid receptor 1 (FFA1) fluorescent tracer. Journal of Medicinal Chemistry, 59(10), pp. 4849-4858. (doi: 10.1021/acs.jmedchem.6b00202) (PMID:27074625)

McCallum, Jennifer E., Mackenzie, Amanda E., Divorty, Nina, Clarke, Carolyn, Delles, Christian ORCID logoORCID: https://orcid.org/0000-0003-2238-2612, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2016) G protein-coupled receptor 35 mediates human saphenous vein vascular smooth muscle cell migration and endothelial cell proliferation. Journal of Vascular Research, 52(6), pp. 383-395. (doi: 10.1159/000444754) (PMID:27064272) (PMCID:PMC4959467)

Prihandoko, Rudi, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Butcher, Adrian J., Ulven, Trond, Miller, Ashley M., Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2016) Distinct phosphorylation clusters determines the signalling outcome of the free fatty acid receptor FFA4/GPR120. Molecular Pharmacology, 89(5), pp. 505-520. (doi: 10.1124/mol.115.101949) (PMID:26873857)

Schrage, R. et al. (2015) The experimental power of FR900359 to study Gq-regulated biological processes. Nature Communications, 6, p. 10156. (doi: 10.1038/ncomms10156) (PMID:26658454) (PMCID:PMC4682109)

Brown, J.H., Catterall, W.A., Conn, P.J., Cull-Candy, S.G., Dingledine, R., Harden, T.K., Insel, P.A., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Traynelis, S.F. (2015) The first 50 years of molecular pharmacology. Molecular Pharmacology, 88(1), pp. 139-140. (doi: 10.1124/mol.115.099564) (PMID:25943115)

Mckinney, C.A., Kennedy, S. ORCID logoORCID: https://orcid.org/0000-0003-0887-5840, Baillie, G.S. ORCID logoORCID: https://orcid.org/0000-0003-2469-6316, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, S.A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2015) Angiotensin-(1-7) and angiotensin-(1-9) inhibit vascular smooth muscle cell growth and migration in vitro and vascular remodelling in vivo. Atherosclerosis, 241(1), e44. (doi: 10.1016/j.atherosclerosis.2015.04.158)

Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Alvarez-Curto, E. ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Watterson, K.R. ORCID logoORCID: https://orcid.org/0000-0003-3819-4026, Ulven, T. and Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 (2015) Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4. British Journal of Pharmacology, 172(13), pp. 3254-3265. (doi: 10.1111/bph.12879) (PMID:25131623)

Marsango, Sara, Caltabiano, Gianluigi, Pou, Chantevy, Varela Liste, Maria Jose and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Analysis of human dopamine D3 receptor quaternary structure. Journal of Biological Chemistry, 290, pp. 15146-15162. (doi: 10.1074/jbc.M114.630681) (PMID:25931118) (PMCID:PMC4463457)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Liste, María José Varela, Caltabiano, Gianluigi Caltabiano, Alvarez-Curto, Elisa and Marsango, Sara (2015) Defining the organizational structure of dopamine and muscarninic acetylcholine receptors. SpringerPlus, 4(Sup 1), L7. (doi: 10.1186/2193-1801-4-s1-l7) (PMID:27386224) (PMCID:PMC4796694)

Aslanoglou, Despoina, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Distinct agonist regulation of muscarinic acetylcholine M2-M3 heteromers and their corresponding homomers. Journal of Biological Chemistry, 290(23), pp. 14785-14796. (doi: 10.1074/jbc.M115.649079) (PMID:25918156) (PMCID:PMC4505543)

Christiansen, E. et al. (2015) Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases. British Journal of Nutrition, 113(11), pp. 1677-1688. (doi: 10.1017/S000711451500118X) (PMID:25916176)

Liste, Maria J., Caltabiano, Gianluigi, Ward, Richard J., Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Marsango, Sara and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) The molecular basis of oligomeric organization of the human m3 muscarinic acetylcholine receptor. Molecular Pharmacology, 87(6), pp. 936-953. (doi: 10.1124/mol.114.096925) (PMID:25769304)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Godin, Antoine G. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Regulation of oligomeric organization of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor observed by spatial intensity distribution analysis. Journal of Biological Chemistry, 290(20), pp. 12844-12857. (doi: 10.1074/jbc.M115.644724) (PMID:25825490) (PMCID:PMC4432300)

Divorty, Nina, Mackenzie, Amanda, Nicklin, Stuart ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) G protein-coupled receptor 35: an emerging target in inflammatory and cardiovascular disease. Frontiers in Pharmacology, 6, 41. (doi: 10.3389/fphar.2015.00041) (PMID:25805994) (PMCID:PMC4354270)

Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Christiansen, Elisabeth, Murdoch, Hannah, Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Hansen, Anders Højgaard, Madsen, Ole, Ulven, Trond and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2014) Complex pharmacology of novel allosteric free fatty acid 3 receptor ligands. Molecular Pharmacology, 86(2), pp. 200-210. (doi: 10.1124/mol.114.093294)

Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Shimpukade, Bharat, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, Trond (2014) The molecular basis of ligand interaction at free fatty acid receptor 4 (FFA4/GPR120). Journal of Biological Chemistry, 289, pp. 20345-20358. (doi: 10.1074/jbc.M114.561449) (PMID:24860101) (PMCID:PMC4106347)

Zakrys, Linas, Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Godin, Antoine G., Graham, Gerard J. ORCID logoORCID: https://orcid.org/0000-0002-7801-204X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2014) Roundabout 1 exists predominantly as a basal dimeric complex and this is unaffected by binding of the ligand Slit2. Biochemical Journal, 461(1), pp. 61-73. (doi: 10.1042/BJ20140190)

Butcher, Adrian J., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Shimpukade, Bharat, Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Prihandoko, Rudi, Ulven, Trond, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Tobin, Andrew B. ORCID logoORCID: https://orcid.org/0000-0002-1807-3123 (2014) Concomitant action of structural elements and receptor phosphorylation determine arrestin-3 interaction with the free fatty acid receptor FFA4. Journal of Biological Chemistry, 289, pp. 18451-18465. (doi: 10.1074/jbc.M114.568816) (PMID:24817122) (PMCID:PMC4140278)

Fjaere, E. et al. (2014) Indomethacin treatment prevents high fat diet-induced obesity and insulin resistance but not glucose intolerance in C57BL/6J mice. Journal of Biological Chemistry, 289(23), pp. 16032-16045. (doi: 10.1074/jbc.M113.525220)

McKinney, Clare A., Fattah, Caroline, Loughrey, Christopher M. ORCID logoORCID: https://orcid.org/0000-0003-1297-9159, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2014) Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodeling. Clinical Science, 126, pp. 815-827. (doi: 10.1042/CS20130436)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Ulven, Trond, Murdoch, Hannah and Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091 (2014) G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets. British Journal of Nutrition, 111(S1), S3-S7. (doi: 10.1017/S0007114513002249)

Ferre, Sergi, Casado, Vicent, Devi, Lakshmi A., Filizola, Marta, Jockers, Ralf, Lohse, Martin J., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Pin, Jean-Philippe and Guitart, Xavier (2014) G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives. Pharmacological Reviews, 66(2), pp. 413-434. (doi: 10.1124/pr.113.008052)

Ward, R.J. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2014) Structural and biophysical characterisation of G protein-coupled receptor ligand binding using resonance energy transfer and fluorescent labelling techniques. Biochimica et Biophysica Acta: Biomembranes, 1838(1A), pp. 3-14. (doi: 10.1016/j.bbamem.2013.04.007)

Mackenzie, A.E. et al. (2014) The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat gpr35. Molecular Pharmacology, 85(1), pp. 91-104. (doi: 10.1124/mol.113.089482)

Watterson, Kenneth R. ORCID logoORCID: https://orcid.org/0000-0003-3819-4026, Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Ulven, Trond and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2014) Treatment of type 2 diabetes by free fatty acid receptor agonists. Frontiers in Endocrinology, 5, 137. (doi: 10.3389/fendo.2014.00137) (PMID:25221541) (PMCID:PMC4147718)

Horobin, R.W. ORCID logoORCID: https://orcid.org/0000-0002-6612-6664, Rashid-Doubell, F., Pediani, J.D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) Predicting small molecule fluorescent probe localization in living cells using QSAR modeling. 1. Overview and models for probes of structure, properties and function in single cells. Biotechnic and Histochemistry, 88(8), pp. 440-460. (doi: 10.3109/10520295.2013.780634)

Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Shimpukade, B., Mackenzie, A.E., Butcher, A.J., Pediani, J.D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Christiansen, E., Heathcote, H., Tobin, A.B., Ulven, T. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) The pharmacology of TUG-891, a potent and selective agonist of the free fatty acid receptor 4 (FFA4/GPR120), demonstrates both potential opportunity and possible challenges to therapeutic agonism. Molecular Pharmacology, 84(5), pp. 710-725. (doi: 10.1124/mol.113.087783)

Perez-Aso, M., Segura, V., Montó, F., Barettino, D., Noguera, M.A., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and D'Ocon, P. (2013) The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation. Biochimica et Biophysica Acta: Molecular Cell Research, 1833(10), pp. 2322-2333. (doi: 10.1016/j.bbamcr.2013.06.013)

Scott, Elizabeth, Loya, Komal, Mountford, Joanne, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Baker, Andrew H. (2013) MicroRNA regulation of endothelial homeostasis and commitment—implications for vascular regeneration strategies using stem cell therapies. Free Radical Biology and Medicine, 64, pp. 52-60. (doi: 10.1016/j.freeradbiomed.2013.04.037)

Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Murdoch, H. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) The effects of species ortholog and SNP variation on receptors for free fatty acids. Molecular Endocrinology, 27(8), pp. 1177-1187. (doi: 10.1210/me.2013-1085)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) The prevalence, maintenance, and relevance of G protein-coupled receptor oligomerization. Molecular Pharmacology, 84(1), pp. 158-169. (doi: 10.1124/mol.113.084780)

Hudson, B.D. et al. (2013) Defining the molecular basis for the first potent and selective orthosteric agonists of the FFA2 free fatty acid receptor. Journal of Biological Chemistry, 288(24), pp. 17296-17312. (doi: 10.1074/jbc.M113.455337)

Christiansen, E. et al. (2013) Discovery of TUG-770: a highly potent free fatty acid receptor 1 (FFA1/GPR40) agonist for treatment of type 2 diabetes. ACS Medicinal Chemistry Letters, 4(5), pp. 441-445. (doi: 10.1021/ml4000673)

Neetoo-Isseljee, Z., MacKenzie, A.E., Southern, C., Jerman, J., McIver, E. G., Harries, N., Taylor, D. L. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) High-throughput identification and characterization of novel, species-selective GPR35 agonists. Journal of Pharmacology and Experimental Therapeutics, 344(3), pp. 568-578. (doi: 10.1124/jpet.112.201798)

Christiansen, E. et al. (2013) Discovery of a potent and selective free fatty acid receptor 1 agonist with low lipophilicity and high oral bioavailability. Journal of Medicinal Chemistry, 56(3), pp. 982-992. (doi: 10.1021/jm301470a)

Clarke, Carolyn, Flores-Muñoz, Monica, McKinney, Clare A., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2013) Regulation of cardiovascular remodeling by the counter-regulatory axis of the renin–angiotensin system. Future Cardiology, 9(1), pp. 23-38. (doi: 10.2217/fca.12.75)

Howard, Lynsey, MacKenzie, Ruth M., Pchelintsev, Nikolay A., McBryan, Tony, McClure, John D. ORCID logoORCID: https://orcid.org/0000-0003-4839-5462, McBride, Martin W. ORCID logoORCID: https://orcid.org/0000-0002-6323-124X, Kane, Nicole M., Adams, Peter D., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Baker, Andrew H. (2013) Profiling of transcriptional and epigenetic changes during directed endothelial differentiation of human embryonic stem cells identifies FOXA2 as a marker of early mesoderm commitment. Stem Cell Research and Therapy, 4(2), Art. 36. (doi: 10.1186/scrt192)

Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Ulven, Trond and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs. Current Topics in Medicinal Chemistry, 13(1), pp. 14-25. (doi: 10.2174/1568026611313010004)

Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Harries, N., Lappin, J.E., MacKenzie, A.E., Neetoo-Isseljee, Z., Southern, C., McIver, E.G., Nicklin, S.A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210, Taylor, D.L. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) Antagonists of GPR35 display high species ortholog selectivity and varying modes of action. Journal of Pharmacology and Experimental Therapeutics, 343(3), pp. 683-695. (doi: 10.1124/jpet.112.198945) (PMID:22967846) (PMCID:PMC3500541)

Mackenzie, Amanda Elaine, Neetoo-Isseljee, Zaynab, Southern, Craig, Jerman, Jeff, McIver, Edward G., Hudson, Brian D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Taylor, Debra L. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) Novel and potent GPR35 agonists aid identification of residues important in ligand interaction. FASEB Journal, 27, 655.1.

Patowary, S., Alvarez-Curto, E. ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Xu, T.-R., Holz, J.D., Oliver, J.A., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Raicu, V. (2013) The muscarinic M3acetylcholine receptor exists as two differently sized complexes at the plasma membrane. Biochemical Journal, 452(2), pp. 303-312. (doi: 10.1042/BJ20121902) (PMID:23521066)

Segura, V., Pérez-Aso, M., Montó, F., Carceller, E., Noguera, M.A., Pediani, J. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, McGrath, I.C. ORCID logoORCID: https://orcid.org/0000-0002-5276-0381 and D’Ocon, P. (2013) Differences in the signaling pathways of α1A- and α1B-adrenoceptors are related to different endosomal targeting. PLoS ONE, 8(5), e64996. (doi: 10.1371/journal.pone.0064996) (PMID:23717684) (PMCID:PMC3663791)

Ward, R.W., Xu, T.-X. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2013) GPCR oligomerization and receptor trafficking. Methods in Enzymology, 521, pp. 69-90. (doi: 10.1016/B978-0-12-391862-8.00004-1)

Moreno, J.L. et al. (2012) Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A{middle dot}mGlu2) receptor heteromerization and its psychoactive behavioral function. Journal of Biological Chemistry, 287(53), pp. 44301-44319. (doi: 10.1074/jbc.M112.413161)

Hudson, B. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Christiansen, E., Tikhonova, I.G., Grundmann, M., Kostenis, E., Adams, D.R., Ulven, T. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs. FASEB Journal, 26(12), pp. 4951-4965. (doi: 10.1096/fj.12-213314)

Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Tikhonova, I.G., Pandey, S.K., Ulven, T. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3. Journal of Biological Chemistry, 287(49), pp. 41195-41209. (doi: 10.1074/jbc.M112.396259)

Christiansen, E. et al. (2012) Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties. Journal of Medicinal Chemistry, 55(14), pp. 6624-6628. (doi: 10.1021/jm3002026)

Cunningham, Margaret R., McIntosh, Kathryn A., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Robben, Joris, Cooke, Alexandra E., Nilsson, Mary, Gould, Gwyn W. ORCID logoORCID: https://orcid.org/0000-0001-6571-2875, Mundell, Stuart, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Plevin, Robin (2012) Novel role for proteinase-activated receptor 2 (PAR2) in membrane trafficking of proteinase-activated receptor 4 (PAR4). Journal of Biological Chemistry, 287(20), pp. 16656-16669. (doi: 10.1074/jbc.M111.315911)

Shimpukade, B., Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Hogaard, C.K., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Ulven, T. (2012) Discovery of a potent and selective GPR120 agonist. Journal of Medicinal Chemistry, 55(9), pp. 4511-4515. (doi: 10.1021/jm300215x)

Xu, Tian-Rui, Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation. Journal of Biological Chemistry, 287, pp. 14937-14949. (doi: 10.1074/jbc.M111.334300)

Kane, N. M. et al. (2012) Role of MicroRNAs 99b, 181a, and 181b in the differentiation of human embryonic stem cells to vascular endothelial cells. Stem Cells, 30(4), pp. 643-654. (doi: 10.1002/stem.1026)

White, Katie, Kane, Nicole M., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Baker, Andrew H. (2012) The role of miRNA in stem cell pluripotency and commitment to the vascular endothelial lineage. Microcirculation, 19(3), pp. 196-207. (doi: 10.1111/j.1549-8719.2012.00161.x)

Xu, Tian-Rui, Lu, Rui-Fang, Romano, David, Pitt, Andrew, Houslay, Miles D., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kolch, Walter (2012) Eukaryotic translation initiation factor 3, subunit a, regulates the extracellular signal-regulated kinase pathway. Molecular and Cellular Biology, 32(1), pp. 88-95. (doi: 10.1128/​MCB.05770-11)

Flores, M., Graham, D. ORCID logoORCID: https://orcid.org/0000-0002-7328-4708, Dominiczak, A.F. ORCID logoORCID: https://orcid.org/0000-0003-4913-3608, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Baker, A.H. and Nicklin, S.A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2012) Angiotensin-(1-9) antagonises Angiotensin II-induced cardiac remodeling via the angiotensin type 2 receptor. Proceedings of the Physiological Society, 27, C1.

Flores, Monica, Graham, Delyth ORCID logoORCID: https://orcid.org/0000-0002-7328-4708, Dominiczak, Anna F. ORCID logoORCID: https://orcid.org/0000-0003-4913-3608, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Baker, Andrew H. and Nicklin, Stuart A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2012) Abstract 231: angiotensin-(1-9) antagonises cardiac remodelling in a mouse model of Angiotensin Ii-induced hypertension. Hypertension, 60, A231.

Georgoussi, Z., Georganta, E.M. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) The other side of opioid receptor signalling: regulation by protein-protein interaction. Current Drug Targets, 13(1), pp. 80-102. (doi: 10.2174/138945012798868470)

Laarman, A.J. et al. (2012) Staphylococcus aureus Staphopain A inhibits CXCR2-dependent neutrophil activation and chemotaxis. EMBO Journal, 31(17), pp. 3607-3619. (doi: 10.1038/emboj.2012.212)

Pou, C., Mannoury la Cour, C., Stoddart, L.A., Millan, M.J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2012) Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface. Journal of Biological Chemistry, 287(12), pp. 8864-8878. (doi: 10.1074/jbc.M111.326678)

Terhzaz, S. ORCID logoORCID: https://orcid.org/0000-0002-6192-6558, Cabrero, P. ORCID logoORCID: https://orcid.org/0000-0003-2141-7852, Robben, J.H., Radford, J.C., Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Dow, J.A.T. ORCID logoORCID: https://orcid.org/0000-0002-9595-5146 and Davies, S.A. ORCID logoORCID: https://orcid.org/0000-0002-0472-1302 (2012) Mechanism and function of drosophila capa GPCR: a desiccation stress-responsive receptor with functional homology to human neuromedinU receptor. PLoS ONE, 7(1), e29897. (doi: 10.1371/journal.pone.0029897) (PMID:22253819) (PMCID:PMC3256212)

Mackenzie, A.E., Lappin, J.E., Taylor, D.L., Nicklin, S.A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) GPR35 as a novel therapeutic target. Frontiers in Endocrinology, 2, 68. (doi: 10.3389/fendo.2011.00068) (PMID:22654822) (PMCID:PMC3356001)

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Prihandoko, Rudi, Tautermann, Christofer S., Zwier, Jurriaan M., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Lohse, Martin J., Hoffmann, Carsten, Tobin, Andrew B. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Developing chemical genetic approaches to explore G protein-coupled receptor function: validation of the use of a Receptor Activated Solely by Synthetic Ligand (RASSL). Molecular Pharmacology, 80(6), pp. 1033-1046. (doi: 10.1124/mol.111.074674) (PMID:21880827) (PMCID:PMC3228535)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Heteromultimerization of cannabinoid CB1 receptor and orexin OX1 receptor generates a unique complex in which both protomers are regulated by orexin A. Journal of Biological Chemistry, 286(43), pp. 37414-37428. (doi: 10.1074/jbc.M111.287649)

Howard, Lynsey, Kane, Nicole, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Baker, Andrew H. (2011) MicroRNAs regulating cell pluripotency and vascular differentiation. Vascular Pharmacology, 55(4), pp. 69-78. (doi: 10.1016/j.vph.2011.08.002)

Xu, Tian‑Rui, Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) The orexin OX1 receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands. Biochemical Journal, 439(1), pp. 171-183. (doi: 10.1042/BJ20110230)

Van Lith, Marcel, Tiwari, Shweta, Pediani, John ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Bulleid, Neil J. ORCID logoORCID: https://orcid.org/0000-0002-9839-5279 (2011) Real-time monitoring of redox changes in the mammalian endoplasmic reticulum. Journal of Cell Science, 124(14), pp. 2349-2356. (doi: 10.1242/jcs.085530)

Smith, N.J. et al. (2011) Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator. Molecular Pharmacology, 80(1), pp. 163-173. (doi: 10.1124/mol.110.070789)

Nejsum, L.N., Christensen, T.M., Robben, J.H., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Deen, P.M.T., Bichet, D.G. and Levin, K. (2011) Novel mutation in the AVPR2 gene in a Danish male with nephrogenic diabetes insipidus caused by ER retention and subsequent lysosomal degradation of the mutant receptor. NDT Plus, 4(3), pp. 158-163. (doi: 10.1093/ndtplus/sfr010) (PMID:21629670) (PMCID:PMC3103721)

Schmidt, J. et al. (2011) Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. Journal of Biological Chemistry, 286(12), pp. 10628-10640. (doi: 10.1074/jbc.M110.210872)

Anthony, D.F., Sin, Y.Y. ORCID logoORCID: https://orcid.org/0000-0001-6537-5266, Vadrevu, S., Advant, N., Day, J.P., Byrne, A.M., Lynch, M.J., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Houslay, M.D. and Baillie, G.S. ORCID logoORCID: https://orcid.org/0000-0003-2469-6316 (2011) β-Arrestin 1 inhibits the GAP function of ARHGAP21 so as to promote the activation of RhoA following angiotensin II type 1A receptor stimulation. Molecular and Cellular Biology, 31(5), pp. 1066-1075. (doi: 10.1128/MCB.00883-10) (PMID:21173159) (PMCID:PMC3067824)

Ward, Richard J., Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Ligand-induced internalisation of the orexin OX1 and cannabinoid CB1 receptors assessed via N-terminal SNAP and CLIP-tagging. British Journal of Pharmacology, 162(6), pp. 1439-1452. (doi: 10.1111/j.1476-5381.2010.01156.x)

Flores-Munoz, M., Smith, N. J., Haggerty, C., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nicklin, S. A. ORCID logoORCID: https://orcid.org/0000-0002-9691-6210 (2011) Angiotensin1-9 antagonises pro-hypertrophic signalling in cardiomyocytes via the angiotensin type 2 receptor. Journal of Physiology, 589(4), pp. 939-951. (doi: 10.1113/jphysiol.2010.203075)

Smith, N.J., Bennett, K. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) When simple agonism is not enough: Emerging modalities of GPCR ligands. Molecular and Cellular Endocrinology, 331(2), pp. 241-247. (doi: 10.1016/j.mce.2010.07.009)

Dimond, P. et al. (2011) G protein-coupled receptor modulation with pepducins: moving closer to the clinic. Annals of the New York Academy of Sciences, 1226(1), pp. 34-49. (doi: 10.1111/j.1749-6632.2011.06039.x)

Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Orthologue selectivity and ligand bias: translating the pharmacology of GPR35. Trends in Pharmacological Sciences, 32(5), pp. 317-325. (doi: 10.1016/j.tips.2011.02.002)

Schröder, R. et al. (2011) Applying label-free dynamic mass redistribution technology to frame signaling of G protein–coupled receptors noninvasively in living cells. Nature Protocols, 6(11), pp. 1748-1760. (doi: 10.1038/nprot.2011.386)

Tarrasón, G. et al. (2011) The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice. International Immunopharmacology, 11(11), pp. 1773-1779. (doi: 10.1016/j.intimp.2011.07.004)

Ward, R.J., Alvarez-Curto, E. ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Using the Flp-In™ T-Rex™ System to Regulate GPCR Expression. Methods in Molecular Biology, 746, pp. 21-37. (doi: 10.1007/978-1-61779-126-0_2)

Burton, P. et al. (2010) Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) blocks differentiation and maintains the expression of pluripotency markers in human embryonic stem cells. Biochemical Journal, 432(3), pp. 575-584. (doi: 10.1042/BJ20100726)

Kane, N. M. et al. (2010) Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors. Molecular Therapy, 18(12), pp. 2139-2145. (doi: 10.1038/mt.2010.231)

Smith, Nicola J. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Allostery at G protein-coupled receptor Homo- and Heteromers: uncharted pharmacological landscapes. Pharmacological Reviews, 62(4), pp. 701-725. (doi: 10.1124/pr.110.002667) (PMID:21079041) (PMCID:PMC2993260)

Lopez-Gimenez, J.F. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Opioid regulation of Mu receptor internalisation: relevance to the development of tolerance and dependence. CNS and Neurological Disorders: Drug Targets, 9(5), pp. 616-626. (doi: 10.2174/187152710793361522) (PMID:20632966)

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors. Analytical and Bioanalytical Chemistry, 398(1), pp. 167-180. (doi: 10.1007/s00216-010-3823-4) (PMID:20517598)

Schroder, R. et al. (2010) Deconvolution of complex G protein-coupled receptor signaling in live cells using dynamic mass redistribution measurements. Nature Biotechnology, 28(9), pp. 943-949. (doi: 10.1038/nbt.1671)

Burton, P. et al. (2010) Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells. Biochemical Society Transactions, 38(4), pp. 1058-1061. (doi: 10.1042/BST0381058)

Alvarez-Curto, Elisa, Ward, Richard J., Pediani, John D. and Milligan, Graeme (2010) Ligand regulation of the quaternary organization of cell surface M3 muscarinic acetylcholine receptors analyzed by fluorescence resonance energy transfer (FRET) imaging and homogenous time-resolved FRET. Journal of Biological Chemistry, 285(30), pp. 23318-23330. (doi: 10.1074/jbc.M110.122184) (PMID:20489201) (PMCID:PMC2906324)

Khelashvili, G. et al. (2010) GPCR-OKB: the G protein coupled receptor oligomer knowledge base. Bioinformatics, 26(14), pp. 1804-1805. (doi: 10.1093/bioinformatics/btq264)

Kane, Nicole M., Meloni, Marco, Spencer, Helen L., Craig, Margaret A., Strehl, Raimund, Milligan, Graeme, Houslay, Miles D., Mountford, Joanne C., Emanueli, Costanza and Baker, Andrew H. (2010) Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo. Arteriosclerosis, Thrombosis, and Vascular Biology, 30(7), pp. 1389-1397. (doi: 10.1161/ATVBAHA.110.204800)

del Burgo, Laura Saenz and Milligan, Graeme (2010) Heterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening. Expert Opinion on Drug Discovery, 5(5), pp. 461-474. (doi: 10.1517/17460441003720467) (PMID:22823130)

Milligan, Graeme (2010) The role of dimerisation in the cellular trafficking of G-protein-coupled receptors. Current Opinion in Pharmacology, 10(1), pp. 23-29. (doi: 10.1016/j.coph.2009.09.010) (PMID:19850521)

Andrews, P. et al. (2010) High content screening of feeder-free human embryonic stem cells to identify pro-survival small molecules. Biochemical Journal, 432(Pt 1), pp. 21-33. (doi: 10.1042/BJ20101022)

Burton, P. et al. (2010) Identification and characterization of small-molecule ligands that maintain pluripotency of human embryonic stem cells. Biochemical Society Transactions, 38(4), pp. 1058-1061. (doi: 10.1042/BST0381058)

Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Alvarez-Curto, E. ORCID logoORCID: https://orcid.org/0000-0003-4004-4545, Campbell, Kate, De Munnik, Sabrina, Canals Buj, M., Schlyer, Sabine and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β-arrestin-2. British Journal of Pharmacology, 162(3), pp. 733-748. (doi: 10.1111/j.1476-5381.2010.01082.x)

Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Brea, J., Smith, N.J., Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Reilly, G., Bryant, N.J., Castro, M., Loza, M.I. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13. Biochemical Journal, 432(3), pp. 451-459. (doi: 10.1042/BJ20101287)

Stoddart, L.A. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2010) Constitutive activity of GPR40/FFA1 intrinsic or assay dependent? Methods in Enzymology, 484, pp. 569-590. (doi: 10.1016/B978-0-12-381298-8.00028-9) (PMID:21036251)

Xu, T. et al. (2010) Inferring signaling pathway topologies from multiple perturbation measurements of specific biochemical species. Science Signaling, 3(113), ra20. (doi: 10.1126/scisignal.2000517)

Robben, J.H., Fenton, R.A., Vargas, S.L., Schweer, H., Peti-Peterdi, J., Deen, P.M.T. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) Localization of the succinate receptor in the distal nephron and its signaling in polarized MDCK cells. Kidney International, 76(12), pp. 1258-1267. (doi: 10.1038/ki.2009.360)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. British Journal of Pharmacology, 158(1), pp. 5-14. (doi: 10.1111/j.1476-5381.2009.00169.x) (PMID:19309353) (PMCID:PMC2795239)

Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and McGrath, J.C. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) GPCR theme editorial. British Journal of Pharmacology, 158(1), pp. 1-4. (doi: 10.1111/j.1476-5381.2009.00422.x)

Robben, J.H., Kortenoeven, M.L.A., Sze, M., Yae, C., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Oorschot, V.M., Klumperman, J., Knoers, N.V.A.M. and Deen, P.M.T. (2009) Intracellular activation of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus by nonpeptide agonists. Proceedings of the National Academy of Sciences of the United States of America, 106(29), pp. 12195-12200. (doi: 10.1073/pnas.0900130106)

Smith, N.J., Stoddart, L.A., Devine, N.M., Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547 and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1. Journal of Biological Chemistry, 284(26), pp. 17527-17539. (doi: 10.1074/jbc.M109.012849) (PMID:19398560) (PMCID:PMC2719392)

Idris, A.I., Sophocleous, A., Landao-Bassonga, E., Merkouris, M., Milligan, G., Baker, D., van't Hof, R.J. and Ralston, S.H. (2009) Cannabinoid receptor type 1 protects against age-related bone loss by regulating osteoblast and adipocyte differentiation of bone marrow stromal cells. Bone, 44(Supple), S222. (doi: 10.1016/j.bone.2009.03.067)

Ward, Richard J., Jenkins, Laura ORCID logoORCID: https://orcid.org/0000-0003-1382-8547 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) Selectivity and functional consequences of interactions of family A G protein-coupled receptors with neurochondrin and periplakin. Journal of Neurochemistry, 109(1), pp. 182-192. (doi: 10.1111/j.1471-4159.2009.05918.x)

Ferre, S. et al. (2009) Building a new conceptual framework for receptor heteromers. Nature Chemical Biology, 5(3), pp. 131-134. (doi: 10.1038/nchembio0309-131)

Canals, Meritxell, Lopez-Gimenez, Juan F. and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective α1b-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. Biochemical Journal, 417(1), pp. 161-172. (doi: 10.1042/BJ20081227)

Bennett, K.A., Langmead, C.J., Wise, A. and Milligan, G. (2009) Growth hormone secretagogues and growth hormone releasing peptides act as orthosteric super-agonists but not allosteric regulators for activation of the G protein G{alpha}o1 by the ghrelin receptor. Molecular Pharmacology, 76(4), pp. 802-811. (doi: 10.1124/mol.109.056101)

Brea, J.H. et al. (2009) Evidence for distinct antagonist-revealed functional states of 5-HT2A receptor homodimers. Molecular Pharmacology, 75(6), pp. 1380-1391. (doi: 10.1124/mol.108.054395)

Idris, A. I., Sophocleous, A., Landa-Bassonga, E., Canals, M., Milligan, G., Baker, D., van't Hof, R. J. and Ralston, S. (2009) Cannabinoid receptor type 1 protects against age-related bone loss by regulating osteoblast and adipocyte differentiation of bone marrow stromal cells. Cell Metabolism, 10(2), pp. 139-147. (doi: 10.1016/j.cmet.2009.07.006)

Milligan, G., Stoddart, L.A. and Smith, N.J. (2009) Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3. British Journal of Pharmacology, 158(1), pp. 146-153. (doi: 10.1111/j.1476-5381.2009.00421.x) (PMID:19719777) (PMCID:PMC2795255)

Lopez-Gimenez, Juan F., Vilaro, M. Teresa and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) Morphine desensitization, internalization and down-regulation of the μ opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor co-activation. Molecular Pharmacology, 74(5), pp. 1278-1291. (doi: 10.1124/mol.108.048272) (PMID:18703670)

Xu, Tian-Rui, Baillie, George S. ORCID logoORCID: https://orcid.org/0000-0003-2469-6316, Bhari, Narinder, Houslay, Thomas M., Pitt, Andrew M., Adams, David R., Kolch, Walter, Houslay, Miles D. and Milligan, Graeme (2008) Mutations of β-arrestin 2 that limit self-association also interfere with interactions with the β2-adrenoceptor and the ERK1/2 MAPKs: implications for β2-adrenoceptor signalling via the ERK1/2 MAPKs. Biochemical Journal, 413(1), pp. 51-60. (doi: 10.1042/BJ20080685)

Canals Buj, Meritxell and Milligan, Graeme (2008) Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors. Journal of Biological Chemistry, 283(17), pp. 11424-11434. (doi: 10.1074/jbc.M710300200)

González-Maeso, J. et al. (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature, 452(7183), pp. 93-97. (doi: 10.1038/nature06612)

Milligan, G. (2008) A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. British Journal of Pharmacology, 153(.), S216-S229. (doi: 10.1038/sj.bjp.0707490)

Hill, C., Brownlie, Z., Davey, J., Milligan, G. and Ladds, G. (2008) Isolation and characterization of a novel human RGS mutant displaying gain-of-function activity. Cellular Signalling, 20(2), pp. 323-336. (doi: 10.1016/j.cellsig.2007.10.016) (PMID:18031991)

Lane, J.R., Henderson, D., Powney, B., Wise, A., Rees, S., Daniels, D., Plumpton, C., Kinghorn, I. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) Antibodies that identify only the active conformation of Gi family G protein α subunits. FASEB Journal, 22, pp. 1924-1932. (doi: 10.1096/fj.07-100388)

Lane, J.R., Powney, B., Wise, A., Rees, S. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) G protein-coupling and ligand selectivity of the D2L and D3 dopamine receptors. Journal of Pharmacology and Experimental Therapeutics, 325(1), pp. 319-330. (doi: 10.1124/jpet.107.134296)

McCulloch, CV, Morrow, V, Milasta, S, Comerford, I, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Graham, GJ ORCID logoORCID: https://orcid.org/0000-0002-7801-204X, Isaacs, NW and Nibbs, RJ (2008) Multiple roles for the C-terminal tail of the chemokine scavenger D6. Journal of Biological Chemistry, 283(12), pp. 7972-7982. (doi: 10.1074/jbc.M710128200)

Noubade, R., Saligrama, N., Spach, K., del Rio, R., Blankenhorn, E.P., Kantidakis, T., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Rincon, M. and Teuscher, C. (2008) Autoimmune disease-associated histamine receptor H1 alleles exhibit differential protein trafficking and cell surface expression. Journal of Immunology, 180(11), pp. 7471-7479.

Parenty, G., Applebe, S. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) CXCR2 chemokine receptor antagonism enhances DOP opioid receptor function via allosteric regulation of the CXCR2-DOP receptor hetero-dimer. Biochemical Journal, 412(Pt2), pp. 215-256. (doi: 10.1042/BJ20071689)

Stoddart, L. A., Smith, N. J., Jenkins, L. ORCID logoORCID: https://orcid.org/0000-0003-1382-8547, Brown, A. J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids. Journal of Biological Chemistry, 283(47), pp. 32913-32924. (doi: 10.1074/jbc.M805601200) (PMID:18801738)

Snook, L.A., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Kieffer, B.L. and Massotte, D. (2007) Co-expression of mu and delta opioid receptors as receptor-G protein fusions enhances both mu and delta signalling via distinct mechanisms. Journal of Neurochemistry, 105(3), pp. 865-873. (doi: 10.1111/j.1471-4159.2008.05215.x)

Noubade, R, Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Zachary, J.F., Blankenhorn, E.P., del Rio, R., Rincorn, M. and Teuscher, C. (2007) Histamine receptor H1 is required for TCR-mediated p38 MAPK activation and optimal IFN-γ production in mice. Journal of Clinical Investigation, 117(11), pp. 3507-3518.

Baillie, G.S. et al. (2007) Mapping binding sites for the PDE4D5 cAMP-specific phosphodiesterase to the N- and C-domains of beta-arrestin using spot-immobilized peptide arrays. Biochemical Journal, 404(1), pp. 71-80. (doi: 10.1042%2FBJ20070005)

Skrabanek, L. et al. (2007) Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base. BMC Bioinformatics, 8(177), (doi: 10.1186/1471-2105-8-177)

Lopez-Gimenez, Juan F., Canals Buj, Meritxell, Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) The 1b-adrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Molecular Pharmacology, 71(4), pp. 1015-1029. (doi: 10.1124/mol.106.033035)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) G protein-coupled receptor dimerisation: molecular basis and relevance to function. Biochimica et Biophysica Acta: Biomembranes, 1768(4), pp. 825-835. (doi: 10.1016/j.bbamem.2006.09.021)

Pin, J.P. et al. (2007) International union of basic and clinical pharmacology. LXVII. Recommendations for the recognition and nomenclature of g protein-coupled receptor heteromultimers. Pharmacological Reviews, 59(1), pp. 5-13. (doi: 10.1124/pr.59.1.5)

Bouvier, Michel, Heveker, Nikolaus, Jockers, Ralf, Marullo, Stefano and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) BRET analysis of GPCR oligomerization: newer does not mean better. Nature Methods, 4(1), pp. 3-4. (doi: 10.1038/nmeth0107-3)

Fredholm, BB, Hokfelt, T and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) G-protein-coupled receptors: an update. Acta Physiologica, 190, pp. 3-7. (doi: 10.1111/j.1748-1716.2007.01689.x)

Jameson, EE, Pei, J, Wade, SM, Neubig, RR, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kennedy, RT (2007) Capillary electrophoresis assay for G protein-coupled receptor-mediated GTPase activity. Analytical Chemistry, 79, pp. 1158-1163. (doi: 10.1021/ac061099g)

Lane, JR, Powney, B, Wise, A, Rees, S and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) Protean agonism at the dopamine D-2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of G(o1) but an antagonist/inverse agonist for G(i1), G(i2), and G(i3). Molecular Pharmacology, 71, pp. 1349-1359. (doi: 10.1124/mol.106.032722)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) Allosteric modulation of heterodimeric G-protein-coupled receptors. Trends in Pharmacological Sciences, 28(12), pp. 615-620. (doi: 10.1016/j.tips.2007.11.001)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Parenty, G, Stoddart, LA and Lane, JR (2007) Novel pharmacological applications of G-protein-coupled receptor-G protein fusions. Current Opinion in Pharmacology, 7, pp. 521-526. (doi: 10.1016/j.coph.2007.06.007)

Noubade, R, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Zachary, JF, Blankenhorn, EP, del Rio, R, Rincon, M and Teuscherl, C (2007) Histamine receptor H-1 is-required for TCR-mediated p38 MAPK activation and optimal IFN-gamma production in mice. Journal of Clinical Investigation, 117, pp. 3507-3518. (doi: 10.1172/JC132792)

Orth, JHC, Lang, SN, Preuss, I, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Aktories, K (2007) Action of Pasteurella multocida toxin on G alpha(q) is persistent and independent of interaction with G-protein-coupled receptors. Cellular Signalling, 19, pp. 2174-2182. (doi: 10.1016/j.cellsig.2007.06.016)

Sartania, Nana ORCID logoORCID: https://orcid.org/0000-0002-3196-2312, Appelbe, Shirley, Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme (2007) Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta(2)-adrenoceptor. Cellular Signalling, 19, pp. 1928-1938. (doi: 10.1016/j.cellsig.2007.05.002)

Stoddart, LA, Brown, AJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2007) Uncovering the pharmacology of the G protein-coupled receptor GPR40: High apparent constitutive activity in guanosine 5'-O-(3-[S-35] thio) triphosphate binding studies reflects binding of an endogenous agonist. Molecular Pharmacology, 71, pp. 994-1005. (doi: 10.1124/mol.106.031534)

Ellis, J., Pediani, J.D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X, Canals Buj, M., Milasta, S. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function. Journal of Biological Chemistry, 281(25), pp. 38812-38824. (doi: 10.1074/jbc.M602494200)

Comerford, Iain, Milasta, Sandra, Morrow, Valerie, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Nibbs, Robert ORCID logoORCID: https://orcid.org/0000-0002-8150-0044 (2006) The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro. European Journal of Immunology, 36(7), pp. 1904-1916. (doi: 10.1002/eji.200535716)

Batenburg, W. et al. (2006) Carvedilol-induced antagonism of angiotensin II: a matter of alpha(1)-adrenoceptor blockade. Journal of Hypertension, 24, pp. 1355-1363.

Canals, M, Jenkins, L, Kellett, E and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of G(q)/G(11) by MAS. Journal of Biological Chemistry, 281, pp. 16757-16767. (doi: 10.1074/jbc.M601121200)

Ciruela, F. et al. (2006) Presynaptic control of striatal glutamatergic neurotransmission by adenosine A(1)-A(2A) receptor heteromers. Journal of Neuroscience, 26, pp. 2080-2087. (doi: 10.1523/JNEUROSCI.3574-05.2006)

Francke, F, Ward, RJ, Jenkins, L, Kellett, E, Richter, D, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Bachner, D (2006) Interaction of neurochondrin with the melanin-concentrating hormone receptor 1 interferes with G protein-coupled signal transduction but not agonist-mediated internalization. Journal of Biological Chemistry, 281, pp. 32496-32507. (doi: 10.1074/jbc.M602889200)

Milasta, S, Pediani, J, Appelbe, S, Trim, S, Wyatt, M, Cox, P, Fidock, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) Interactions between the Mas-related receptors MrgD and MrgE alter signalling and trafficking of MrgD. Molecular Pharmacology, 69, pp. 479-491. (doi: 10.1124/mol.105.018788)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) G-protein-coupled receptor heterodimers: pharmacology, function and relevance to drug discovery. Drug Discovery Today, 11, pp. 541-549. (doi: 10.1016/j.drudis.2006.04.007)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kostenis, E (2006) Heterotrimeric G-proteins: a short history. British Journal of Pharmacology, 147, S46-S55.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Pediani, JD, Canals, M and Lopez-Gimenez, JF (2006) Oligomeric structure of the alpha(1b)-adrenoceptor: Comparisons with rhodopsin. Vision Research, 46, pp. 4434-4441. (doi: 10.1016/j.visres.2006.08.007)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Stoddart, LA and Brown, AJ (2006) G protein-coupled receptors for free fatty acids. Cellular Signalling, 18, pp. 1360-1365. (doi: 10.1016/j.cellsig.2006.03.011)

Novotny, J, Durchankova, D, Ward, RJ, Carrillo, JJ, Svoboda, P and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2006) Functional interactions between the alpha(1b)-adrenoceptor and G alpha(11) are compromised by de-palmitoylation of the G protein but not of the receptor. Cellular Signalling, 18, pp. 1244-1251. (doi: 10.1016/j.cellsig.2005.10.004)

Snook, LA, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Kieffer, BL and Massotte, D (2006) mu-delta opioid receptor functional interaction: Insight using receptor-G protein fusions. Journal of Pharmacology and Experimental Therapeutics, 318, pp. 683-690. (doi: 10.1124/jpet.106.101220)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Bouvier, Michel (2005) Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS Journal, 272(12), pp. 2914-2925. (doi: 10.1111/j.1742-4658.2005.04731.x)

Barclay, E, OReilly, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Activation of an alpha(2A)-adrenoceptor-G alpha(o1), fusion protein dynamically regulates the palmitoylation status of the G protein but not of the receptor. Biochemical Journal, 385, pp. 197-206.

Barnes, WG, Reiter, E, Violin, JD, Ren, XR, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Lefkowitz, RJ (2005) beta-arrestin 1 and G(alpha q/11) coordinately activate RhoA and stress fiber formation following receptor stimulation. Journal of Biological Chemistry, 280, pp. 8041-8050. (doi: 10.1074/jbc.M412924200)

Holdsworth, G, Slocombe, P, Hutchinson, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Analysis of endogenous S1P and LPA receptor expression in CHO-K1 cells. Gene, 350, pp. 59-63. (doi: 10.1016/j.gene.2005.01.016)

Hunton, DL, Barnes, WG, Kim, J, Ren, XR, Violin, JD, Reiter, E, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Patel, DD and Lefkowitz, RJ (2005) beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis. Molecular Pharmacology, 67, pp. 1229-1236. (doi: 10.1124/mol.104.006270)

Kostenis, E, Martini, L, Ellis, J, Waldhoer, M, Heydorn, A, Rosenkilde, MM, Norregaard, PK, Jorgensen, R, Whistler, JL and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) A highly conserved glycine within linker I and the extreme C terminus of G protein alpha subunits interact cooperatively in switching G protein-coupled receptor-to-effector specificity. Journal of Pharmacology and Experimental Therapeutics, 313, pp. 78-87. (doi: 10.1124/jpet.104.080424)

Kostenis, E. et al. (2005) (G)-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation, 111, pp. 1806-1813. (doi: 10.1161/01.CIR.0000160867.23556.7D)

Kostenis, E, Waelbroeck, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Techniques: Promiscuous G alpha proteins in basic research and drug discovery. Trends in Pharmacological Sciences, 26, pp. 595-602. (doi: 10.1016/j.tips.2005.09.007)

Milasta, S, Evans, NA, Ormiston, L, Wilson, S, Lefkowitz, RJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) The sustainability of interactions between the orexin-1 receptor and beta-arrestin-2 is defined by a single C-terminal cluster of hydroxy amino acids and modulates the kinetics of ERK MAPK regulation. Biochemical Journal, 387, pp. 573-584.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Opioid receptors and their interacting proteins. Neuromolecular Medicine, 7, pp. 51-59. (doi: 10.1385/NMM)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Wilson, S and Lopez-Gimenez, JF (2005) The specificity and molecular basis of alpha(1)-adrenoceptor and CXCR chemokine receptor dimerization. Journal of Molecular Neuroscience, 26, pp. 161-167. (doi: 10.1385/JMN/26)

Murdoch, H, Feng, GJ, Bachner, DB, Ormiston, L, White, JH, Richter, D and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Periplakin interferes with g protein activation by the melanin-concentrating hormone receptor-1 by binding to the proximal segment of the receptor C-terminal tail. Journal of Biological Chemistry, 280, pp. 8208-8220. (doi: 10.1074/jbc.M405215200)

Pascal, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) Functional complementation and the analysis of opioid receptor homodimerization. Molecular Pharmacology, 68, pp. 905-915. (doi: 10.1124/mol.105.013847)

Pediani, JD, Colston, JF, Caldwell, D, Milligan, G, Daly, CJ and McGrath, JC (2005) beta-arrestin-dependent spontaneous alpha(1a)-adrenoceptor endocytosis causes intracellular transportation of alpha-blockers via recycling compartments. Molecular Pharmacology, 67, pp. 992-1004. (doi: 10.1124/mol.104.008417)

Rudajev, V, Novotny, J, Hejnova, L, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Svoboda, P (2005) Dominant portion of thyrotropin-releasing hormone receptor is excluded from lipid domains. Detergent-resistant and detergent-sensitive pools of TRH receptor and G(q)alpha/G(11)alpha protein. Journal of Biochemistry, 138, pp. 111-125. (doi: 10.1093/jb/mvi114)

Ward, RJ and Milligan, G (2005) A key serine for the GTPase-activating protein function of regulator of G protein signaling proteins is not a general target for 14-3-3 interactions. Molecular Pharmacology, 68, pp. 1821-1830. (doi: 10.1124/moi.105.015073) (PMID:16160139)

Wilson, S, Wilkinson, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2005) The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. Journal of Biological Chemistry, 280, pp. 28663-28674. (doi: 10.1074/jbc.M413475200)

Milligan, G., Feng, G.J., Ward, R.J., Sartania, Nana ORCID logoORCID: https://orcid.org/0000-0002-3196-2312, Ramsay, D., McLean, A.J. and Carrillo, J.J. (2004) G protein-coupled receptor fusion proteins in drug discovery. Current Pharmaceutical Design, 10(17), pp. 1989-2001. (doi: 10.2174/1381612043384295) (PMID:15279540)

Bakker, RA, Dees, G, Carrillo, JJ, Booth, RG, Lopez-Gimenez, JF, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Strange, PG and Leurs, R (2004) Domain swapping in the human histamine H-1 receptor. Journal of Pharmacology and Experimental Therapeutics, 311, pp. 131-138. (doi: 10.1124/jpet.104.067041)

Carrillo, JJ, Lopez-Gimenez, JF and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) Multiple interactions between transmembrane helices generate the oligomeric alpha(1b)-adrenoceptor. Molecular Pharmacology, 66, pp. 1123-1137. (doi: 10.1124/mol.104.001586)

Heydorn, A, Ward, RJ, Jorgensen, R, Rosenkilde, MM, Frimurer, TM, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kostenis, E (2004) Identification of a novel site within G protein alpha subunits important for specificity of receptor-G protein interaction. Molecular Pharmacology, 66, pp. 250-259.

Holdsworth, G., Osborne, D.A., Thi Pham, T., Fells, J.I., Hutchinson, G., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Parrill, A.L. (2004) A single amino acid determines preference between phospholipids and reveals length restriction for activation ofthe S1P4 receptor. BMC Biochemistry, 5(12), (doi: 10.1186/1471-2091-5-12)

Klaasse, E, de Ligt, RAF, Roerink, SF, Lorenzen, A, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Leurs, R and IJzerman, AP (2004) Allosteric modulation and constitutive activity of fusion proteins between the adenosine A(1) receptor and different (351)Cys-mutated G(i) alpha-subunits. European Journal of Pharmacology, 499, pp. 91-98. (doi: 10.1016/j.ejphar.2004.07.108)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) Applications of bioluminescence- and fluorescence resonance energy transfer to drug discovery at G protein-coupled receptors. European Journal of Pharmaceutical Sciences, 21, pp. 397-405. (doi: 10.1016/j.ejps.2003.11.010)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) G protein-coupled receptor dimerization: Function and ligand pharmacology. Molecular Pharmacology, 66, pp. 1-7. (doi: 10.1124/mol.104.000497)

Milligan, G (2004) A single amino acid determines preference between phospholipids and reveals length restriction for activation ofthe S1P4 receptor. BMC Biochemistry, 5(12), pp. 1-12. (doi: 10.1186/1471-2091-5-12)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Lopez-Gimenez, J, Wilson, S and Carrillo, JJ (2004) Selectivity in the oligomerisation of G protein-coupled receptors. Seminars in Cell and Developmental Biology, 15, pp. 263-268. (doi: 10.1016/j.semcdb.2003.12.012)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Murdoch, H, Kellett, E, White, JH and Feng, GJ (2004) Interactions between G-protein-coupled receptors and periplakin: a selective means to regulate G-protein activation. Biochemical Society Transactions, 32, pp. 878-880.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Pascal, G and Carrillo, JJ (2004) Monitoring receptor dimerisation. Medicinal Chemistry Research, 13, pp. 18-24.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Pediani, J, Fidock, M and Lopez-Gimenez, JF (2004) Dimerization of alpha(1)-adrenoceptors. Biochemical Society Transactions, 32, pp. 847-850.

Moravcova, Z., Rudajev, V., Stohr, J., Novotny, J., Cerny, J., Parenti, M., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Svoboda, P. (2004) Long-term agonist stimulation of IP prostanoid receptor depletes the cognate G(s)alpha protein in membrane domains but does not change the receptor level. Biochimica et Biophysica Acta: Molecular Cell Research, 1691, pp. 51-65. (doi: 10.1016/j.bbamcr.2003.12.004)

Ramsay, D, Carr, IC, Pediani, J, Lopez-Gimenez, JF, Thurlow, R, Fidock, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) High-affinity interactions between human alpha(1A)-adrenoceptor C-terminal splice variants produce homo- and heterodimers but do not generate the alpha(1L)-adrenoceptor. Molecular Pharmacology, 66, pp. 228-239.

Ward, R.J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2004) Analysis of function of receptor-G-protein and receptor-RGS fusion proteins. Methods in Molecular Biology, 259, pp. 225-247. (PMID:15250496)

Adie, EJ, Francis, MJ, Davies, J, Smith, L, Marenghi, A, Hather, C, Hadingham, K, Michael, NP, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Gamel, S (2003) CypHer 5: A generic approach for measuring the activation and trafficking of G protein-coupled receptors in live cells. Assay and Drug Development Technologies, 1, pp. 251-259.

Bahia, Daljit S., Sartania, Nana ORCID logoORCID: https://orcid.org/0000-0002-3196-2312, Ward, Richard j., Cavalli, Antonella, Jones, Teresa L.Z., Druey, Kirk M. and Milligan, Graeme (2003) Concerted stimulation and deactivation of pertussis toxin-sensitive G proteins by chimeric G protein-coupled receptor-regulator of G protein signaling 4 fusion proteins: analysis of the contribution of palmitoylated cysteine residues to the GAP activity o. Journal of Neurochemistry, 85(5), pp. 1289-1298. (doi: 10.1046/j.1471-4159.2003.01769.x) (PMID:12753087)

Benians, A, Leaney, JL, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Tinker, A (2003) The dynamics of formation and action of the ternary complex revealed in living cells using a G-protein-gated K+ channel as a biosensor. Journal of Biological Chemistry, 278, pp. 10851-10858. (doi: 10.1074/jbc.M212299200)

Bertaso, F, Ward, RJ, Viard, P, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Dolphin, AC (2003) Mechanism of action of G(q) to inhibit G beta gamma modulation of Ca(v)2.2 calcium channels: Probed by the use of receptor-G alpha tandems. Molecular Pharmacology, 63, pp. 832-843.

Bourova, L, Kostrnova, A, Hejnova, L, Moravcova, Z, Moon, HE, Novotny, J, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Svoboda, P (2003) delta-Opioid receptors exhibit high efficiency when activating trimeric G proteins in membrane domains. Journal of Neurochemistry, 85, pp. 34-49. (doi: 10.1046/j.1471-4159.2003.01667.x)

Carrillo, JJ, Pediani, J and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Dimers of class A G protein-coupled receptors function via agonist-mediated trans-activation of associated G proteins. Journal of Biological Chemistry, 278, pp. 42578-42587. (doi: 10.1074/jbc.M306165200)

Derrien, A, Zheng, B, Osterhout, JL, Ma, YC, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Farquhar, MG and Druey, KM (2003) Src-mediated RGS16 tyrosine phosphorylation promotes RGS16 stability. Journal of Biological Chemistry, 278, pp. 16107-16116. (doi: 10.1074/jbc.M210371200)

Feng, GJ, Kellett, E, Scorer, CA, Wilde, J, White, JH and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Selective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activation. Journal of Biological Chemistry, 278, pp. 33400-33407. (doi: 10.1074/jbc.M305866200)

Hiol, A, Davey, PC, Osterhout, JL, Waheed, AA, Fischer, ER, Chen, CK, Milligan, G, Druey, KM and Jones, TLZ (2003) Palmitoylation regulates regulators of G-protein signaling (RGS) 16 function - I. Mutation of amino-terminal cysteine residues on RGS16 prevents its targeting to lipid rafts and palmitoylation of an internal cysteine residue. Journal of Biological Chemistry, 278, pp. 19301-19308. (doi: 10.1074/jbc.M210123200) (PMID:12642593)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Molecular Pharmacology, 64, pp. 1271-1276.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) High-content assays for ligand regulation of G-protein-coupled receptors. Drug Discovery Today, 8, pp. 579-585.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Mechanism of action of Gq to inhibit Gbg modulation of Cav2.2 calcium channls probed by use of receptor-Ga tandems. Molecular Pharmacology, 63(4), pp. 832-843. (doi: 10.1124/mol.63.4.832)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2003) Principles: Extending the utility of [S-35]GTP gamma S binding assays. Trends in Pharmacological Sciences, 24, pp. 87-90.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Ramsay, D, Pascal, G and Carrillo, JJ (2003) GPCR dimerisation. Life Sciences, 74, pp. 181-188. (doi: 10.1016/j.lfs.2003.09.005)

Osterhout, JL, Waheed, AA, Hiol, A, Ward, RJ, Davey, PC, Nini, L, Wang, J, Milligan, G, Jones, TLZ and Druey, KM (2003) Palmitoylation regulates regulator of G-protein signaling (RGS) 16 function - II. Palmitoylation of a cysteine residue in the RGS box is critical for RGS16 GTPase accelerating activity and regulation of G(i)-coupled signaling. Journal of Biological Chemistry, 278, pp. 19309-19316. (doi: 10.1074/jbc.M210124200) (PMID:12642592)

Zeng, FY, McLean, AJ, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Lerner, M, Chalmers, DT and Behan, DP (2003) Ligand specific up-regulation of a Renilla reniformis luciferase-tagged, structurally unstable muscarinic M-3 chimeric G protein-coupled receptor. Molecular Pharmacology, 64, pp. 1474-1484.

Adamson, P, Wilbourn, B, Etienne-Manneville, S, Calder, V, Beraud, E, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Couraud, PO and Greenwood, J (2002) Lymphocyte trafficking through the blood-brain barrier is dependent on endothelial cell heterotrimeric G-protein signaling. FASEB Journal, 16,

Adie, EJ, Kalinka, S, Smith, L, Francis, MJ, Marenghi, A, Cooper, ME, Briggs, M, Michael, NP, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Game, S (2002) A pH-sensitive fluor, CypHer (TM) 5, used to monitor agonist-induced g protein-coupled receptor internalization in live cells. Biotechniques, 33, pp. 1152-1157.

Carrillo, JJ, Stevens, PA and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Measurement of agonist-dependent and -independent signal initiation of alpha(1b)-adrenoceptor mutants by direct analysis of guanine nucleotide exchange on the G protein G alpha(11). Journal of Pharmacology and Experimental Therapeutics, 302, pp. 1080-1088. (doi: 10.1124/jpet.102.035501)

Feng, GJ, Cavalli, A and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Engineering a V-2 vasopressin receptor agonist- and regulator of G-protein-signaling-sensitive G protein. Analytical Biochemistry, 300, pp. 212-220. (doi: 10.1006/abio.2001.5448)

Liu, S, Carrillo, JJ, Pediani, JD and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Effective information transfer from the alpha(1b)-adrenoceptor to G alpha(11) requires both beta/gamma interactions and an aromatic group four amino acids from the C terminus of the G protein. Journal of Biological Chemistry, 277, pp. 25707-25714. (doi: 10.1074/jbc.M201015200)

Lyall, F, Lye, SJ, Teoh, TG, Cousins, F, Milligan, G and Robson, SC (2002) Expression of Gs alpha, connexin-43, connexin-26, and EP1, 3, and 4 receptors in myometrium of prelabor singleton versus multiple gestations and the effects of mechanical stretch and steroids on Gs alpha. Journal of the Society For Gynecologic Investigation, 9, pp. 299-307.

Massotte, D, Brillet, K, Kieffer, B and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Agonists activate G(i1)alpha or G(i2)alpha fused to the human mu opioid receptor differently. Journal of Neurochemistry, 81, pp. 1372-1382.

McLean, AJ, Zeng, FY, Behan, D, Chalmers, D and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Generation and analysis of constitutively active and physically destabilized mutants of the human beta(1)-adrenoceptor. Molecular Pharmacology, 62, pp. 747-755.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Construction and analysis of function of G protein-coupled receptor-G protein fusion proteins. G Protein Pathways, Pt A, Receptors, 343, pp. 260-273.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Strategies to identify ligands for orphan G-protein-coupled receptors. Biochemical Society Transactions, 30, pp. 789-793.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) The use of receptor G-protein fusion proteins for the study of ligand activity. Receptors and Channels, 8, pp. 309-317. (doi: 10.1080/10606820290005281)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Stevens, PA, Ramsay, D and McLean, AJ (2002) Ligand rescue of constitutively active mutant receptors. Neurosignals, 11, pp. 29-33.

Ramsay, Douglas, Kellett, Elaine, McVey, Mary ORCID logoORCID: https://orcid.org/0000-0003-3740-6023, Rees, Stephen and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less. Biochemical Journal, 365, pp. 429-440. (doi: 10.1042/BJ20020251)

Ward, RJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Reciprocal mutations of highly conserved residues in transmembrane helices 2 and 7 of the alpha(2A)-adrenoceptor restore agonist activation of G(i1 alpha). Cellular Signalling, 14, pp. 139-144.

Welsby, PJ, Carr, IC, Wilkinson, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Regulation of the avidity of ternary complexes containing the human 5-HT1A receptor by mutation of a receptor contact site on the interacting G protein alpha subunit. British Journal of Pharmacology, 137, pp. 345-352. (doi: 10.1038/sj.bjp.0704880)

Welsby, PJ, Kellett, E, Wilkinson, G and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2002) Enhanced detection of receptor constitutive activity in the presence of regulators of G protein signaling: Applications to the detection and analysis of inverse agonists and low-efficacy partial agonists. Molecular Pharmacology, 61, pp. 1211-1221.

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and White, Julia H. (2001) Protein-protein interactions at G-protein-coupled receptors. Trends in Pharmacological Sciences, 22(10), pp. 513-518. (doi: 10.1016/S0165-6147(00)01801-0)

Evans, NA, Groarke, DA, Warrack, J, Greenwood, CJ, Dodgson, K, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Wilson, S (2001) Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors. Journal of Neurochemistry, 77, pp. 476-485.

Fernandez-Fernandez, JM, Abogadie, FC, Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Delmas, P and Brown, DA (2001) Multiple pertussis toxin-sensitive G-proteins can couple receptors to GIRK channels in rat sympathetic neurons when expressed heterologously, but only native G(i)-proteins do so in situ. European Journal of Neuroscience, 14, pp. 283-292.

Groarke, DA, Drmota, T, Bahia, DS, Evans, NA, Wilson, S and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Analysis of the C-terminal tail of the rat thyrotropin-releasing hormone receptor-1 in interactions and cointernalization with beta-arrestin 1-green fluorescent protein. Molecular Pharmacology, 59, pp. 375-385.

Hoffmann, M, Ward, RJ, Cavalli, A, Carr, IC and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Differential capacities of the RGS1, RGS16 and RGS-GAIP regulators of G protein signaling to enhance alpha(2A)-adrenoreceptor agonist-stimulated GTPase activity of G(o1)alpha. Journal of Neurochemistry, 78, pp. 797-806.

McVey, M, Ramsay, D, Kellett, E, Rees, S, Wilson, S, Pope, AJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Monitoring receptor oligomerization using time-resolved fluorescence resonance energy transfer and bioluminescence resonance energy transfer - The human delta-opioid receptor displays constitutive oligomerization at the cell surface, which is not regulate. Journal of Biological Chemistry, 276, pp. 14092-14099.

Millan, M. et al. (2001) Antiparkinsonian agent piribedil displays antagonist properties at native, rat, and cloned, human alpha(2)-adrenoceptors: Cellular and functional characterization. Journal of Pharmacology and Experimental Therapeutics, 297, pp. 876-887.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) The human d opioid receptor activates Gi1a more efficiently than Go1a. Journal of Neurochemistry, 76(6), pp. 1805-1813. (doi: 10.1046/j.1471-4159.2001.00196.x)

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Oligomerisation of G-protein-coupled receptors. Journal of Cell Science, 114, pp. 1265-1271.

Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Kellett, E, Dacquet, C, Dubreuil, V, Jacoby, E, Millan, MJ, Lavielle, G and Spedding, M (2001) S 14506: novel receptor coupling at 5-HT1A receptors. Neuropharmacology, 40, pp. 334-344.

Moon, HE, Bahia, DS, Cavalli, A, Hoffmann, M and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Control of the efficiency of agonist-induced information transfer and stability of the ternary complex containing the delta opioid receptor and the alpha subunit of G(i1) by mutation of a receptor/G protein contact interface. Neuropharmacology, 41, pp. 321-330.

Moon, HE, Cavalli, A, Bahia, DS, Hoffmann, M, Massotte, D and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) The human delta opioid receptor activates G(i1)alpha more efficiently than G(o1)alpha. Journal of Neurochemistry, 76, pp. 1805-1813.

Ramsay, D, Bevan, N, Rees, S and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Detection of receptor ligands by monitoring selective stabilization of a Renilla luciferase-tagged, constitutively active mutant, G-protein-coupled receptor. British Journal of Pharmacology, 133, pp. 315-323.

Stevens, PA, Pediani, J, Carrillo, JJ and Milligan, G ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2001) Coordinated agonist regulation of receptor and G protein palmitoylation and functional rescue of palmitoylation-deficient mutants of the G protein G(11)alpha following fusion to the alpha(1b)-adrenoreceptor - Palmitoylation of G(11 alpha) is not required. Journal of Biological Chemistry, 276, pp. 35883-35890.

Daly, C.J. ORCID logoORCID: https://orcid.org/0000-0002-0410-7548, Milligan, C.M., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Mackenzie, J.F. and McGrath, J.C. ORCID logoORCID: https://orcid.org/0000-0002-5276-0381 (1998) Cellular localization and pharmacological characterization of functioning alpha-1 adrenoceptors by fluorescent ligand binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors. Journal of Pharmacology and Experimental Therapeutics, 286(2), pp. 984-990.

Ross, Brian M., McLaughlin, Mark ORCID logoORCID: https://orcid.org/0000-0001-5317-2090, Roberts, Margaret, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, McCulloch, James and Knowler, John T. (1993) Alterations in the activity of adenylate cyclase and high affinity GTPase in Alzheimer's disease. Brain Research, 622(1-2), pp. 35-42. (doi: 10.1016/0006-8993(93)90798-R) (PMID:8242380)

McLaughlin, Mark ORCID logoORCID: https://orcid.org/0000-0001-5317-2090, Ross, Brian M., Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, McCulloch, James and Knowler, John T. (1991) Robustness of G proteins in Alzheimer's disease: an immunoblot study. Journal of Neurochemistry, 57(1), pp. 9-14. (doi: 10.1111/j.1471-4159.1991.tb02092.x) (PMID:1904911)

Pyne, N.J., Anderson, N., Lavan, B.E., Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Nimmo, H.G. ORCID logoORCID: https://orcid.org/0000-0003-1389-7147 and Houslay, M.D. (1987) Specific antibodies and the selective inhibitor ICI 118233 demonstrate that the hormonally stimulated 'dense-vesicle' and peripheral-plasma-membrane cyclic AMP phosphodiesterases display distinct tissue distributions in the rat. Biochemical Journal, 248(3), pp. 897-901. (doi: 10.1042/bj2480897) (PMID:2829845) (PMCID:PMC1148634)

Book Sections

Ward, Richard J., Marsango, Sara, Pediani, John D. ORCID logoORCID: https://orcid.org/0000-0001-6615-537X and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2017) The use of spatial intensity distribution analysis to examine G protein-coupled receptor oligomerization. In: Herrick-Davis, Katharine, Milligan, Graeme and Di Giovanni, Giuseppe (eds.) G-Protein-Coupled Receptor Dimers. Series: Receptors (33). Humana Press: Cham, pp. 15-38. ISBN 9783319601724 (doi: 10.1007/978-3-319-60174-8_2)

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519, Bolognini, Daniele and Sergeev, Eugenia ORCID logoORCID: https://orcid.org/0000-0001-8271-3693 (2017) Ligands at the free fatty acid receptors 2/3 (GPR43/GPR41). In: Milligan, Graeme and Kimura, Ikuo (eds.) Free Fatty Acid Receptors. Series: Handbook of experimental pharmacology (236). Springer International Publishing, pp. 17-32. ISBN 9783319506920 (doi: 10.1007/164_2016_49)

Alvarez-Curto, Elisa ORCID logoORCID: https://orcid.org/0000-0003-4004-4545 and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Defining the functional equivalence of wild-type and chemically engineered G protein-coupled receptors. In: Thiel, Gerald (ed.) Designer Receptors Exclusively Activated by Designer Drugs. Series: Neuromethods (108). Springer New York, pp. 1-28. ISBN 9781493929436 (doi: 10.1007/978-1-4939-2944-3_1)

Marsango, Sara, Varela, María José and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2015) Approaches to characterize and quantify oligomerization of GPCRs. In: Filizola, Marta (ed.) G Protein-Coupled Receptors in Drug Discovery. Series: Methods in Molecular Biology, 1335 (1335). Springer New York, pp. 95-105. ISBN 9781493929139 (doi: 10.1007/978-1-4939-2914-6_7)

Hudson, B.D. ORCID logoORCID: https://orcid.org/0000-0001-7059-0091, Smith, N.J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors. In: Neubig, R.R. (ed.) Pharmacology of G Protein Coupled Receptors. Series: Advances in Pharmacology (62). Elsevier Academic Press: Amsterdam, The Netherlands, pp. 175-218. ISBN 9780123859525 (doi: 10.1016/B978-0-12-385952-5.00006-3)

Saenz del Burgo, L. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2011) Ligand regulation of GPCR quaternary structure. In: Giraldo, J. and Pin, J.-P. (eds.) G Protein-Coupled Receptors: From Structure to Function G Protein-Coupled Receptors: From Structure to Function. Series: RSC drug discovery (8). RSC Publishing: Cambridge, UK, pp. 111-152. ISBN 9781849733441 (doi: 10.1039/9781849733441-00111)

Appelbe, Shirley and Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2009) Hetero‐Oligomerization of Chemokine Receptors. In: Chemokines, Part B. Series: Methods in Enzymology., 461. Academic Press, pp. 207-225. ISBN 9780123749079 (doi: 10.1016/S0076-6879(09)05410-X)

Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Vanderbauwhede, W. ORCID logoORCID: https://orcid.org/0000-0001-6768-0037 (2007) Implementation of finite state machines on a reconfigurable device. In: Arslan, T. (ed.) Second NASA/ESA Conference on Adaptive Hardware and Systems (AHS 2007), 5-8 Aug. 2007, Edinburgh, UK. IEEE Computer Society: Los Alamitos, USA, pp. 386-396. ISBN 9780769528663 (doi: 10.1109/AHS.2007.64)

Book Reviews

Stoddart, L. A., Smith, N. J. and Milligan, G. ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 (2008) International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions. Pharmacological Reviews, 60(4), pp. 405-417. (doi: 10.1124/pr.108.00802)[Book Review]

Edited Books

Herrick-Davis, Katharine, Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Di Giovanni, Giuseppe (Eds.) (2017) G-Protein-Coupled Receptor Dimers. Series: Receptors. Humana Press: Cham. ISBN 9783319601724

Milligan, Graeme ORCID logoORCID: https://orcid.org/0000-0002-6946-3519 and Kimura, Ikuo (Eds.) (2017) Free Fatty Acid Receptors. Series: Handbook of experimental pharmacology. Springer International Publishing. ISBN 9783319506920

Patents

MX PA/A/2005/012546 (2011) Materials and Methods Relating to G-Protein Coupled Oligomers. .

US 10/555,709 (2011) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

US 12/119,401 (2011) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

CN 200480017258.7 (2011) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

TW 093114280 (2011) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

US 09/913, 762 (2011) Receptor Assay. .

PA/A/2005/012546 (2010) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

10/555709 (2008) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

093114280 (2004) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

60/472025 (2003) Materials and Methods Relating to G-Protein Coupled Receptor Oligomers. .

This list was generated on Sun Jun 15 03:29:00 2025 BST.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • A novel paradigm of intracrine fatty acid receptor signalling at lipid droplets: implications for adipocyte physiology and metabolic disease
    Medical Research Council
    2024 - 2027
     
  • GPR35: mechanisms of action and is agonism a potential therapeutic strategy for non-alcoholic fatty liver diseases
    Medical Research Council
    2023 - 2025
     
  • Novel roles of the short chain fatty acid receptors FFA2 and FFA3
    Biotechnology and Biological Sciences Research Council
    2022 - 2025
     
  • ONCORNET 2.0
    European Commission
    2020 - 2024
     
  • Molecular and patho-physiological analysis of the G protein-coupled receptor GPR84
    Nxera Pharma UK Limited
    2020 - 2024
     
  • Inhibitory G protein S-acylation as a therapeutic target in heart failure
    British Heart Foundation
    2019 - 2022
     
  • Defining physiological and pathophysiological roles of the Free Fatty Acid Receptor 2 by analysis of novel transgenic mouse models
    Biotechnology and Biological Sciences Research Council (BBSRC)
    2018 - 2021
     
  • BBSRC IAA application
    Biotechnology and Biological Sciences Research Council
    2018 - 2021
     
  • Proximity to Discovery (P2D): Industry Engagement Fund 2018
    Medical Research Council
    2018 - 2019
     
  • Defining the functional modes of action, and therapeutic potential of targeting, the free fatty acid receptor FFA4 in the lung
    Medical Research Council
    2018 - 2020
     
  • Defining signal selection from the free fatty acid receptor FFA4; implications for
    Biotechnology and Biological Sciences Research Council
    2017 - 2021
     
  • Defining the functional roles of the enigmatic G protein coupled receptor GPR35
    Biotechnology and Biological Sciences Research Council
    2017 - 2021
     
  • Functional analysis of insect neuropeptide G protein-coupled receptors
    Biotechnology and Biological Sciences Research Council
    2017 - 2020
     
  • GRACE II: new horizons and consolidation
    Medical Research Council
    2017 - 2018
     
  • Glasgow Research Accelerator Collaborative Exchange (GRACE) - translating research excellence to realise solutions.
    Medical Research Council
    2015 - 2017
     
  • ONCORNET
    European Commission
    2015 - 2018
     
  • Designer Receptor Exclusively Activated by Designer Drug' to define the role of short chain fatty acids in metabolic disease and inflammation (Fatty acid DREADD)
    Biotechnology and Biological Sciences Research Council
    2014 - 2014
     
  • The organisational structure of class A GPCRs: Implications for pharmacology, function and therapeutic regulation
    Medical Research Council
    2014 - 2019
     
  • Production of pan-species antagonists and validation of GPR43 as an ant-inflammatory and anti-diabetic target
    Scottish Universities Life Sciences Alliance
    2014 - 2015
     
  • Angiotensin-(1-7) and angiotensin-(1-9): assessment as therapeutic targets in acute vascular injury and remodelling.
    Medical Research Council
    2014 - 2017
     
  • BHF centre of excellence
    British Heart Foundation
    2014 - 2019
     
  • Red blood cell programme
    Scottish Enterprise
    2013 - 2016
     
  • GPR120: a G protein-coupled receptor with the potential to regulate insulin secretion and inflammation
    Biotechnology and Biological Sciences Research Council
    2013 - 2017
     
  • FFARMED - The molecular effects of food on metabolic diseases through nutrient sensing free fatty acid receptors
    Danish Agency for Science, Technology and Innovation
    2012 - 2017
     
  • Characterisation of T16, a novel stem cell survival compound (ISSF Catalyst Fund)
    Wellcome Trust
    2011 - 2014
     
  • Identification of novel FFA1 and GPR120 ligands and their use in elucidating the pharmacology, function, and clinical utility of these receptors in the treatment of obesity and diabetes
    Canadian Institutes of Health Research
    2011 - 2014
     
  • Red blood cell programme
    Scottish Funding Council
    2011 - 2016
     
  • Developing selective ligands for Free Fatty Acid Receptor 2 with novel pharmacological propertiesrn
    Wellcome Trust
    2010 - 2013
     
  • Dissecting the mechanism of action of the novel renin angiotensin hormone angiotensin1-9
    Medical Research Council
    2010 - 2013
     
  • Wellcome VIP award
    Wellcome Trust
    2010 - 2010
     
  • The organisational structure of class A GPCRs: implications for function and drug design
    Medical Research Council
    2009 - 2014
     
  • Interrogation and manipulation of micro RNA during differentiation of human ES cells to cardiomyocyte and vascular lineages
    British Heart Foundation
    2009 - 2013
     
  • Molecular basis of the functional regulation of mu opioid receptors by co-expressed Gq/G11-coupled GPCRs
    Biotechnology and Biological Sciences Research Council
    2008 - 2011
     
  • Uncovering the pharmacology of the G-protein coupled reception GPR40
    Biotechnology and Biological Sciences Research Council
    2008 - 2011
     
  • Regulation of bone metabolism by cannabinoid receptors: mechanisms of action and implications for the treatment of bone disease
    Arthritis Research Campaign
    2008 - 2008
     
  • Exploring the selectivity and consequences of GPCR homo and hetero dimerisation/oligomerisation using receptors activated solely by ......
    Biotechnology and Biological Sciences Research Council
    2007 - 2010
     
  • The molecular basis of cannabinoid CB1 receptor regulation of the sensitivity of orexin-1 receptor signalling
    Biotechnology and Biological Sciences Research Council
    2005 - 2009
     
  • The existence and functional importance of interactions between opiod receptors and the CXCR1/2 chemokine receptors
    Wellcome Trust
    2005 - 2008
     
  • Protein interactions and compartmentalisation in cell signalling
    Medical Research Council
    2005 - 2008
     
  • The quaternary structure of G-protein coupled receptors - implications for function and drug design.
    Medical Research Council
    2004 - 2009
     
  • Mechanisms and basis of G protein-indepedent signal transduction by the orexin-1 receptor
    Wellcome Trust
    2004 - 2007
     
  • H1R Signalling and Immune Deviation in EAE
    National Institutes of Health
    2003 - 2005
     
  • Subcellular compartmentalisation analysis by confocal microscopy
    Biotechnology and Biological Sciences Research Council
    2003 - 2007
     
  • The interactions between G11 alpha and regulators of G protein signalling and the mechanisms of receptor dimerisation monitored by single..
    Wellcome Trust
    2003 - 2006
     
  • Post transitional modification and the function of regulator of G protien signalling
    Biotechnology and Biological Sciences Research Council
    2003 - 2006
     
  • The specificity and basis of GPRC hetero-oligomerisation
    Biotechnology and Biological Sciences Research Council
    2003 - 2006
     

Supervision

  • Gibson, Katharine
    Investigation of the spreading of disease causing misfolded protein in neurodegenerative disease
  • Yin, Ruijing
    function and regulation of GPR84

Additional information

Editorial Board

  • 2015 - present: Pharmacological Reviews
  • 2004 - present: BMC Cell Biology
  • 1996 - 1999: British Journal of Pharmacology
  • 1995 - present: Molecular Pharmacology
  • 1995 - 2002: Biochemical Journal
  • 1989 - 2002: Biochemical Pharmacology

Grant Advisory Board

  • 2010 - present: Anchor Therapeutics - Member of Scientific Advisory Board (http://www.anchortx.com/)
  • 2007 - 2011: Heptares Therapeutics Limited - Member of Scientific Advisory Board. http://www.heptares.com/
  • 2006 - present: Faculty of 1000 - Section Head 'Molecular Pharmacology'
  • 2005 - present: IUPHAR - Member Nomenclature committee; GPCR dimer committee
  • 2005 - present: Cara Therapeutics - Member of Scientific Advisory Board. http://www.caratherapeutics.com/
  • 2004 - present: MRC - Member of College of Experts, Molecular and Cellular Medicine Board.
  • 2003 - present: Caledonian Research Foundation - Biomedical Research Fellowship Committee for the RSE
  • 2001 - 2004: Wellcome Trust - Physiology & Pharmacology Panel
  • 1998 - 2004: MRC - Advisory Board
  • 1995 - 1998: MRC - PMIB "A"

Invited International Presentations

  • 2017: Barga, Italy - Molecular Pharmacology 'Gordon Conference': GPCRs - 'From Single Molecules to New Forms of Treatment'.
  • 2016: London, UK - Pharmacology 2016
  • 2016: Melbourne, Australia - ASCEPT/MPGPCR meeting, British Pharmacological Society
  • 2016: Berlin, Germany - European Pharma Summit: 3rd GPCR Targeted Screening meeting, Keynote presentation
  • 2016: Leicester, UK - BPS 6th Cell Signalling Meeting
  • 2016: University of Liege, Belgium
  • 2016: Keystone, Colorado, USA - Keystone Symposium: 'G Protein-Coupled Receptors: Structure, Signaling and Drug Discovery'.
  • 2015: Amsterdam, The Netherlands - ONCORNET initial meeting
  • 2015: Bonn, Germany - German Society for Pharmacology
  • 2015: Sweden - Astra-Zeneca
  • 2015: Milwaukee, Wisconsin - International Two-photon Microscopy Symposium
  • 2015: Glasgow, UK - International Society for Advancement of Cytometry. Keynote 'State of the Art' lecture.
  • 2015: Tartu, Estonia - European Society for Neurochemistry. 'Signal transduction models in CNS - from calculations to in vivo assay.'
  • 2015: Tokyo, Japan - 12th GPCR research meeting
  • 2015: Tokyo, Japan - Tokyo University of Agriculture and Technology
  • 2015: Berlin, Germany - 'GPCR Targeted Screening' - Keynote Speaker
  • 2015: Allschwill, Switzerland - GLISTEN GPCR meeting, Actelion Pharmaceuticals
  • 2014: Braine-L'Alleud, Belgium - SRC/KVCV Medchem 2014
  • 2014: Braine-L'Alleud, Belgium - UCB
  • 2014: Dijon, France - ECRO (European Chemoreception Research Organisation) meeting
  • 2014: Leiden, The Netherlands - GPCR Lorentz workshop 'Exploring the biology of GPCRs'
  • 2014: Mopani Lodge, Kruger National Park, South Africa - 9th Adrenoceptor/GPCR James Black Conference
  • 2014: University of Bonn, Germany
  • 2014: Leicester, UK - BPS 5th Cell Signalling Meeting
  • 2014: Berlin, Germany - Drug Discovery Innovations
  • 2014: Molndal, Sweden - Astra-Zeneca, GLAZgo Discovery Centre Inaugral meeting.
  • 2013: Aachen, Germany - Grunenthal GmbH
  • 2013: Molndal, Sweden - Astra-Zeneca, Symposium: Maximizing success in GPCRs.
  • 2013: The Netherlands - University of Utrecht Medical Centre
  • 2013: Amsterdam, The Netherlands - The 'Nauta' awards symposium
  • 2013: San Francisco, CA, USA - The Endocrine Society, Plenary Lecture: 'The year in GPCRs'.
  • 2013: San Francisco, CA, USA - The Endocrine Society, Keynote Lecture, G protein-coupled receptor forum: 'New light on GPCRs in the pathophysiology of diabetes and metabolic disorders'.
  • 2013: Paris, France - Galapagos
  • 2013: S'Agaro, Spain - Esteve Foundation Discussion Group
  • 2013: Barga, Italy - Molecular Pharmacology 'Gordon Research Conference'.
  • 2013: Boston, MA, USA - 4th GPCR Colloquium, Boston
  • 2013: Boston, MA, USA - American Society for Experimental Pharmacology and Therapeutics and British Society of Pharmacology Symposium at Experimental Biology 2013.
  • 2013: Milwaukee, Wisconsin, USA - National Science Foundation-PFI workshop 'Innovation in Two-Photon Microscopy'
  • 2013: Berlin, Germany - Drug Discovery Innovations
  • 2013: Berlin, Germany - Symposium: 'Exploring New Avenues for Small Molecule Drug Discovery'.
  • 2012: Molndal, Sweden - Astra Zeneca
  • 2012: Wurzburg, Germany - GPCR meeting
  • 2012: Bratislava, Slovakia - European Association for Animal Production (EAAP) 2012 Conference
  • 2012: Edinburgh, UK - Physiological Society Meeting, FFARmacology in diabetes – an emerging picture for the free fatty acid receptor family in disease
  • 2012: La Jolla, CA, USA - Johnson and Johnson
  • 2012: San Diego, CA, USA - American Society for Experimental Pharmacology and Therapeutics, symposium at Experimental Biology 2012
  • 2012: Paris, France - Servier
  • 2012: Berlin, Germany - 10th Annual Informa Life Sciences GPCR meeting
  • 2011: Milwaukee, USA - UW-Milwaukee Workshop on Fluorescence Microspectroscopy
  • 2011: Lunteren, The Netherlands - Dutch GPCR club
  • 2011: Washington, DC, USA - American Society for Experimental Pharmacology and Therapeutics
  • 2011: Indianapolis, IN, USA - Lilly Research Laboratories
  • 2011: Istanbul, Turkey - EHPAR symposium at Turkish Pharmacological Society meeting
  • 2011: Istanbul, Turkey - EHPAR symposium at Turkish Pharmacological Society meeting
  • 2011: Ventura, CA USA - Gordon Research Conference 'Molecular Pharmacology'
  • 2011: Indianapolis, IN, USA - Lilly Research Laboratories
  • 2011: Bonn, Germany - 'Integrated Pharmacology: Signaling from Cells to Systems'
  • 2011: Washington DC, USA - American Society for Experimental Pharmacology and Therapeutics, symposium at Experimental Biology
  • 2011: Manchester, UK - 5th ELRIG Drug Discovery meeting
  • 2011: Istanbul, Turkey - EHPAR symposium
  • 2011: Berlin, Germany - 9th Annual IIR GPCR meeting, Keynote presentation
  • 2010: Montreux Switzerland - 2nd Annual GPCRs Congress
  • 2010: Helsinki, Finland - GPCRs 2010
  • 2010: Boston, MA, USA - 2010 Pepducin Science Symposium
  • 2010: Uppsala University, Sweden - The Svedberg Lecture Series
  • 2010: Barcelona, Spain - Screening Europe 2010, 'Keynote' lecture 'What are the right assays to select?'
  • 2010: Boston, MA, USA - GPCR-based Drug Discovery: Designing and Optimizing Therapies Targeting GPCRs
  • 2010: Nottingham, UK - Systems biology of GPCR signalling' - Plenary Lecture
  • 2010: Toronto, Canada - 11th annual Great Lakes GPCR retreat, Keynote Address: The Hyman Niznik Memorial Lecture
  • 2010: Berlin, Germany - Keynote Presentation: 8th Annual 'G Protein-Coupled Receptors in Drug Discovery' meeting. 'Cutting edge developments in GPCR science and their impact on drug discovery'
  • 2009: Wuerzburg, Germany - GPCR dimerisation meeting
  • 2009: Boston, MA, USA - Keynote presentation, Cambridge Healthtech Institute 'Discovery on Target' GPCR-based drug discovery
  • 2009: Leicester, U.K. - 3rd British Pharmacological Society Focused Meeting on Cell Signalling
  • 2009: Lille, France - Society for Biomolecular Sciences, Bioassay & Technology Innovation: 15 Years of Shaping Drug Discovery
  • 2009: Lille, France - Programme Chair, GPCR Drug Discovery Symposium
  • 2009: GSK, Stevenage, UK - Biochemical Society Focused meeting 'Revolutionising Drug Discovery with Stem Cell Technology'
  • 2009: Noordwijkerhout, Holland - Programme Chair, Noordwijkerhout Camerino-Cyprus Symposium 'Trends in Drug Research'
  • 2009: Barcelona, Spain - 7th IBC/IIR Annual GPCR meeting
  • 2009: Barcelona, Spain - Chairperson of the 7th Annual Congress: G Protein-Coupled Receptors in Drug Discovery. Keynote presentation, 'Orthosteric and allosteric control of the free fatty acid receptors FFA2 and FFA3',
  • 2009: Barga, Italy - Programme Chair, 'Gordon' Conference, Molecular Pharmacology
  • 2009: Graz, Austria - Austrian Pharmacological Society, The EPHAR lecture.
  • 2009: Portland, USA - Programme Chair, 35th International Narcotics Research Conference
  • 2008: San Diego, CA, USA - American Society of Pharmacology and Experimental Therapeutics (ASPET) 100th Anniversary meeting
  • 2008: Berlin, Germany - 6th Annual G protein-coupled receptors in drug discovery
  • 2008: Federation of European Pharmacological Societies (EPHAR),
  • 2008: Barcelona, Spain - European College of Neuropsychopharmacology
  • 2007: Lisbon, Portugal - Keynote Presentation IIR GPCR meeting
  • 2007: Leiden, Holland - University of Leiden
  • 2007: Boston, MA, USA - Genzyme
  • 2007: Southampton, England - Ferring Pharmaceuticals, Symposium on G-protein coupled receptors.
  • 2007: Biddeford, Maine, USA. - Gordon Research Conference on "Phosphorylation and G Protein Mediated Signaling Networks", University of New England
  • 2007: Barcelona, Spain - Keynote Presentation, 'Novel Assay Technologies for the Discovery of GPCR Drugs", Screening Europe Conference
  • 2007: Lexington, MA, USA - EPIX Pharmaceuticals
  • 2007: Glasgow, Scotland - LifeSciences 2007
  • 2007: Prague, Czech Republic. - 6th International Conference of the Czech Neuroscience Society
  • 2007: Melbourne, Australia - Molecular pharmacology of G protein-coupled receptors
  • 2007: Leicester, England - British Society for Pharmacology, Cell Signalling meeting,
  • 2007: Ridgefield, CT, USA. - Boehringer Ingelheim
  • 2006: Las Vegas, Nevada, USA - Plenary Lecture, 11th IBC 'G protein coupled receptor meeting'.
  • 2006: Beijing, China - Speaker and Chair of the Symposium' Frontiers in G-Protein Coupled Receptor Research' - 15th International Union of Pharmacology (IUPHAR)
  • 2006: Biberach, Germany - Boehringer-Ingelheim
  • 2006: Keystone, CO, USA - Co-chair and co-organiser of Keystone Conference on G protein coupled receptors. Evolving concepts and drug discovery.
  • 2006: Glasgow, Scotland - 8th European Congress of Endocrinology,
  • 2006: La Jolla, CA, USA - Plenary Lecture - CHI Drug Discovery Chemistry, G protein coupled receptor drug discovery
  • 2006: Sarasota, FL, USA - Association for Chemoreception Sciences.
  • 2006: Istanbul, Turkey - Plenary lecture: 19th International Symposium on Medicinal Chemistry
  • 2006: Santiago de Compostela, Spain - Plenary Lecture Spanish Society of Pharmacology
  • 2006: Oss, The Netherlands - Organon plc.
  • 2006: Fort Lauderdale, FL, USA - Association for Research in Vision and Ophthalmology, 'Rhodopsin, advances and perspectives'.
  • 2006: Stockholm, Sweden - Nordic GPCR meeting 'G protein-coupled receptors-From molecular aspects to novel therapy'. Karolinska Institute, Nobel Forum
  • 2006: Lunteren, The Netherlands - Ariens Award Lecture, Dutch Pharmacological Society
  • 2006: Barcelona, Spain - Plenary Lecture at 4th IIR Annual GPCR Congress.
  • 2006: Berlin, Germany - Ernst Schering Foundation Symposium on 'G protein-coupled receptors: from deorphanisation to lead structure identification'.
  • 2006: Frankfurt, Germany - Plenary Lecture at GDCh medicinal chemistry meeting.
  • 2005: Boston, MA, USA - 'The Health of Nations'. Scotland and America-defining Life Science Partnerships. 'Tartan Day' 2005
  • 2005: Amsterdam, Holland - Plenary Lecture at 3rd Annual European Conference on G Protein Coupled Receptors in Drug Discovery
  • 2005: Washington DC, USA - PharmaDiscovery, Washington DC Convention Centre
  • 2005: Philadelphia PA, USA - Merck GPCR symposium 'GPCR dimerization: implications for pharmacology and function'
  • 2005: Leicester, UK - Plenary Lecture, BPS 'Cell Signalling meeting'
  • 2005: Washington DC Convention Centre, Washington DC, USA - PharmaDiscovery 2005
  • 2005: Hilton Waikoloa Village, Waikoloa, Hawaii, USA - 44th Annual American College of Neuropsychopharmacology meeting.
  • 2005: Bellvue, Washington State, USA - Plenary Lecture at 10th IBC G protein-coupled receptor meeting.
  • 2005: Amsterdam, Holland - 3rd Annual European Conference on G Protein Coupled Receptors in Drug Discovery
  • 2004: Kyoto, Japan. - 2nd International Pharmaceutical Sciences World Congress, 'The global translation of science into drug development in advancing therapy'
  • 2004: University of Freiberg, Germany.
  • 2004: Frankfurt, Germany. - 16th Friedrich Merz Guest Professorship Symposium. GPCRs as targets for the treatment of CNS diseases.
  • 2004: Stockholm, Sweden. - International Wenner-Gren Symposium 'Receptor-receptor interactions among heptaspanning membrane receptors: From structure to function'
  • 2004: Organon plc Newhouse, UK. - Biochemical Society 'Allosterism & GPCR accessory proteins: new insights into drug discovery'
  • 2004: Glasgow, UK. - BioScience 2004. From molecules to organisms.
  • 2004: Copenhagen, Denmark. - 18th International Symposium on Medicinal Chemistry.
  • 2004: Taos, New Mexico, USA. - Keystone Conference on G protein coupled receptors.
  • 2004: San Diego, CA, USA - Plenary Lecture, 9th IBC International G-protein coupled receptors conference
  • 2004: Genentech, San Francisco, CA, USA.
  • 2004: Amsterdam, The Netherlands. - 2nd annual IIR conference on G Protein Coupled Receptors in Drug Discovery.
  • 2004: Aventis plc, Tucson, Arizona, USA
  • 2004: American Chemical Society, Anaheim, CA, USA.
  • 2004: London, UK. - G protein coupled receptors, New approaches to maximise the impact of GPCRs in drug discovery.
  • 2004: Novasite, San Diego, CA, USA.
  • 2003: Hinxton Hall, Cambridge, UK. - Recent advances in protein kinase and G protein coupled receptor drug discovery.
  • 2003: Almirall Prodesfarma, Barcelona.
  • 2003: Free University of Amsterdam, Amsterdam, The Netherlands.
  • 2003: Prague, Czech Republic. - 16th European College of Neuropsychopharmacology
  • 2003: Cologne, Germany. - Cellular Assay Technologies GPCR's * Kinases * Ion Channels * Nuclear Receptors.
  • 2003: Boston, MA, USA. - 8th Annual IBC International Conference on 'G protein-coupled receptors'
  • 2003: Camerino, Italy. - 14th Camerino-Noordwijkerhout Symposium
  • 2003: Institute of Physiology, Czech Acamedy of Sciences, Prague, Czech Republic.
  • 2003: Perpignan, France. - International Narcotics Research Conference.
  • 2003: San Diego, CA, USA. - Experimental Biology
  • 2003: Fukui, Japan. - 4th International Symposium on receptor mechanisms.
  • 2003: Strasbourg, France. - G protein coupled receptors in Drug Discovery
  • 2003: Zurich, Switzerland. - Smart Assays for Screening
  • 2002: Aventis PLC, Frankfurt, Germany.
  • 2002: Cambridge, UK. - 1st British Pharmacological Society
  • 2002: Axaron, Heidelberg, Germany
  • 2002: San Diego, CA, USA. - 7th Annual IBC International Conference on G protein-coupled receptors.
  • 2002: Charles University, Prague, Czech Republic.
  • 2002: University of Melbourne, Melbourne, Australia. - Molecular pharmacology of G protein-coupled receptors. The Australasian Society for Clinical and Experimental Pharmacology and Toxocology.
  • 2002: S'Aguru, Spain. - Esteve Foundation meeting on "Inverse Agonism"
  • 2002: 7-TM Pharma, Copenhagen, Denmark.
  • 2002: Berlin Germany. - Assay Development: Developing successful assays and infrastructure for advanced screening in the drug discovery industry.
  • 2002: University of Hamburg, Germany.
  • 2001: Institute of Cellular Signalling, University of Nijmegen, The Netherlands.
  • 2001: Novasite Pharmaceuticals, San Diego CA, USA.
  • 2001: Scottsdale, AZ, USA - 6th Annual IBC International Conference on G protein-coupled receptors. New Insights and Drug Discoveries.
  • 2001: Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
  • 2001: Institute of Molecular and Cellular Biology, Singapore.
  • 2001: Instituto Cajal, Madrid, Spain.
  • 2001: Noordwijkerhout, Holland. - Noordwijkerhout-Camerino Symposium, "Trends in Drug Research"
  • 2001: Orlando FL, USA. - American Society for Pharmacology and Experimental Therapeutics (ASPET) symposium on
  • 2001: Vrije Universiteit, Amsterdam. The Netherlands. - The 1st NAUTA Prize Lecture.
  • 2001: Christchurch, New Zealand. - 34th International Congress of Physiological Sciences: From Molecule to Malady.
  • 2001: University of Western Australia, Perth, Australia
  • 2001: Utrecht, The Netherlands - Dutch G protein-coupled receptor symposium.
  • 2001: Western Australian Institute for Medical Research, Perth, Australia.
  • 2001: Athens, Greece. - "Demokritos"
  • 2001: Laboratory of Allergic Diseases, NIAID/NIH, Bethesda MD, USA

Prizes, Awards and Distinctions

  • 2006: Dutch Pharmacological Society 'Ariens' Prize
  • 2001: First Nauta Visiting Professor to the Vrije Universiteit Amsterdam
  • 1998: Poulsson Medal for Pharmacology, Norwegian Society of Pharmacology & Toxicology

Professional Learned Society

  • 1998 - present: Royal Society of Edinburgh - Fellow